
<html lang="en"     class="pb-page"  data-request-id="381f9678-e694-46c2-bc76-6ada3e0ca439"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.9b01100;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2019.62.issue-20;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Identification of 2,6-Disubstituted 3H-Imidazo[4,5-b]pyridines as Therapeutic Agents for Dysferlinopathies through Phenotypic Screening on Patient-Derived Induced Pluripotent Stem Cells" /></meta><meta name="dc.Creator" content="Hiroyuki  Takada" /></meta><meta name="dc.Creator" content="Akira  Kaieda" /></meta><meta name="dc.Creator" content="Michiko  Tawada" /></meta><meta name="dc.Creator" content="Tomoko  Nagino" /></meta><meta name="dc.Creator" content="Katsunori  Sasa" /></meta><meta name="dc.Creator" content="Tatsuo  Oikawa" /></meta><meta name="dc.Creator" content="Akiko  Oki" /></meta><meta name="dc.Creator" content="Tomoya  Sameshima" /></meta><meta name="dc.Creator" content="Kazumasa  Miyamoto" /></meta><meta name="dc.Creator" content="Makoto  Miyamoto" /></meta><meta name="dc.Creator" content="Yuko  Kokubu" /></meta><meta name="dc.Creator" content="Ryuichi  Tozawa" /></meta><meta name="dc.Creator" content="Hidetoshi  Sakurai" /></meta><meta name="dc.Creator" content="Bunnai  Saito" /></meta><meta name="dc.Description" content="Dysferlinopathies, which are muscular diseases caused by mutations in the dysferlin gene, remain serious medical problems due to the lack of therapeutic agents. Herein, we report the design, synthe..." /></meta><meta name="Description" content="Dysferlinopathies, which are muscular diseases caused by mutations in the dysferlin gene, remain serious medical problems due to the lack of therapeutic agents. Herein, we report the design, synthe..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 24, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01100" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01100" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01100" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01100" /></link>
        
    
    

<title>Identification of 2,6-Disubstituted 3H-Imidazo[4,5-b]pyridines as Therapeutic Agents for Dysferlinopathies through Phenotypic Screening on Patient-Derived Induced Pluripotent Stem Cells | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01100" /></meta><meta property="og:title" content="Identification of 2,6-Disubstituted 3H-Imidazo[4,5-b]pyridines as Therapeutic Agents for Dysferlinopathies through Phenotypic Screening on Patient-Derived Induced Pluripotent Stem Cells" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/large/jm9b01100_0014.jpeg" /></meta><meta property="og:description" content="Dysferlinopathies, which are muscular diseases caused by mutations in the dysferlin gene, remain serious medical problems due to the lack of therapeutic agents. Herein, we report the design, synthesis, and structure–activity relationships of a 2,6-disubstituted 3H-imidazo[4,5-b]pyridine series, which was identified from the phenotypic screening of chemicals that increase the level of dysferlin in myocytes differentiated from patient-derived induced pluripotent stem cells (iPSCs). Optimization studies with cell-based phenotypic assay led to the identification of a highly potent compound, 19, with dysferlin elevation effects at double-digit nanomolar concentrations. In addition, the molecular target of our chemical series was identified as tubulin, through a tubulin polymerization assay and a competitive binding assay using a photoaffinity labeling probe." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01100"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01100">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01100&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01100&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01100&amp;href=/doi/10.1021/acs.jmedchem.9b01100" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 20</span><span class="cit-fg-pageRange">, 9175-9187</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/20" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01079" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b01108" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Identification of 2,6-Disubstituted 3<i>H</i>-Imidazo[4,5-<i>b</i>]pyridines as Therapeutic Agents for Dysferlinopathies through Phenotypic Screening on Patient-Derived Induced Pluripotent Stem Cells</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Hiroyuki Takada</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hiroyuki Takada</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#8fe7e6fde0f6fae4e6a1fbeee4eeebeebecffbeee4eaebeea1ece0e2"><span class="__cf_email__" data-cfemail="deb6b7acb1a7abb5b7f0aabfb5bfbabfef9eaabfb5bbbabff0bdb1b3">[email protected]</span></a>. Phone: (+81)466-32-2076. Fax: (+81)466-29-4449.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hiroyuki++Takada">Hiroyuki Takada</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6650-7902" title="Orcid link">http://orcid.org/0000-0001-6650-7902</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Akira Kaieda</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Akira Kaieda</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Akira++Kaieda">Akira Kaieda</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1782-2345" title="Orcid link">http://orcid.org/0000-0003-1782-2345</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michiko Tawada</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michiko Tawada</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michiko++Tawada">Michiko Tawada</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tomoko Nagino</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tomoko Nagino</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">T-CiRA Discovery, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tomoko++Nagino">Tomoko Nagino</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Katsunori Sasa</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Katsunori Sasa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">T-CiRA Discovery, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Katsunori++Sasa">Katsunori Sasa</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tatsuo Oikawa</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tatsuo Oikawa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">T-CiRA Discovery, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tatsuo++Oikawa">Tatsuo Oikawa</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Akiko Oki</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Akiko Oki</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Akiko++Oki">Akiko Oki</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tomoya Sameshima</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tomoya Sameshima</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tomoya++Sameshima">Tomoya Sameshima</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3580-3095" title="Orcid link">http://orcid.org/0000-0002-3580-3095</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kazumasa Miyamoto</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kazumasa Miyamoto</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kazumasa++Miyamoto">Kazumasa Miyamoto</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Makoto Miyamoto</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Makoto Miyamoto</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Makoto++Miyamoto">Makoto Miyamoto</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yuko Kokubu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yuko Kokubu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for iPS Cell Research and Application, Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yuko++Kokubu">Yuko Kokubu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ryuichi Tozawa</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ryuichi Tozawa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">T-CiRA Discovery, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ryuichi++Tozawa">Ryuichi Tozawa</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hidetoshi Sakurai</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hidetoshi Sakurai</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for iPS Cell Research and Application, Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hidetoshi++Sakurai">Hidetoshi Sakurai</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Bunnai Saito</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bunnai Saito</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bunnai++Saito">Bunnai Saito</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01100&amp;href=/doi/10.1021%2Facs.jmedchem.9b01100" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 20</span><span class="cit-pageRange">, 9175–9187</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 24, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>8 July 2019</li><li><span class="item_label"><b>Published</b> online</span>24 September 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 October 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01100" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01100</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9175%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DHiroyuki%2BTakada%252C%2BAkira%2BKaieda%252C%2BMichiko%2BTawada%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D20%26contentID%3Dacs.jmedchem.9b01100%26title%3DIdentification%2Bof%2B2%252C6-Disubstituted%2B3H-Imidazo%255B4%252C5-b%255Dpyridines%2Bas%2BTherapeutic%2BAgents%2Bfor%2BDysferlinopathies%2Bthrough%2BPhenotypic%2BScreening%2Bon%2BPatient-Derived%2BInduced%2BPluripotent%2BStem%2BCells%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9187%26publicationDate%3DOctober%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01100"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1662</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">3</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01100" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Identification of 2,6-Disubstituted 3H-Imidazo[4,5-b]pyridines as Therapeutic Agents for Dysferlinopathies through Phenotypic Screening on Patient-Derived Induced Pluripotent Stem Cells&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Hiroyuki&quot;,&quot;last_name&quot;:&quot;Takada&quot;},{&quot;first_name&quot;:&quot;Akira&quot;,&quot;last_name&quot;:&quot;Kaieda&quot;},{&quot;first_name&quot;:&quot;Michiko&quot;,&quot;last_name&quot;:&quot;Tawada&quot;},{&quot;first_name&quot;:&quot;Tomoko&quot;,&quot;last_name&quot;:&quot;Nagino&quot;},{&quot;first_name&quot;:&quot;Katsunori&quot;,&quot;last_name&quot;:&quot;Sasa&quot;},{&quot;first_name&quot;:&quot;Tatsuo&quot;,&quot;last_name&quot;:&quot;Oikawa&quot;},{&quot;first_name&quot;:&quot;Akiko&quot;,&quot;last_name&quot;:&quot;Oki&quot;},{&quot;first_name&quot;:&quot;Tomoya&quot;,&quot;last_name&quot;:&quot;Sameshima&quot;},{&quot;first_name&quot;:&quot;Kazumasa&quot;,&quot;last_name&quot;:&quot;Miyamoto&quot;},{&quot;first_name&quot;:&quot;Makoto&quot;,&quot;last_name&quot;:&quot;Miyamoto&quot;},{&quot;first_name&quot;:&quot;Yuko&quot;,&quot;last_name&quot;:&quot;Kokubu&quot;},{&quot;first_name&quot;:&quot;Ryuichi&quot;,&quot;last_name&quot;:&quot;Tozawa&quot;},{&quot;first_name&quot;:&quot;Hidetoshi&quot;,&quot;last_name&quot;:&quot;Sakurai&quot;},{&quot;first_name&quot;:&quot;Bunnai&quot;,&quot;last_name&quot;:&quot;Saito&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;9175-9187&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01100&quot;},&quot;abstract&quot;:&quot;Dysferlinopathies, which are muscular diseases caused by mutations in the dysferlin gene, remain serious medical problems due to the lack of therapeutic agents. Herein, we report the design, synthesis, and structure–activity relationships of a 2,6-disubstituted 3H-imidazo[4,5-b]pyridine series, which was identified from the phenotypic screening of chemicals that increase the level of dysferlin in myocytes differentiated from patient-derived induced pluripotent stem cells (iPSCs). Optimization studies with cell-based phenotypic assay led to the identification of a highly potent compound, 19, with dysferlin elevation effects at double-digit nanomolar concentrations. In addition, the molecular target of our chemical series was identified as tubulin, through a tubulin polymerization assay and a competitive binding assay using a photoaffinity labeling probe.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01100&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01100" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01100&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01100" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01100&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01100" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01100&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01100&amp;href=/doi/10.1021/acs.jmedchem.9b01100" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01100" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01100" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01100%26sid%3Dliteratum%253Aachs%26pmid%3D31550153%26genre%3Darticle%26aulast%3DTakada%26date%3D2019%26atitle%3DIdentification%2Bof%2B2%252C6-Disubstituted%2B3H-Imidazo%255B4%252C5-b%255Dpyridines%2Bas%2BTherapeutic%2BAgents%2Bfor%2BDysferlinopathies%2Bthrough%2BPhenotypic%2BScreening%2Bon%2BPatient-Derived%2BInduced%2BPluripotent%2BStem%2BCells%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D20%26spage%3D9175%26epage%3D9187%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291011" title="High-performance liquid chromatography">High-performance liquid chromatography</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=291352" title="Screening assays">Screening assays</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/20" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/jmcmar.2019.62.issue-20/20191024/jmcmar.2019.62.issue-20.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/medium/jm9b01100_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/large/jm9b01100_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01100&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Dysferlinopathies, which are muscular diseases caused by mutations in the dysferlin gene, remain serious medical problems due to the lack of therapeutic agents. Herein, we report the design, synthesis, and structure–activity relationships of a 2,6-disubstituted 3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine series, which was identified from the phenotypic screening of chemicals that increase the level of dysferlin in myocytes differentiated from patient-derived induced pluripotent stem cells (iPSCs). Optimization studies with cell-based phenotypic assay led to the identification of a highly potent compound, <b>19</b>, with dysferlin elevation effects at double-digit nanomolar concentrations. In addition, the molecular target of our chemical series was identified as tubulin, through a tubulin polymerization assay and a competitive binding assay using a photoaffinity labeling probe.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51213" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51213" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cell-based phenotypic screening is an attractive drug discovery approach because it does not require an established biological knowledge of molecular targets and it leads to the discovery of novel druggable targets and therapeutic agents.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> In particular, phenotypic screening using patient-derived induced pluripotent stem cells (iPSCs) is expected to be one of the most disease-relevant evaluation systems.<a onclick="showRef(event, 'ref3 ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5 ref6">(3−6)</a> Dysferlinopathies are autosomal recessive muscular disorders that are caused by mutations in the dysferlin gene.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> Dysferlin is dominantly expressed in skeletal or cardiac muscles and plays an essential role in the repair of damaged and disrupted plasma membranes.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9−11)</a> The loss or reduction of dysferlin results in the weakening of muscles as the muscle membrane is not restored sufficiently. Dysferlinopathies are clinically categorized into at least three phenotypes based on the initial pattern of muscle weakness: limb girdle muscular dystrophy 2B (LGMD2B), Miyoshi myopathy (MM), and distal myopathy with anterior tibial onset (DMAT). Currently, there is no effective treatment for dysferlinopathies; therefore, the development of novel therapeutic agents is highly desired.</div><div class="NLM_p">Many types of dysferlin mutations have been reported, and it is evident that dysferlin level in human fibroblasts with the c.2997G > T (p.W999C) missense mutation is much lower than that in normal human fibroblasts.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Additionally, treatment with a proteasomal inhibitor, MG-132, increased the level of p.W999C mutated dysferlin protein, and the membrane blebbing level was also restored depending on the increase in the level of mutated dysferlin. Therefore, it is suggested that p.W999C mutated dysferlin protein possesses a membrane resealing function. Indeed, a clinical study reported that patients with the homozygous c.2997G > T mutation had late onset of dysferlinopathies relative to those with the heterozygous c.2997G > T mutation.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> These observations indicate that an increase in the level of p.W999C mutated dysferlin protein could alleviate the symptoms of dysferlinopathies. Moreover, we previously developed a rapid, efficient, and reproducible method to differentiate iPSCs into mature myocytes, and we demonstrated its application in a disease model of MM.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> This method enabled us to establish an assay system to screen chemicals that could increase the dysferlin level in myocytes differentiated from MM patient-derived iPSCs.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The pilot screening of 622 commercially available compounds identified nocodazole, a tubulin inhibitor, as a hit compound, which was found to restore membrane resealing function.</div><div class="NLM_p last">Following the pilot screening, we carried out a more extensive high-throughput screening of small molecules to find more potent and drug-like compounds. From a screen of structurally diverse and drug-like small molecules (ca. 6400), we identified 2,6-disubstituted 3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine <b>1</b> as a hit compound, which showed dysferlin elevation effects in a dose-dependent manner. Compound <b>1</b> and its derivatives were originally derived in Takeda’s legacy project, where these compounds exhibited growth inhibition of HER2-positive cell lines such as SK-BR-3 and BT-474; however, their molecular target remains unknown.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> In the present study, we describe the structure–activity relationships (SAR) of 2,6-disubstituted 3<i>H</i>-imidazo[4,5-<i>b</i>]pyridines and our efforts on the target deconvolution of our chemical series.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16410" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16410" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In the dysferlin elevation assay,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> the threshold value for detecting an increase in the dysferlin level was set as median + 3 standard deviations of vehicle controls, which converged to slightly less than 1.5-fold relative to the median value of vehicle controls. Therefore, we defined the indicator of potency, EC<sub>150</sub>, as a compound concentration at which the dysferlin level is increased by 1.5-fold. As a result of the high throughput screening, we identified a hit compound <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), which exhibited an EC<sub>150</sub> value of 5.9 μM and acceptable physicochemical properties such as solubility and membrane permeability. As our assay was a cell-based phenotypic screening, it is noteworthy that compound <b>1</b> did not show any cytotoxic effect on HepG2 cells even at 100 μM. Thus, we executed SAR studies in order to understand which features are crucial for cellular activity and identify highly potent compounds. The SAR information is also required for target identification approaches such as chemical proteomics or correlation analysis with target-based assay results;<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17,18)</a> for example, it is crucial for the preparation of chemical probes to clarify which part of the compound turns toward the solvent region to attach a linker motif without disrupting the potency. In developing the cell-based SAR using the dysferlin elevation assay, the structure of compound <b>1</b> was divided into three structural units: (1) C-2 substituents on imidazopyridine; (2) C-6 aryl groups on imidazopyridine; (3) imidazopyridine core scaffold. We carried out systematic modifications of each structural unit and evaluated the effects on the dysferlin level.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/medium/jm9b01100_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/large/jm9b01100_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of hit compound <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/large/jm9b01100_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01100&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">First, the effects of C-2 substituents on cellular activity were investigated (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Replacing the phenethyl group at C-2 with a phenyl (<b>2</b>) or benzyl (<b>3</b>) group resulted in the loss of cellular activity. To confirm the tolerability of substitution on the terminal phenyl ring, a chlorine atom was introduced into the <i>ortho-</i>, <i>meta-</i>, and <i>para</i>-positions. Among these, <i>para</i>-substituted <b>6</b> showed a potency comparable to <b>1</b>, whereas <i>ortho</i>- (<b>4</b>) or <i>meta</i>-substituted (<b>5</b>) compounds showed reduced potency. The <i>para</i>-substitution was tolerated, and hence, a variety of <i>para</i>-substitutions were explored. Consequently, a fluorophenethyl group (<b>9</b>) increased potency by approximately 6-fold compared to hit compound <b>1</b>. In contrast, an electron donating methyl (<b>7</b>) or methoxy group (<b>8</b>) and an electron withdrawing trifluoromethyl (<b>10</b>) or cyano group (<b>11</b>) resulted in a loss in potency, suggesting the size limitations of the binding pocket around the terminal phenyl ring.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structure–Activity Relationships of C-2 and C-6 Groups</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/medium/jm9b01100_0008.gif" alt="" id="gr2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/medium/jm9b01100_0009.gif" alt="" id="gr3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last"><i>n</i> = 8, 95% confidence intervals shown in parentheses.</p></div></div><div></div></div><div class="NLM_p">With the potent compound <b>9</b> in hand, we explored the aryl group at C-6 (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). While replacing the furan ring with a benzene ring (<b>12</b>) hardly affected cellular activity, compound <b>13</b> containing a thiophene ring exhibited an approximately 7-fold increase in potency as compared to <b>9</b>. The addition of a methyl group into the 3-position of the thiophene ring (<b>14</b>) was tolerated; however, the substitution at the 4- or 5-position (<b>15</b> or <b>16</b>) resulted in a reduction of cellular activity. As in compound <b>17</b>, the ether-linked C-2 group resulted in an approximately 2-fold increase in potency compared to the corresponding carbon-linked analogue <b>13</b>. Surprisingly, the elimination of the fluorine atom on the phenyl ring of compound <b>17</b> slightly enhanced the potency as in compound <b>18</b>. In addition, it should be noted that compound <b>18</b> exhibited no cytotoxic effect as with the case of hit compound <b>1</b>. Given that the 3-position methyl group on the thiophene ring was tolerated as in <b>14</b>, a bulkier isopropyl group was introduced into the thiophene ring of compound <b>18</b>, which led to an approximately 3-fold increase in potency (<b>19</b>).</div><div class="NLM_p">Next, we investigated the role of the imidazopyridine core in cellular activity (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Oxazolo[4,5-<i>b</i>]pyridines <b>20</b> and <b>21</b> exhibited a considerable loss in potency, indicating that the NH group of the imidazole ring might contribute to cellular activity by the formation of a hydrogen bond with the target protein. Similarly, upon the removal of the nitrogen atom of the pyridine ring, the resultant benzimidazole <b>22</b> did not exhibit a dysferlin elevation effect even at 10 μM. Furthermore, the introduction of a methyl group adjacent to the pyridine nitrogen resulted in the loss of cellular activity as in <b>23</b>. These results implied that the pyridine nitrogen possibly made a hydrogen bond with the target protein, thereby contributing to cellular activity. In contrast, the introduction of a methyl group at the 7-position of imidazopyridine ring was relatively well tolerated, as in <b>24</b>. As a result, 3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine was found to be the optimal core structure for cellular activity.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Structure–Activity Relationships of the Center Ring</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/medium/jm9b01100_0010.gif" alt="" id="gr4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/medium/jm9b01100_0011.gif" alt="" id="gr5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last"><i>n</i> = 8, 95% confidence intervals shown in parentheses.</p></div></div><div></div></div><div class="NLM_p">Furthermore, we sought to elucidate the plausible target of the chemical series. We previously reported that the tubulin inhibitors, nocodazole and colchicine,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> increased the level of dysferlin in our dysferlin elevation assay.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Accordingly, we proposed that the cellular activity of the 2,6-disubstituted 3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine series would be mediated by the inhibition of tubulin polymerization. The inhibitory effects of several analogues on tubulin polymerization were evaluated in HepG2 cells to determine whether they are correlated with dysferlin elevation effects on iPSC-derived myocytes (for the structure of measured compounds, see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01100/suppl_file/jm9b01100_si_001.pdf" class="ext-link">Table S1</a>, Supporting Information). As hypothesized, the correlation plot suggests that the inhibition of tubulin polymerization caused the elevation of dysferlin in the chemical series (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). It is worth noting that the compound series did not exhibit inhibitory activities against kinases through competitive binding assays, although 3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine is a typical hinge binder (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01100/suppl_file/jm9b01100_si_001.pdf" class="ext-link">Figure S1</a>, Supporting Information).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/medium/jm9b01100_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/large/jm9b01100_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Correlation plot of pEC<sub>150</sub> with tubulin depolymerization pMEC. MEC, minimal effective concentration; <i>R</i>, correlation coefficient. The EC<sub>150</sub> value of compounds represented as square or triangle is >10 μM. The MEC value of compounds represented as circle or square is <0.080 μM or >50 μM, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/large/jm9b01100_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01100&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Encouraged by these results, we performed docking studies in order to further elucidate the binding modes of the chemical series with tubulin molecules. It is reported that nocodazole binds to the interface of α/β-tubulin heterodimers, which is known as the colchicine binding site.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Nocodazole contains an imidazole ring, which is an essential moiety for cellular activity in our chemical series, and hence, we thought nocodazole and our chemical series might bind to a common binding site (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>a). We conducted the docking calculation for compound <b>19</b> based on the X-ray cocrystal structure of nocodazole with tubulin (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5CA1">5CA1</a>; <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>b,c). Our docking analysis suggested that the NH-group of the imidazole ring made a hydrogen bond with the backbone oxygen atom of Val236 of β-tubulin. The loss in potency of oxazolo[4,5-<i>b</i>]pyridines <b>20</b> and <b>21</b> should be attributed to the absence of this interaction. In addition, the nitrogen atom of the pyridine ring formed a water-mediated hydrogen bond with Gly235 and Cys239 of β-tubulin. In the X-ray cocrystal structure of nocodazole, the water molecule tightly binds to Gly235 and Cys239, and the water-mediated interaction is formed by the carbonyl group on the thiophene ring (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>d).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> These results are consistent with the observation that benzimidazole <b>22</b> without the nitrogen atom had a considerable loss in potency. The isopropyl group on the thiophene ring occupies the hydrophobic region consisting of Leu246, Leu253, Asn256, and Met257 of β-tubulin. This hydrophobic interaction is considered to contribute to the high potency of compound <b>19</b>. Generally, our docking model explains the SAR of the chemical series.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/medium/jm9b01100_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/large/jm9b01100_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (a) Structure and cellular activity of nocodazole and compound <b>19</b>. (b) Docking model of <b>19</b> with an α/β-tubulin heterodimer. Compound <b>19</b> is light blue, α-tubulin is black, and β-tubulin is gray. (c) The binding site of <b>19</b>. Residues that form hydrogen bonds or hydrophobic interactions with <b>19</b> are shown as sticks and are labeled. (d) X-ray cocrystal of nocodazole with tubulin (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5CA1">5CA1</a>). Residues that form hydrogen bonds with the ligand are shown as sticks and are labeled. (e) Surface of residues within 4.0 Å of <b>19</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/large/jm9b01100_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01100&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Our docking model was found to be consistent with the SAR, and hence, we tried to confirm the direct binding between our compounds and tubulins using a photoaffinity labeling (PAL) probe, which covalently binds to its target protein after ultraviolet irradiation.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Our docking model indicated that there was a long and narrow cavity exposed to the solvent region around the 3- and 4-positions of the thiophene ring, suggesting that a chemical probe linker could be attached without disrupting the binding affinity to tubulins (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>e). Thus, we introduced a linker motif into the thiophene ring of compound <b>18</b> and evaluated its effect on the level of dysferlin. First, an amide group was introduced because it is synthetically feasible to extend various linker parts by amide coupling. Unlike in the case of the methyl or isopropyl group, a methylamide group at the 3-position of the thiophene ring resulted in a considerable loss of cellular activity (<b>25</b>). In contrast, compound <b>26</b> containing a methylamide group at the 4-position sustained high potency. Furthermore, a 2-(2-methoxyethoxy)ethylamide group was also tolerated, as in compound <b>27</b>, suggesting that the terminal alkoxy chain should turn toward the solvent region. Based on these results, we synthesized a PAL probe <b>28</b> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>), containing a photoreactive diazirine group and an alkyne tag, which exhibited cellular activity at sub-micromolar concentrations.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Preparation of PAL Probe <b>28</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/medium/jm9b01100_0012.gif" alt="" id="gr8" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/medium/jm9b01100_0013.gif" alt="" id="gr9" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last"><i>n</i> = 8, 95% confidence intervals shown in parentheses.</p></div></div><div></div></div><div class="NLM_p">With probe <b>28</b> and purified tubulins, a competitive binding assay was carried out. Commercially available porcine brain tubulins were incubated with <b>28</b> after preincubation with or without competitive compounds, followed by ultraviolet irradiation for cross-linking between <b>28</b> and tubulins. Subsequently, the cross-linked tubulins were labeled with a fluorescent dye, tetramethylrhodamine (TAMRA), by alkyne–azide click reaction. The tubulins were separated by SDS-PAGE, and the images for fluorescently labeled tubulins and total tubulins were captured (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). The fluorescently labeled tubulins were clearly observed without competitive compounds, suggesting that probe <b>28</b> was effectively bound to the tubulins. In addition, the same fluorescent band was not detected in the case where the porcine brain tubulins were preincubated with compound <b>18</b> (EC<sub>150</sub> = 0.039 μM) before the treatment with <b>28</b>, whereas preincubation with compound <b>21</b> (EC<sub>150</sub> > 10 μM) hardly affected the fluorescent labeling. Furthermore, competitive inhibition was observed when the porcine tubulins were pretreated with colchicine binding site inhibitors such as colchicine and nocodazole. In contrast, preincubation with vinblastine and paclitaxel, which are known to bind to other biding sites,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> did not inhibit the binding of probe <b>28</b>. These results demonstrated that our chemical series increased the dysferlin level because of tubulin depolymerization caused by direct binding to the colchicine binding site of tubulins.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/medium/jm9b01100_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/large/jm9b01100_0004.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Image of SDS-PAGE for PAL probe-labeled tubulins. The tubulins were labeled with PAL probe <b>28</b> after preincubation with nonlabeled active or inactive compound (compound <b>18</b> or <b>21</b>, respectively) or known tubulin binders. PAL probe <b>28</b>, which has an acetylene group, was probed with TAMRA-azide by click reaction. (a) The samples were analyzed by SDS-PAGE, and the fluorescence images were captured to detect the PAL-probe-labeled tubulins. (b) Subsequently, the gel was stained with Coomassie brilliant blue to visualize the total tubulin. (c) Structure and cellular activity of nocodazole and vinblastine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/large/jm9b01100_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01100&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12331" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12331" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we investigated the SAR of a 2,6-disubstituted 3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine series using a cell-based phenotypic screening in myocytes differentiated from MM patient-derived iPSCs to identify compound <b>19</b>, which exhibited dysferlin elevation effects at double-digit nanomolar concentrations. The cellular activity of this chemical series correlated with their inhibitory activity on tubulin polymerization. The competitive binding assay using purified tubulins demonstrated that PAL probe <b>28</b> covalently bound to tubulins and it was competitively inhibited by the active compound <b>18</b> or the colchicine binding site inhibitors, colchicine and nocodazole. These observations indicated that 2,6-disubstituted 3<i>H</i>-imidazo[4,5-<i>b</i>]pyridines increased the level of dysferlin through the inhibition of tubulin polymerization, mediated by direct binding of the compounds to the colchicine binding site of tubulins. These results are consistent with our previous work, where we demonstrated that nocodazole increased dysferlin protein levels and improved the membrane resealing function. Considering that misfolded proteins are transported along microtubules to form autophagosomes in the autophagy system, it is suggested that the upregulation of dysferlin should be attributed to the blockage of the microtubule-dependent autophagy, which might contribute to degradation of mutated dysferlin protein. Indeed, upon the treatment with nocodazole, the accumulation of p62 and LC3 II were observed, which indicated disruption of autophagy.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Further investigation for the elucidation of the detailed mechanism of action is underway. On the other hand, due to potential adverse effects of microtubule disruption, such as cell cycle arrest, further optimization of the chemical series was discontinued.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> However, we strongly believe that compound <b>19</b> can be used as a tool compound to elucidate the detailed mechanism of action. Thus, it can contribute to the discovery of druggable molecular targets and ultimately novel therapeutic agents for dysferlinopathies.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76870" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76870" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthesis of compound <b>17</b> is outlined in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Commercially available 5-bromo-2,3-diamino-pyridine was coupled with 2-(4-fluorophenoxy)acetic acid in the presence of 2-(7-aza-1<i>H</i>-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HATU) and <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA), followed by intramolecular condensation under acidic conditions to afford imidazopyridine intermediate <b>29</b>. The intermediate <b>29</b> was converted to compound <b>17</b> by Suzuki–Miyaura coupling with thiophen-2-ylboronic acid. Compounds <b>1</b>–<b>19</b> and <b>22</b>–<b>25</b> were prepared in a manner similar to <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>.</div><figure id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/medium/jm9b01100_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/large/jm9b01100_0005.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compound <b>17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/large/jm9b01100_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01100&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) HATU, DIPEA, 2-(4-fluorophenoxy)acetic acid, DMF; (ii) AcOH, reflux, 70% (2 steps); (b) Pd(Amphos)Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, thiophen-2-ylboronic acid, DME, water, microwave 120 °C, 17%.</p></p></figure><div class="NLM_p">Compound <b>21</b> was prepared according to <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Commercially available 3-(4-fluorophenyl)propanoic acid was converted to carboxamide <b>30</b>, and the subsequent dehydration afforded the corresponding nitrile <b>31</b>. Compound <b>31</b> was reacted with methanol under acidic conditions to give <i>ortho</i>-ester <b>32</b>, followed by condensation with aminohydroxypridine <b>33</b> prepared from commercially available 2-amino-5-bromopyridin-3-ol via Suzuki–Miyaura coupling to afford compound <b>21</b>. Compound <b>20</b>, a regioisomer of <b>21</b>, was prepared in a manner similar to <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>.</div><figure id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/medium/jm9b01100_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/large/jm9b01100_0006.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compound <b>21</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/large/jm9b01100_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01100&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) (COCl)<sub>2</sub>, DMF (cat), CHCl<sub>3</sub>; (ii) NH<sub>3</sub>, CHCl<sub>3</sub>, 0 °C to RT, 76% (2 steps); (b) trifluoroacetic anhydride, 90%; (c) (i) HCl gas, MeOH, Et<sub>2</sub>O, 0–4 °C; (ii) MeOH, hexane; (d) PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, thiophen-2-ylboronic acid, 1,4-dioxane, water, 110 °C, 59%; (e) <b>32</b>, AcOH, toluene, reflux, 73%.</p></p></figure><div class="NLM_p">The synthesis of PAL probe <b>28</b> is outlined in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. The intermediate <b>34</b> was prepared according to <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> and then hydrolyzed to give carboxylic acid <b>35</b>. Compound <b>28</b> was obtained through amide coupling between carboxylic acid <b>35</b> and 2-(3-(but-3-yn-1-yl)-3<i>H</i>-diazirin-3-yl)ethan-1-amine. Compounds <b>26</b> and <b>27</b> were prepared in a manner similar to <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>.</div><figure id="sch3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/medium/jm9b01100_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/large/jm9b01100_0007.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compound <b>28</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/large/jm9b01100_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01100&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaOH aq., MeOH, THF, 86%; (b) HATU, DIPEA, 2-(3-(but-3-yn-1-yl)-3H-diazirin-3-yl)ethan-1-amine, DMF, 65%.</p></p></figure></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48223" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48223" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> General Chemistry Information</h3><div class="NLM_p"><sup>1</sup>H NMR spectra were recorded on Bruker AVANCE 300, 400, or 500 (300, 400, or 500 MHz). Chemical shifts are given in parts per million (ppm) with tetramethylsilane as an internal standard. Abbreviations used are as follows: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, dd = doublet of doublets, td = triplet of doublets, brs = broad singlet. Coupling constants (<i>J</i> values) are given in hertz (Hz). The acidic protons were not frequently observed in <sup>1</sup>H NMR spectra. Low-resolution mass spectra (MS) were acquired using an Agilent LC/MS system (Agilent1200SL/Agilent6130MS) or Shimadzu UFLC/MS (Prominence UFLC high pressure gradient system/LCMS-2020) operating in an electrospray ionization mode (ESI+). The column used was an L-column 2 ODS (3.0 mm × 50 mm ID, 3 μm, CERI) with a temperature of 40 °C and a flow rate of 1.2 or 1.5 mL/min. Condition 1: Mobile phases A and B under acidic conditions were 0.05% TFA in water and 0.05% TFA in MeCN, respectively. The ratio of mobile phase B was increased linearly from 5% to 90% over 0.9 min, 90% over the next 1.1 min. Condition 2: Mobile phases A and B under neutral conditions were a mixture of 5 mM AcONH<sub>4</sub> and MeCN (9/1, v/v) and a mixture of 5 mM AcONH<sub>4</sub> and MeCN (1/9, v/v), respectively. The ratio of mobile phase B was increased linearly from 5 to 90% over 0.9 min, 90% over the next 1.1 min. Chemical intermediates were characterized by <sup>1</sup>H NMR or mass spectral data or both. Unless otherwise stated, the purities of synthesized compounds for biological testing were >95% determined by analytical HPLC. (The purities of <b>15</b>, <b>S4</b>, and <b>S6</b> were 94.9%, 91.9%, and 90.2%, respectively.) Analytical HPLC was carried out using Corona CAD (Charged Aerosol Detector) or photo diode array detector. The column was a Capcell Pak C18AQ (50 mm × 3.0 mm ID, Shiseido, Japan) or L-column 2 ODS (30 mm × 2.0 mm ID, CERI, Japan) with a temperature of 50 °C and a flow rate of 0.5 mL/min. Mobile phases A and B under neutral conditions were a mixture of 50 mM AcONH<sub>4</sub>, water, and MeCN (1:8:1, v/v/v) and a mixture of 50 mM AcONH<sub>4</sub> and MeCN (1:9, v/v), respectively. The ratio of mobile phase B was increased linearly from 5% to 95% over 3 min, 95% over the next 1 min. Mobile phases A and B under acidic conditions were a mixture of 0.2% formic acid in 10 mM ammonium formate and 0.2% formic acid in MeCN, respectively. The ratio of mobile phase B was increased linearly from 14% to 86% over 3 min, 86% over the next 1 min. Reaction progress was determined by thin layer chromatography (TLC) analysis on Merck Kieselgel 60 F254 plates or Fuji Silysia NH plates. Chromatographic purification was carried out on silica gel columns (Merck Kieselgel 60, 70–230 mesh or 230–400 mesh, Merck; Chromatorex NH-DM 1020, 100–200 mesh, Fuji Silysia Chemical; Inject column and Universal column, YAMAZEN, <a href="http://yamazenusa.com/products/columns/" class="extLink">http://yamazenusa.com/products/columns/</a>, or Purif-Pack Si or NH, Shoko Scientific, <a href="https://www.shoko-sc.co.jp/en/products/coulumn/purif_pack_ex/index.html" class="extLink">https://www.shoko-sc.co.jp/en/products/coulumn/purif_pack_ex/index.html</a>). Preparative HPLC was performed on a Gilson Preparative HPLC System using a YMC-Actus Triart C18 column (150 mm × 20 mm ID, 5 μm, YMC). Condition 1: Mobile phases A and B under acidic conditions were 0.1% TFA in water and 0.1% TFA in MeCN, respectively. Condition 2: Mobile phases A and B under neutral conditions were 10 mM ammonium bicarbonate and MeCN, respectively. The ratio of mobile phase B was increased linearly in 5–10 min. All commercially available solvents and reagents were used without further purification. Yields were not optimized.</div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> 6-(Furan-2-yl)-2-phenethyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>1</b>)</h4><div class="NLM_p last">A mixture of 6-bromo-2-phenethyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>36</b>) (150 mg, 0.497 mmol), 2-(tributylstannyl)furan (0.18 M DMF solution, 5.0 mL), and PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (17 mg, 0.024 mmol) was stirred at 80 °C under Ar for 18 h. The mixture was poured into water at room temperature and extracted with EtOAc–THF. The organic layer was separated, washed with water and brine, dried over MgSO<sub>4</sub>, and concentrated in vacuo. The residue was purified by column chromatography (silica gel, eluted with 50% EtOAc in chloroform) to give <b>1</b> (72 mg, 50%) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.10–3.20 (4H, m), 6.62 (1H, td, <i>J</i> = 3.3, 1.8 Hz), 7.02 (1H, dd, <i>J</i> = 8.3, 3.3 Hz), 7.15–7.22 (1H, m), 7.24–7.30 (4H, m), 7.78 (1H, dd, <i>J</i> = 4.2, 1.2 Hz), 8.00–8.18 (1H, m), 8.60–8.74 (1H, m), 12.56–13.01 (1H, m). MS <i>m</i>/<i>z</i>: 290.1 [M + H]<sup>+</sup>. HPLC purity 96.0%.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> 6-(Furan-2-yl)-2-phenyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>2</b>)</h4><div class="NLM_p last">Compound <b>2</b> was prepared from 6-bromo-2-phenyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>37</b>) in a manner similar to that described for the synthesis of <b>1</b> and obtained (57% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 6.65 (1H, dd, <i>J</i> = 3.4, 1.9 Hz), 7.07–7.10 (1H, m), 7.53–7.63 (3H, m), 7.81 (1H, dd, <i>J</i> = 1.8, 0.7 Hz), 8.19–8.28 (3H, m), 8.77 (1H, d, <i>J</i> = 2.0 Hz). MS <i>m</i>/<i>z</i>: 262.1 [M + H]<sup>+</sup>. HPLC purity 99.2%.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> 2-Benzyl-6-(furan-2-yl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>3</b>)</h4><div class="NLM_p last">Compound <b>3</b> was prepared from 2-benzyl-6-bromo-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>38</b>) in a manner similar to that described for the synthesis of <b>1</b> and obtained (82% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 4.21 (2H, s), 6.62 (1H, dd, <i>J</i> = 3.4, 1.8 Hz), 7.01 (1H, dd, <i>J</i> = 3.4, 0.7 Hz), 7.22–7.38 (5H, m), 7.78 (1H, dd, <i>J</i> = 1.8, 0.7 Hz), 8.11 (1H, brs), 8.68 (1H, d, <i>J</i> = 1.8 Hz), 12.70–13.04 (1H, m). MS <i>m</i>/<i>z</i>: 276.1 [M + H]<sup>+</sup>. HPLC purity 99.4%.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> 2-(2-Chlorophenethyl)-6-(furan-2-yl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>4</b>)</h4><div class="NLM_p last">A mixture of 6-bromo-2-(2-chlorophenethyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>39</b>) (200 mg, 0.594 mmol), furan-2-ylboronic acid (100 mg, 0.894 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (60 mg, 0.052 mmol), 2 M Na<sub>2</sub>CO<sub>3</sub> aq. (1.8 mL) in toluene (4 mL), THF (1 mL), and DMF (2 mL) was stirred at 110 °C under Ar for 12 h. The mixture was poured into water at room temperature and extracted with EtOAc. The organic layer was separated, washed with water and brine, dried over MgSO<sub>4</sub>, and concentrated in vacuo. The residue was purified by column chromatography (silica gel, eluted with 33–100% EtOAc in hexane) to give <b>4</b> (90 mg, 47%) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.13–3.29 (4H, m), 6.62 (1H, dd, <i>J</i> = 3.4, 1.8 Hz), 7.02 (1H, dd, <i>J</i> = 3.4, 0.7 Hz), 7.22–7.47 (4H, m), 7.78 (1H, dd, <i>J</i> = 1.8, 0.7 Hz), 8.12 (1H, d, <i>J</i> = 1.9 Hz), 8.68 (1H, d, <i>J</i> = 2.0 Hz), 12.74–12.96 (1H, m). MS <i>m</i>/<i>z</i>: 324.1 [M + H]<sup>+</sup>. HPLC purity 98.7%.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 2-(3-Chlorophenethyl)-6-(furan-2-yl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>5</b>)</h4><div class="NLM_p last">Compound <b>5</b> was prepared from 6-bromo-2-(3-chlorophenethyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>40</b>) in a manner similar to that described for the synthesis of <b>4</b> and obtained (17% yield) as a pale yellow solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.17 (4H, s), 6.62 (1H, dd, <i>J</i> = 3.4, 1.8 Hz), 7.02 (1H, dd, <i>J</i> = 3.4, 0.7 Hz), 7.21–7.38 (4H, m), 7.78 (1H, dd, <i>J</i> = 1.8, 0.7 Hz), 8.11 (1H, d, <i>J</i> = 1.7 Hz), 8.67 (1H, d, <i>J</i> = 2.0 Hz), 12.59–13.00 (1H, brs). MS <i>m</i>/<i>z</i>: 324.2 [M + H]<sup>+</sup>. HPLC purity 97.7%.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 2-(4-Chlorophenethyl)-6-(furan-2-yl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>6</b>)</h4><div class="NLM_p last">Compound <b>6</b> was prepared from 6-bromo-2-(4-chlorophenethyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>41</b>) in a manner similar to that described for the synthesis of <b>4</b> and obtained (28% yield) as a pale yellow solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.15 (4H, s), 6.62 (1H, dd, <i>J</i> = 3.4, 1.8 Hz), 7.02 (1H, d, <i>J</i> = 3.0 Hz), 7.26–7.36 (4H, m), 7.78 (1H, d, <i>J</i> = 1.2 Hz), 8.14 (1H, brs), 8.66 (1H, brs), 12.51–13.02 (1H, m). MS <i>m</i>/<i>z</i>: 324.1 [M + H]<sup>+</sup>. HPLC purity 98.7%.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 6-(Furan-2-yl)-2-(4-methylphenethyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>7</b>)</h4><div class="NLM_p last">Compound <b>7</b> was prepared from 6-bromo-2-(4-methylphenethyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>42</b>) in a manner similar to that described for the synthesis of <b>4</b> and obtained (63% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.24 (3H, s), 3.11 (4H, brs), 6.58–6.66 (1H, m), 6.98–7.19 (5H, m), 7.78 (1H, s), 7.99–8.21 (1H, m), 8.59–8.76 (1H, m), 12.50–13.13 (1H, m). MS <i>m</i>/<i>z</i>: 304.3 [M + H]<sup>+</sup>. HPLC purity 100.0%.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 6-(Furan-2-yl)-2-(4-methoxyphenethyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>8</b>)</h4><div class="NLM_p last">Compound <b>8</b> was prepared from 6-bromo-2-(4-methoxyphenethyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>43</b>) in a manner similar to that described for the synthesis of <b>4</b> and obtained (28% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.02–3.16 (4H, m), 3.70 (3H, s), 6.62 (1H, dd, <i>J</i> = 3.4, 1.8 Hz), 6.80–6.87 (2H, m), 7.02 (1H, d, <i>J</i> = 4.1 Hz), 7.14–7.21 (2H, m), 7.78 (1H, dd, <i>J</i> = 1.8, 0.7 Hz), 8.10 (1H, d, <i>J</i> = 1.8 Hz), 8.66 (1H, d, <i>J</i> = 2.0 Hz), 12.40–13.06 (1H, m). MS <i>m</i>/<i>z</i>: 320.2 [M + H]<sup>+</sup>. HPLC purity 99.2%.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 2-(4-Fluorophenethyl)-6-(furan-2-yl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>9</b>)</h4><div class="NLM_p last">Compound <b>9</b> was prepared from 6-bromo-2-(4-fluorophenethyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>44</b>) in a manner similar to that described for the synthesis of <b>4</b> and obtained (51% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.14 (4H, s), 6.62 (1H, dd, <i>J</i> = 3.3, 1.8 Hz), 6.99–7.14 (3H, m), 7.25–7.34 (2H, m), 7.78 (1H, s), 7.99–8.20 (1H, m), 8.60–8.75 (1H, m), 12.52–13.01 (1H, m). MS <i>m</i>/<i>z</i>: 308.1 [M + H]<sup>+</sup>. HPLC purity 96.9%.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 6-(Furan-2-yl)-2-(4-(trifluoromethyl)phenethyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>10</b>)</h4><div class="NLM_p last">Compound <b>10</b> was prepared from 6-bromo-2-(4-(trifluoromethyl)phenethyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>45</b>) in a manner similar to that described for the synthesis of <b>4</b> and obtained (48% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.19–3.26 (4H, m), 6.62 (1H, dd, <i>J</i> = 3.4, 1.8 Hz), 7.02 (1H, dd, <i>J</i> = 3.4, 0.7 Hz), 7.50 (2H, d, <i>J</i> = 7.9 Hz), 7.65 (2H, d, <i>J</i> = 8.0 Hz), 7.78 (1H, dd, <i>J</i> = 1.8, 0.7 Hz), 8.11 (1H, d, <i>J</i> = 2.0 Hz), 8.67 (1H, d, <i>J</i> = 2.0 Hz). MS <i>m</i>/<i>z</i>: 358.3 [M + H]<sup>+</sup>. HPLC purity 99.0%.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 4-(2-(6-(Furan-2-yl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2-yl)ethyl)benzonitrile (<b>11</b>)</h4><div class="NLM_p last">Compound <b>11</b> was prepared from 4-(2-(6-bromo-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2-yl)ethyl)benzonitrile (<b>46</b>) in a manner similar to that described for the synthesis of <b>4</b> and obtained (19% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.16–3.28 (4H, m), 6.62 (1H, dd, <i>J</i> = 3.4, 1.8 Hz), 7.02 (1H, dd, <i>J</i> = 3.4, 0.7 Hz), 7.46–7.51 (2H, m), 7.72–7.79 (3H, m), 8.11 (1H, d, <i>J</i> = 1.9 Hz), 8.67 (1H, d, <i>J</i> = 2.0 Hz), 12.82 (1H, brs). MS <i>m</i>/<i>z</i>: 315.2 [M + H]<sup>+</sup>. HPLC purity 99.2%.</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 2-(4-Fluorophenethyl)-6-phenyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>12</b>)</h4><div class="NLM_p last">Compound <b>12</b> was prepared from <b>44</b> and phenylboronic acid in a manner similar to that described for the synthesis of <b>4</b> and obtained (35% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.16 (4H, s), 7.06–7.15 (2H, m), 7.26–7.34 (2H, m), 7.35–7.42 (1H, m), 7.46–7.53 (2H, m), 7.69–7.76 (2H, m), 8.11 (1H, d, <i>J</i> = 2.1 Hz), 8.56 (1H, d, <i>J</i> = 2.1 Hz). MS <i>m</i>/<i>z</i>: 318.0 [M + H]<sup>+</sup>. HPLC purity 98.6%.</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 2-(4-Fluorophenethyl)-6-(thiophen-2-yl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>13</b>)</h4><div class="NLM_p last">Compound <b>13</b> was prepared from <b>44</b> in a manner similar to that described for the synthesis of <b>17</b> and obtained (29% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.15 (4H, s), 7.02–7.13 (2H, m), 7.15–7.20 (1H, m), 7.24–7.36 (2H, m), 7.51–7.62 (2H, m), 8.10 (1H, brs), 8.58 (1H, brs), 12.18–13.11 (1H, brs). MS <i>m</i>/<i>z</i>: 324.1 [M + H]<sup>+</sup>. HPLC purity 99.8%.</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 2-(4-Fluorophenethyl)-6-(3-methylthiophen-2-yl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>14</b>)</h4><div class="NLM_p last">Compound <b>14</b> was prepared from <b>44</b> and (3-methylthiophen-2-yl)boronic acid in a manner similar to that described for the synthesis of <b>17</b> and obtained (19% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.28 (3H, s), 3.15 (4H, s), 7.02–7.14 (3H, m), 7.26–7.34 (2H, m), 7.50 (1H, d, <i>J</i> = 5.1 Hz), 7.91 (1H, d, <i>J</i> = 2.1 Hz), 8.33 (1H, d, <i>J</i> = 2.1 Hz). MS <i>m</i>/<i>z</i>: 338.1 [M + H]<sup>+</sup>. HPLC purity 100.0%.</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 2-(4-Fluorophenethyl)-6-(4-methylthiophen-2-yl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>15</b>)</h4><div class="NLM_p last">Compound <b>15</b> was prepared from <b>44</b> and (4-methylthiophen-2-yl)boronic acid in a manner similar to that described for the synthesis of <b>17</b> and obtained (10% yield) as a pale yellow solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.25 (3H, d, <i>J</i> = 0.8 Hz), 3.14 (4H, s), 7.05–7.14 (3H, m), 7.25–7.33 (2H, m), 7.38 (1H, d, <i>J</i> = 1.2 Hz), 8.03 (1H, d, <i>J</i> = 2.1 Hz), 8.53 (1H, d, <i>J</i> = 2.1 Hz), 12.66–12.90 (1H, brs). MS <i>m</i>/<i>z</i>: 338.1 [M + H]<sup>+</sup>. HPLC purity 94.9%.</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 2-(4-Fluorophenethyl)-6-(5-methylthiophen-2-yl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>16</b>)</h4><div class="NLM_p last">Compound <b>16</b> was prepared from <b>44</b> and (5-methylthiophen-2-yl)boronic acid in a manner similar to that described for the synthesis of <b>17</b> and obtained (29% yield) as a pale yellow solid. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ 2.53 (3H, d, <i>J</i> = 0.9 Hz), 3.14–3.27 (4H, m), 6.77–6.84 (1H, m), 6.94–7.03 (2H, m), 7.19–7.28 (3H, m), 8.01 (1H, brs), 8.55 (1H, s). MS <i>m</i>/<i>z</i>: 338.1 [M + H]<sup>+</sup>. HPLC purity 97.5%.</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 2-((4-Fluorophenoxy)methyl)-6-(thiophen-2-yl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>17</b>)</h4><div class="NLM_p last">A mixture of <b>29</b> (50 mg, 0.16 mmol), thiophen-2-ylboronic acid (26 mg, 0.20 mmol), Pd(Amphos)Cl<sub>2</sub> (11 mg, 0.016 mmol), Na<sub>2</sub>CO<sub>3</sub> (82 mg, 0.78 mmol), DME (1.25 mL), and water (0.25 mL) was heated at 120 °C for 2 h under microwave irradiation. The mixture was poured into water at room temperature and extracted with EtOAc. The organic layer was separated, dried over MgSO<sub>4</sub>, and concentrated in vacuo. The residue was purified by column chromatography (NH silica gel, eluted with 50–80% EtOAc in hexane) to give the crude product as a white solid. This solid was dissolved in DMSO and purified by preparative HPLC under neutral conditions to give <b>17</b> (8.7 mg, 17%) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 5.34 (2H, s), 7.09–7.20 (5H, m), 7.56–7.61 (2H, m), 8.16 (1H, d, <i>J</i> = 2.1 Hz), 8.67 (1H, d, <i>J</i> = 2.1 Hz). MS <i>m</i>/<i>z</i>: 326.1 [M + H]<sup>+</sup>. HPLC purity 99.2%.</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 2-(Phenoxymethyl)-6-(thiophen-2-yl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (18)</h4><div class="NLM_p last">Compound <b>18</b> was prepared from 6-bromo-2-(phenoxymethyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>47</b>) in a manner similar to that described for the synthesis of <b>17</b> and obtained (42% yield) as a brown solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 5.31–5.40 (2H, m), 6.95–7.02 (1H, m), 7.07–7.13 (2H, m), 7.18 (1H, dd, <i>J</i> = 5.1, 3.7 Hz), 7.28–7.37 (2H, m), 7.59 (2H, td, <i>J</i> = 4.0, 1.2 Hz), 8.17 (1H, brs), 8.68 (1H, d, <i>J</i> = 2.1 Hz), 13.23 (1H, brs). MS <i>m</i>/<i>z</i>: 308.2 [M + H]<sup>+</sup>. HPLC purity 98.6%.</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 6-(3-Isopropylthiophen-2-yl)-2-(phenoxymethyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>19</b>)</h4><div class="NLM_p">To a solution of <b>47</b> (500 mg, 1.65 mmol), bis(pinacolato)diboron (1.25 g, 4.95 mmol), and potassium acetate (970 mg, 9.90 mmol) in DMF (15 mL) was added PdCl<sub>2</sub>(dppf) (134 mg, 0.183 mmol) at room temperature. The mixture was heated at 110 °C for 1 h under microwave irradiation. The mixture was filtered through a Celite bed and washed with EtOAc. The filtrate was poured into water. The organic layer was separated, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo to give 2-(phenoxymethyl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (800 mg, crude) as a black semisolid. This product was subjected to the next reaction without further purification. MS <i>m</i>/<i>z</i>: 270.21 [M + H]<sup>+</sup>.</div><div class="NLM_p last">To a solution of the crude product (798 mg, 2.27 mmol) and Na<sub>2</sub>CO<sub>3</sub> (547 mg, 5.17 mmol) in 1,4-dioxane (6 mL) and water (2 mL) were added 2-bromo-3-isopropylthiophene (212 mg, 1.03 mmol) and Pd(Amphos)Cl<sub>2</sub> (73 mg, 0.10 mmol) at room temperature. The mixture was heated at 100 °C for 2 h under microwave irradiation. The mixture was filtered through a Celite bed and washed with EtOAc. The organic layer was separated, washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo to give the crude product. The crude product was purified by column chromatography (silica gel, eluted with 30% EtOAc in petroleum ether), followed by preparative HPLC under neutral conditions to give <b>19</b> (16 mg, 3%, overall yield on 2 steps) as an off white solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.19 (6H, d, <i>J</i> = 6.71 Hz), 3.02–3.05 (1H, m), 5.35 (2H, s), 6.99 (1H, t, <i>J</i> = 7.3 Hz), 7.10 (2H, d, <i>J</i> = 7.9 Hz), 7.20 (1H, d, <i>J</i> = 5.2 Hz), 7.30–7.33 (2H, m), 7.53 (1H, d, <i>J</i> = 5.5 Hz), 7.89 (1H, d, <i>J</i> = 2.1 Hz), 8.30 (1H, d, <i>J</i> = 1.8 Hz), 13.34 (1H, brs). MS <i>m</i>/<i>z</i>: 350.31 [M + H]<sup>+</sup>. HPLC purity 95.7%.</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 2-(4-Fluorophenethyl)-6-(thiophen-2-yl)oxazolo[5,4-<i>b</i>]pyridine (<b>20</b>)</h4><div class="NLM_p">To a solution of 3-amino-5-bromopyridin-2-ol (500 mg, 2.65 mmol) in toluene (10 mL) and acetic acid (10 mL) was added <b>32</b> (3.02 g, 13.3 mmol), and the mixture was refluxed for 12 h. After cooling to room temperature, the mixture was concentrated under reduced pressure, and the residue was purified by column chromatography (silica gel, eluted with 0–10% EtOAc in hexane) to give 6-bromo-2-(4-fluorophenethyl)oxazolo[5,4-<i>b</i>]pyridine (115 mg, 14%) as an off white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.10–3.30 (4H, m), 6.97 (2H, t, <i>J</i> = 8.6 Hz), 7.16–7.21(2H, m), 8.08 (1H, d, <i>J</i> = 2.1 Hz), 8.36 (1H, d, <i>J</i> = 2.1 Hz). MS <i>m</i>/<i>z</i>: 320.94 [M + H]<sup>+</sup>.</div><div class="NLM_p last">A mixture of 6-bromo-2-(4-fluorophenethyl)oxazolo[5,4-<i>b</i>]pyridine (61 mg, 0.19 mmol), thiophen-2-ylboronic acid (37 mg, 0.29 mmol), and Na<sub>2</sub>CO<sub>3</sub> (50 mg, 0.48 mmol) in 1,4-dioxane (5 mL) and water (1 mL) was degassed with argon for 10 min. To the resulting mixture was added PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (14 mg, 0.019 mmol), and the mixture was heated at 110 °C for 1 h. The mixture was filtered through a Celite bed, and the filtrate was concentrated under reduced pressure. The residue was purified by column chromatography (silica gel, eluted with 0–15% EtOAc in hexane) to give <b>20</b> (45 mg, 74%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.16 (2H, t, <i>J</i> = 7.6 Hz), 3.28–3.33 (2H, m), 7.11 (2H, t, <i>J</i> = 8.9 Hz), 7.18–7.21 (1H, m), 7.30–7.36 (2H, m), 7.62–7.67 (2H, m), 8.42 (1H, d, <i>J</i> = 2.1 Hz), 8.62 (1H, d, <i>J</i> = 2.0 Hz). MS <i>m</i>/<i>z</i>: 325.3 [M + H]<sup>+</sup>. HPLC purity 96.0%.</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 2-(4-Fluorophenethyl)-6-(thiophen-2-yl)oxazolo[4,5-<i>b</i>]pyridine (<b>21</b>)</h4><div class="NLM_p last">To a solution of <b>33</b> (121 mg, 0.629 mmol) in toluene (2 mL) and AcOH (2 mL) was added <b>32</b> (428 mg, 1.87 mmol), and the mixture was refluxed for 5 h. After cooling to room temperature, the mixture was concentrated under reduced pressure, and the residue was purified by column chromatography (silica gel, eluted with 0–30% EtOAc in hexane) to give <b>21</b> (150 mg, 73%) as an off white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.17 (2H, t, <i>J</i> = 7.6 Hz), 3.28–3.37 (2H, m), 7.11 (2H, t, <i>J</i> = 8.8 Hz), 7.18–7.23 (1H, m), 7.31–7.37 (2H, m), 7.65–7.70 (2H, m), 8.44 (1H, d, <i>J</i> = 1.9 Hz), 8.79 (1H, d, <i>J</i> = 1.9 Hz). MS <i>m</i>/<i>z</i>: 325.2 [M + H]<sup>+</sup>. HPLC purity 98.9%.</div></div><div id="sec5_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 2-(4-Fluorophenethyl)-5-(thiophen-2-yl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>22</b>)</h4><div class="NLM_p last">Compound <b>22</b> was prepared from 5-bromo-2-(4-fluorophenethyl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>48</b>) in a manner similar to that described for the synthesis of <b>17</b> and obtained (50% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.11 (4H, s), 7.05–7.15 (3H, m), 7.25–7.33 (2H, m), 7.39–7.52 (4H, m), 7.71 (1H, brs), 12.32 (1H, brs). MS <i>m</i>/<i>z</i>: 323.1 [M + H]<sup>+</sup>. HPLC purity 97.3%.</div></div><div id="sec5_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 2-(4-Fluorophenethyl)-5-methyl-6-(thiophen-2-yl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>23</b>)</h4><div class="NLM_p last">A solution of 6-bromo-2-(4-fluorophenethyl)-5-methyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>49</b>) (150 mg, 0.449 mmol) and thiophen-2-ylboronic acid (86 mg, 0.67 mmol) in 1,4-dioxane (8 mL) and water (2 mL) was degassed with argon for 10 min. To the mixture were added PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (31.5 mg, 0.0449 mmol) and Na<sub>2</sub>CO<sub>3</sub> (119 mg, 1.12 mmol). The resulting mixture was heated at 110 °C for 16 h. After cooling to room temperature, the mixture was filtered through a Celite bed. The filtrate was concentrated in vacuo, and the residue was purified by column chromatography (silica gel, eluted with 15–20% EtOAc in hexane) to give <b>23</b> (40 mg, 26%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.58 (3H, s), 3.14 (4H, s), 7.05 (2H, t, <i>J</i> = 8.7 Hz), 7.10–7.20 (2H, m), 7.25–7.40 (2H, m), 7.56 (1H, s), 7.79 (1H, s), 12.41 (1H, brs). MS <i>m</i>/<i>z</i>: 338.0 [M + H]<sup>+</sup>. HPLC purity 99.3%.</div></div><div id="sec5_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 2-(4-Fluorophenethyl)-7-methyl-6-(thiophen-2-yl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>24</b>)</h4><div class="NLM_p last">Compound <b>24</b> was prepared from 6-bromo-2-(4-fluorophenethyl)-7-methyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>50</b>) in a manner similar to that described for the synthesis of <b>17</b> and obtained (34% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.58 (3H, s), 3.14 (4H, s), 7.06–7.15 (2H, m), 7.17–7.24 (2H, m), 7.27–7.35 (2H, m), 7.65 (1H, dd, <i>J</i> = 5.1, 1.3 Hz), 8.25 (1H, s), 12.66–12.92 (1H, m). MS <i>m</i>/<i>z</i>: 338.1 [M + H]<sup>+</sup>. HPLC purity 99.4%.</div></div><div id="sec5_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> <i>N</i>-Methyl-2-(2-(phenoxymethyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-6-yl)thiophene-3-carboxamide (<b>25</b>)</h4><div class="NLM_p">To a solution of <b>47</b> (1.8 g, 5.9 mmol) in dichloromethane (20 mL) was added DIPEA (2.1 mL, 12 mmol) and 2-(chloromethoxy)ethyltrimethylsilane (1.3 mL, 7.1 mmol) at 0 °C. The mixture was stirred at 25 °C for 12 h. The mixture was diluted with dichloromethane and washed with water and brine. The organic layer was separated, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo to give 6-bromo-2-(phenoxymethyl)-3-((2-(trimethylsilyl)ethoxy)methyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (1.7 g, 66%) as a yellow oil. MS <i>m</i>/<i>z</i>: 434.1 [M + H]<sup>+</sup>.</div><div class="NLM_p">A mixture of 6-bromo-2-(phenoxymethyl)-3-((2-(trimethylsilyl)ethoxy)methyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (1.5 g, 3.5 mmol), bis(pinacolato)diboron (1.1 g, 4.1 mmol), potassium acetate (1.0 g, 10 mmol), and PdCl<sub>2</sub>(dppf) (253 mg, 0.345 mmol) in 1,4-dioxane (15 mL) was stirred at 90 °C under N<sub>2</sub> for 8 h. The mixture was concentrated in vacuo. The residue was purified by column chromatography (silica gel, eluted with 5–20% EtOAc in petroleum ether) to give 2-(phenoxymethyl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-((2-(trimethylsilyl)ethoxy)methyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (1.5 g, 90%) as a yellow solid. MS <i>m</i>/<i>z</i>: 482.1 [M + H]<sup>+</sup>.</div><div class="NLM_p">To a solution of 2-(phenoxymethyl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-((2-(trimethylsilyl)ethoxy)methyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (100 mg, 0.208 mmol) and 2-bromo-<i>N</i>-methyl-thiophene-3-carboxamide (46 mg, 0.21 mmol) in water (1 mL) and 1,4-dioxane (5 mL) were added potassium carbonate (72 mg, 0.52 mmol) and PdCl<sub>2</sub>(dppf) (15 mg, 0.021 mmol) at room temperature. The mixture was stirred at 90 °C under N<sub>2</sub> for 8 h. The mixture was poured into water at room temperature and extracted with EtOAc. The organic layer was separated, washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The residue was purified by column chromatography (silica gel, 5–30% EtOAc in petroleum ether) to give <i>N</i>-methyl-2-(2-(phenoxymethyl)-3-((2-(trimethylsilyl)ethoxy)methyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-6-yl)thiophene-3-carboxamide (75 mg, 73% yield) as a yellow solid. MS <i>m</i>/<i>z</i>: 495.1 [M + H]<sup>+</sup>.</div><div class="NLM_p last">A mixture of <i>N</i>-methyl-2-(2-(phenoxymethyl)-3-((2-(trimethylsilyl)ethoxy)methyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-6-yl)thiophene-3-carboxamide (70 mg, 0.14 mmol) in dichloromethane (3 mL) and TFA (1 mL) was stirred at 25 °C for 12 h. The mixture was concentrated in vacuo. The residue was purified by preparative HPLC under acidic conditions to give <b>25</b> (26 mg, 50%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.65 (3H, d, <i>J</i> = 4.8 Hz), 5.40 (2H, s), 6.99 (1H, t, <i>J</i> = 7.2 Hz), 7.10 (2H, d, <i>J</i> = 8.0 Hz), 7.31–7.36 (3H, m), 7.65 (1H, d, <i>J</i> = 5.2 Hz), 8.03–8.07 (1H, m), 8.11 (1H, d, <i>J</i> = 4.8 Hz), 8.43 (1H, d, <i>J</i> = 2.0 Hz). MS <i>m</i>/<i>z</i>: 365.1 [M + H]<sup>+</sup>. HPLC purity 98.6%.</div></div><div id="sec5_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> <i>N</i>-Methyl-5-(2-(phenoxymethyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-6-yl)thiophene-3-carboxamide (<b>26</b>)</h4><div class="NLM_p last">Compound <b>26</b> was prepared from methanamine in a manner similar to that described for the synthesis of <b>28</b> and obtained (57% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.78 (3H, d, <i>J</i> = 4.5 Hz), 5.36 (2H, s), 6.95–7.02 (1H, m), 7.08–7.13 (2H, m), 7.29–7.36 (2H, m), 7.89 (1H, d, <i>J</i> = 1.4 Hz), 8.07 (1H, d, <i>J</i> = 1.4 Hz), 8.15 (1H, d, <i>J</i> = 2.1 Hz), 8.30 (1H, d, <i>J</i> = 4.4 Hz), 8.65 (1H, d, <i>J</i> = 2.2 Hz). MS <i>m</i>/<i>z</i>: 365.2 [M + H]<sup>+</sup>. HPLC purity 98.8%.</div></div><div id="sec5_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> <i>N</i>-(2-(2-Methoxyethoxy)ethyl)-5-(2-(phenoxymethyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-6-yl)thiophene-3-carboxamide (<b>27</b>)</h4><div class="NLM_p last">Compound <b>27</b> was prepared from 2-(2-methoxyethoxy)ethan-1-amine in a manner similar to that described for the synthesis of <b>28</b> and obtained (56% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.24 (3H, s), 3.37–3.48 (4H, m), 3.51–3.58 (4H, m), 5.36 (2H, s), 6.95–7.02 (1H, m), 7.07–7.14 (2H, m), 7.29–7.37 (2H, m), 7.93 (1H, d, <i>J</i> = 1.4 Hz), 8.12 (1H, d, <i>J</i> = 1.4 Hz), 8.16 (1H, d, <i>J</i> = 2.1 Hz), 8.40 (1H, t, <i>J</i> = 5.6 Hz), 8.65 (1H, d, <i>J</i> = 2.2 Hz), 12.98–13.53 (1H, m). MS <i>m</i>/<i>z</i>: 453.3 [M + H]<sup>+</sup>. HPLC purity 95.2%.</div></div><div id="sec5_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> <i>N</i>-(2-(3-(But-3-yn-1-yl)-3<i>H</i>-diazirin-3-yl)ethyl)-5-(2-(phenoxymethyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-6-yl)thiophene-3-carboxamide (<b>28</b>)</h4><div class="NLM_p last">A mixture of 2-(3-(but-3-yn-1-yl)-3<i>H</i>-diazirin-3-yl)ethan-1-amine (12 mg, 0.087 mmol), <b>35</b> (30 mg, 0.085 mmol), HATU (39 mg, 0.10 mmol), and DIPEA (18 μL, 0.10 mmol) in DMF (0.6 mL) was stirred at room temperature for 1 h. The mixture was purified by column chromatography (NH silica gel, eluted with 0–15% MeOH in EtOAc) to give <b>28</b> (26 mg, 65%) as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.65 (4H, q, <i>J</i> = 7.3 Hz), 1.98–2.06 (2H, m), 2.85 (1H, t, <i>J</i> = 2.6 Hz), 3.05–3.26 (2H, m), 5.38 (2H, s), 6.96–7.03 (1H, m), 7.08–7.14 (2H, m), 7.29–7.37 (2H, m), 7.91 (1H, d, <i>J</i> = 1.3 Hz), 8.08–8.25 (2H, m), 8.36 (1H, t, <i>J</i> = 5.6 Hz), 8.68 (1H, d, <i>J</i> = 2.1 Hz), 12.98–13.62 (1H, m). MS <i>m</i>/<i>z</i>: 471.2 [M + H]<sup>+</sup>. HPLC purity 99.2%.</div></div><div id="sec5_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 6-Bromo-2-((4-fluorophenoxy)methyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>29</b>)</h4><div class="NLM_p last">To a solution of 5-bromopyridine-2,3-diamine (1.50 g, 7.98 mmol), HATU (3.34 g, 8.78 mmol), and DIPEA (1.53 mL, 8.78 mmol) in DMF (8 mL) was added 2-(4-fluorophenoxy)acetic acid (1.36 g, 7.98 mmol) at room temperature. The mixture was stirred at room temperature for 1 h. The mixture was poured into water at room temperature and extracted with EtOAc. The organic layer was separated, washed with water and brine, dried over MgSO<sub>4</sub>, and concentrated in vacuo. To the residue was added AcOH (10 mL), and the mixture was refluxed overnight. The mixture was quenched with sat. NaHCO<sub>3</sub> aq. at room temperature. The precipitate was collected by filtration and washed with water and EtOAc to give <b>29</b> (1.8 g, 70%) as a pale purple solid. MS <i>m</i>/<i>z</i>: 322.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 3-(4-Fluorophenyl)propanamide (<b>30</b>)</h4><div class="NLM_p last">To a stirred solution of 3-(4-fluorophenyl)propanoic acid (5.0 g, 30 mmol) in chloroform (20 mL) were added DMF (0.231 mL, 2.97 mmol) and oxalyl chloride (2.80 mL, 32.7 mmol) at room temperature. The mixture was stirred at room temperature for 2 h and concentrated in vacuo. The residue was dissolved in chloroform (50 mL), and NH<sub>3</sub> gas was passed through the solution at 0 °C for 30 min. The mixture was stirred at room temperature for 2 h and diluted with dichloromethane and water. The organic layer was separated, washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The residue was purified by column chromatography (silica gel, eluted with 50–70% EtOAc in hexane) to give <b>30</b> (3.8 g, 76%) as white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.49 (2H, t, <i>J</i> = 7.7 Hz), 2.91–2.95 (2H, m), 5.30–5.55 (2H, m), 6.96 (2H, t, <i>J</i> = 8.6 Hz), 7.13–7.19 (2H, m). MS <i>m</i>/<i>z</i>: 168.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 3-(4-Fluorophenyl)propanenitrile (<b>31</b>)</h4><div class="NLM_p last">Compound <b>30</b> (2.5 g, 15 mmol) was dissolved in trifluoroacetic anhydride (8 mL), and the resulting mixture was stirred at room temperature overnight. The mixture was concentrated under reduced pressure, and the residue was diluted with dichloromethane and 2 N NaOH aq. The organic layer was separated, washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The residue was purified by column chromatography (silica gel, eluted with 0–20% EtOAc in hexane) to give <b>31</b> (2.0 g, 90%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.60 (2H, t, <i>J</i> = 7.3 Hz), 2.93 (2H, t, <i>J</i> = 7.3 Hz), 7.02 (2H, t, <i>J</i> = 8.6 Hz), 7.17–7.23 (2H, m).</div></div><div id="sec5_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 1-Fluoro-4-(3,3,3-trimethoxypropyl)benzene (<b>32</b>)</h4><div class="NLM_p last">To a solution of <b>31</b> (6.5 g, 44 mmol) in anhydrous MeOH (2.12 mL) and anhydrous Et<sub>2</sub>O (30 mL) was bubbled HCl gas (freshly generated by adding conc HCl to conc H<sub>2</sub>SO<sub>4</sub>) at 0 °C for 1 h. The mixture was kept at 4 °C under Ar for 24 h. The mixture was concentrated, and to the residue were added anhydrous MeOH (5.30 mL) and hexane (70 mL). The resulting mixture was stirred at room temperature for 48 h, and precipitated ammonium chloride was removed by filtration. The filtrate was concentrated under reduced pressure to give a mixture of <b>32</b> and the corresponding methyl ester (7.0 g, crude mixture) as a colorless liquid. The mixture was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.96–2.05 (2H, m), 2.50–2.65 (2H, m), 3.25 (9H, s), 6.95 (2H, t, <i>J</i> = 8.6 Hz), 7.10–7.16 (2H, m). [Additional peaks of corresponding ester are also present and some peaks are merged with desired compound. Integration in <sup>1</sup>H NMR showed ca. 57% desired compound.]</div></div><div id="sec5_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 2-Amino-5-(thiophen-2-yl)pyridin-3-ol (<b>33</b>)</h4><div class="NLM_p last">A mixture of 2-amino-5-bromopyridin-3-ol (200 mg, 1.06 mmol), thiophen-2-ylboronic acid (203 mg, 1.59 mmol), PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (74 mg, 0.10 mmol), and Na<sub>2</sub>CO<sub>3</sub> (561 mg, 5.29 mmol) in 1,4-dioxane (5 mL) and water (1 mL) was stirred at 110 °C under Ar overnight. After cooling to room temperature, the mixture was filtered through a Celite bed. The filtrate was concentrated under reduced pressure, and the residue was purified by column chromatography (silica gel, eluted with 0–5% MeOH in dichloromethane) to give <b>33</b> (120 mg, 59%) as a brown solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 5.71 (2H, brs), 7.04–7.08 (2H, m), 7.20–7.25 (1H, m), 7.35–7.42 (1H, m), 7.76 (1H, d, <i>J</i> = 1.8 Hz), 9.73 (1H, s). MS <i>m</i>/<i>z</i>: 191.0 [M – H]<sup>−</sup>.</div></div><div id="sec5_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> Methyl 5-(2-(Phenoxymethyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-6-yl)thiophene-3-carboxylate (<b>34</b>)</h4><div class="NLM_p last">Compound <b>34</b> was prepared from <b>47</b> and methyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-3-carboxylate in a manner similar to that described for the synthesis of <b>17</b> and obtained (42% yield) as a brown solid. MS <i>m</i>/<i>z</i>: 366.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 5-(2-(Phenoxymethyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-6-yl)thiophene-3-carboxylic Acid (<b>35</b>)</h4><div class="NLM_p last">To a solution of <b>34</b> (700 mg, 1.92 mmol) in THF (20 mL) and MeOH (10 mL) was added 2 N NaOH aq. (3 mL) at 60 °C. The mixture was stirred at 60 °C for 1 h. The mixture was neutralized with 2 N HCl aq. at room temperature and diluted with water. The resulting solid was collected by filtration and washed with water to give <b>35</b> (580 mg, 86%) as a pale yellow solid. MS <i>m</i>/<i>z</i>: 352.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 6-Bromo-2-phenethyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>36</b>)</h4><div class="NLM_p last">A mixture of 5-bromopyridine-2,3-diamine (1.09 g, 5.80 mmol) and 3-phenylpropanoyl chloride (0.98 g, 5.8 mmol) in diphenylether (0.5 mL) was stirred at 170 °C for 1.5 h. The mixture was diluted with a mixture of chloroform and methanol (10:1) and neutralized with 1 N NaOH aq. at room temperature. The organic layer was separated, washed with water and brine, dried over MgSO<sub>4</sub>, and concentrated in vacuo. The residue was washed with diethyl ether to give <b>36</b> (1.33 g, 76%) as a white solid. MS <i>m</i>/<i>z</i>: 302.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 6-Bromo-2-phenyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>37</b>)</h4><div class="NLM_p last">A mixture of P<sub>2</sub>O<sub>5</sub> (1.70 g, 12.0 mmol) and methanesulfonic acid (6 mL) was stirred at 100 °C for 1 h. To the mixture were added 5-bromopyridine-2,3-diamine (1.13 g, 6.00 mmol) and benzoic acid (0.73 g, 6.0 mmol). The mixture was stirred at 100 °C for 1 h. After cooling to room temperature, the mixture was poured into 4 N NaOH aq. (100 mL) at 0 °C and stirred at room temperature for 40 min. The mixture was neutralized with conc. HCl. The resulting solid was collected by filtration and washed with water and diethyl ether to give <b>37</b> (0.79 g, 48%) as a white solid. MS <i>m</i>/<i>z</i>: 273.8 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 2-Benzyl-6-bromo-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>38</b>)</h4><div class="NLM_p last">Compound <b>38</b> was prepared from 2-phenylacetyl chloride in a manner similar to that described for the synthesis of <b>36</b> and obtained (71% yield) as a white solid. MS <i>m</i>/<i>z</i>: 288.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 6-Bromo-2-(2-chlorophenethyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>39</b>)</h4><div class="NLM_p last">A mixture of 3-(2-chlorophenyl)propanoic acid (2.42 g, 13.1 mmol), 5-bromopyridine-2,3-diamine (2.44 g, 13.0 mmol), and POCl<sub>3</sub> (60 mL) was stirred at 140 °C for 4 h. After cooling to room temperature, the mixture was concentrated in vacuo. The residue was poured into water, neutralized with 1 N NaOH aq., and extracted with EtOAc. The organic layer was separated, washed with water and brine, dried over MgSO<sub>4</sub>, and concentrated in vacuo. The residue was washed with diisopropyl ether to give <b>39</b> (1.95 g, 45%) as a brown solid. MS <i>m</i>/<i>z</i>: 336.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 6-Bromo-2-(3-chlorophenethyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>40</b>)</h4><div class="NLM_p last">Compound <b>40</b> was prepared from 3-(3-chlorophenyl)propanoic acid in a manner similar to that described for the synthesis of <b>39</b> and obtained (72% yield) as a brown solid. MS <i>m</i>/<i>z</i>: 336.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 6-Bromo-2-(4-chlorophenethyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>41</b>)</h4><div class="NLM_p last">Compound <b>41</b> was prepared from 3-(4-chlorophenyl)propanoic acid in a manner similar to that described for the synthesis of <b>39</b> and obtained (20% yield) as a white solid. MS <i>m</i>/<i>z</i>: 336.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 6-Bromo-2-(4-methylphenethyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>42</b>)</h4><div class="NLM_p last">Compound <b>42</b> was prepared from 3-(<i>p</i>-tolyl)propanoic acid in a manner similar to that described for the synthesis of <b>39</b> and obtained (35% yield) as a pale yellow solid. MS <i>m</i>/<i>z</i>: 316.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 6-Bromo-2-(4-methoxyphenethyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>43</b>)</h4><div class="NLM_p last">To a mixture of 3-(4-methoxyphenyl)propanoic acid (1.8 g, 10 mmol) in THF (30 mL) were added oxalyl chloride (1.1 mL, 12 mmol) and DMF (20 μL) at 4 °C. The mixture was stirred at room temperature for 1.5 h. The mixture was concentrated in vacuo, and to the residue was added toluene. The solution was concentrated again to remove an excess amount of oxalyl chloride. To the residual oil was added 5-bromopyridine-2,3-diamine (1.7 g, 9.0 mmol), and the mixture was stirred at 170 °C for 30 min. The mixture was suspended in MeOH and H<sub>2</sub>SO<sub>4</sub> at room temperature and stirred at 80 °C for 3 h. After cooling to room temperature, the mixture was concentrated in vacuo. The residue was poured into water, neutralized with sat. NaHCO<sub>3</sub> aq., and extracted with EtOAc. The organic layer was separated, washed with water and brine, dried over MgSO<sub>4</sub>, and concentrated in vacuo. The residue was purified by column chromatography (silica gel, 50–80% EtOAc in hexane) to give <b>43</b> (600 mg, 20%) as a white solid. MS <i>m</i>/<i>z</i>: 332.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 6-Bromo-2-(4-fluorophenethyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>44</b>)</h4><div class="NLM_p last">Compound <b>44</b> was prepared from 3-(4-fluorophenyl)propanoic acid in a manner similar to that described for the synthesis of <b>29</b> and obtained (65% yield) as a brown solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.04–3.19 (4H, m), 7.00–7.15 (2H, m), 7.23–7.34 (2H, m), 8.16 (1H, d, <i>J</i> = 2.2 Hz), 8.33 (1H, d, <i>J</i> = 2.2 Hz), 12.39–13.29 (1H, m). MS <i>m</i>/<i>z</i>: 320.9 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 6-Bromo-2-(4-(trifluoromethyl)phenethyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>45</b>)</h4><div class="NLM_p last">Compound <b>45</b> was prepared from 3-(4-(trifluoromethyl)phenyl)propanoic acid in a manner similar to that described for the synthesis of <b>39</b> and obtained (78% yield) as a brown solid. MS <i>m</i>/<i>z</i>: 370.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 4-(2-(6-Bromo-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2-yl)ethyl)benzonitrile (<b>46</b>)</h4><div class="NLM_p last">Compound <b>46</b> was prepared from 3-(4-cyanophenyl)propanoic acid in a manner similar to that described for the synthesis of <b>39</b> and obtained (79% yield) as a pale yellow solid. MS <i>m</i>/<i>z</i>: 327.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 6-Bromo-2-(phenoxymethyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>47</b>)</h4><div class="NLM_p last">Compound <b>47</b> was prepared from 2-phenoxyacetic acid in a manner similar to that described for the synthesis of <b>29</b> and obtained (65% yield) as a brown solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 5.28–5.43 (2H, m), 6.94–7.03 (1H, m), 7.06–7.15 (2H, m), 7.26–7.39 (2H, m), 8.18–8.31 (1H, m), 8.37–8.50 (1H, m). MS <i>m</i>/<i>z</i>: 304.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 5-Bromo-2-(4-fluorophenethyl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>48</b>)</h4><div class="NLM_p last">Compound <b>48</b> was prepared from 3-(4-fluorophenyl)propanoic acid and 4-bromobenzene-1,2-diamine in a manner similar to that described for the synthesis of <b>29</b> and obtained (60% yield) as a pale yellow solid. MS <i>m</i>/<i>z</i>: 319.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 6-Bromo-2-(4-fluorophenethyl)-5-methyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>49</b>)</h4><div class="NLM_p last">Compound <b>49</b> was prepared from 3-(4-fluorophenyl)propanoic acid and 4-bromo-5-methylbenzene-1,2-diamine in a manner similar to that described for the synthesis of <b>29</b> and obtained (88% yield) as a pale yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.61 (3H, s), 3.00–3.20 (4H, m), 7.08 (2H, t, <i>J</i> = 8.7 Hz), 7.26 (2H, t, <i>J</i> = 5.8 Hz), 8.13 (1H, s), 12.87 (1H, brs).</div></div><div id="sec5_1_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 6-Bromo-2-(4-fluorophenethyl)-7-methyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>50</b>)</h4><div class="NLM_p last">Compound <b>50</b> was prepared from 3-(4-fluorophenyl)propanoic acid and 4-bromo-3-methylbenzene-1,2-diamine in a manner similar to that described for the synthesis of <b>29</b> and obtained (36% yield) as a brown solid. MS <i>m</i>/<i>z</i>: 335.1 [M + H]<sup>+</sup>.</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Dysferlin Elevation Assay</h3><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> Cells and Reagents</h4><div class="NLM_p last">Patient-derived iPSCs were established from dermal fibroblasts as previously described.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The original dysferlinopathy patient has a compound hetero mutation with both c.2997 G > T (p. W999C) as missense mutation and c.1958 delG as nonsense mutation in the dysferlin gene. Cells from a healthy sibling donor were also used as the normal control. Tet-MyoD1 vector was introduced into iPSCs according to previous methods,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and stably transfected clones were selected for further analysis. These cells were maintained as a feeder-free culture on iMatrix-511 (Nippi. Inc.) in StemFit AK02N (Ajinomoto Healthy Supply Co., Inc.).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Test compounds were dissolved in DMSO and added to culture medium at a final DMSO concentration of 0.1%. Antibodies used in immunostaining were as follows. Primary antibodies: rabbit antidysferlin monoclonal antibody (clone no. JAI-1-49-3, Abcam plc.) and mouse antimyosin heavy chain (MHC) monoclonal antibody (clone no. MF20, R&D Systems). Secondary antibodies: Alexa Fluor 488 conjugated goat anti-rabbit IgG and Alexa Fluor 647 conjugated goat anti-mouse IgG (Thermo Fisher Scientific).</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> Differentiation into Myocyte by MyoD Induction</h4><div class="NLM_p last">The iPSCs were differentiated into myocytes by the inducible expression of MyoD1 as previously described.<a onclick="showRef(event, 'ref14 ref25'); return false;" href="javascript:void(0);" class="ref ref14 ref25">(14,25)</a> Briefly, cells were seeded on matrigel-coated (Corning Inc.) CellCarrier-384 Ultra microplates (PerkinElmer Japan Co., Ltd.) with StemFit AK02N medium containing 10 μM ROCK inhibitor, Y-27632 (FUJIFILM Wako Pure Chemical Corporation), on “day 0”. After 24 h, the medium was changed to Primate ES Cell Medium (REPROCELL Inc.) without basic fibroblast growth factor. After additional 24 h, 1 μg/mL doxycycline (LKT Laboratories, Inc.) was added to the medium. On day 3, the medium was changed to α MEM (Nacalai Tesque Inc.) with 5% KnockOut Serum Replacement (Thermo Fisher Scientific), and 1 μg/mL doxycycline. The medium was changed every other day until the assay.</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> DYSF Immunostaining</h4><div class="NLM_p last">On day 7, each compound diluted in culture medium was added to the wells at final concentrations of 0.003–10 μM. After 24 h treatment, cells were fixed by adding 4% paraformaldehyde (FUJIFILM Wako Pure Chemical Corporation) and incubated for 30 min. Cells were washed with PBS and blocked with 5% goat serum (Invitrogen Corp.)/0.4% TritonX-100 in PBS for 1 h at room temperature followed by the incubation with primary antibodies overnight at 4 °C. On the next day, cells were washed with PBS and incubated with secondary antibodies for 1 h at room temperature. Antibodies were diluted with PBS containing 1% goat serum and 0.4% TritonX-100, and Hoechst 33342 (DOJINDO LABORATORIES) was added to secondary antibody solution for nuclear staining. Stained cells were imaged by Opera Phenix imaging system (PerkinElmer Japan Co., Ltd.). Dysferlin expression levels in differentiated myocyte were determined as the fluorescence intensity at 488 nm in dysferlin/MHC double positive area using Harmony software (PerkinElmer Japan Co., Ltd.).</div></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> Statistical Analysis</h4><div class="NLM_p last">The EC<sub>150</sub> value was defined as the concentration of the test compound required to produce 50% increase of dysferlin expression level. The signal value of the 100% control was obtained from the median value of DMSO treated wells. EC<sub>150</sub> values were calculated with XLfit (IDBS, Guildford, UK) using 4 parameter logistic models.</div></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Aqueous Solubility Assay</h3><div class="NLM_p last">Small volumes of the compound DMSO solutions were added to the aqueous buffer (pH 6.8). After incubation, precipitates were separated from by filtration through a filter plate. The filtrates were analyzed for compound in solution by plate reader or HPLC analysis.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> Parallel Artificial Membrane Permeability Assay</h3><div class="NLM_p last">The donor wells were filled with 200 μL of PRISMA HT buffer (pH 7.4, Pion Inc.) containing 10 μmol/L test compound. The filter on the bottom of each acceptor well was coated with 4 μL of GIT-0 Lipid Solution (Pion Inc.) and filled with 200 μL of Acceptor Sink Buffer (Pion Inc.). The acceptor filter plate was put on the donor plate and incubated for 3 h at room temperature. After incubation, the amount of test compound in both the donor and acceptor wells was measured by LC/MS/MS.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> Cytotoxicity Assay</h3><div class="NLM_p last">HepG2 cells were cultured in DMEM high glucose medium (ThermoFisher Scientific, cat. no. 31053028) containing 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine, 1 mM sodium pyruvate, 5 mM HEPES, 10% (v/v) fetal bovine serum, 100 U mL<sup>–1</sup> penicillin, and 100 μg mL<sup>–1</sup> streptomycin. The cells were seeded at 5000 cells per 20 μL of medium per well on 384-well plates (Greiner Bio-One, Frickenhausen, Germany) for nearly 24 h at 37 °C/5% CO<sub>2</sub>. Subsequently, 20 μL of the medium containing the test compounds was added to the plate, followed by 24 h of incubation at 37 °C/5% CO<sub>2</sub>. Subsequently, 20 μL of the Cell Titer Glo (Promega, Madison, WI) reagent was added to each well, and the luminescence signal was measured using an EnVision plate reader. The signal values of the 0% and 100% inhibition controls were obtained from wells containing DMSO treated cells and the medium only, respectively. The percentage of inhibition was calculated using <a class="ref internalNav" href="#eq1" aria-label="eq 1">eq 1</a>.<span class="NLM_disp-formula" id="eq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/medium/jm9b01100_m001.gif" alt="" id="_i72" /></img><span class="labelSpan">(1)</span></span>where <i>T</i> is the value of the wells containing test compounds, and μ<sub>H</sub> and μ<sub>L</sub> are the mean values of the 0% and 100% inhibition control wells, respectively. IC<sub>50</sub> values were calculated by fitting a sigmoidal dose–response curve to the plot of the percentage of inhibition as a function of inhibitor concentration. Fittings were performed using XLfit software (IDBS, Guildford, UK).</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> Fluorescence Imaging of Tubulin Depolymerization</h3><div class="NLM_p last">HepG2 cells were seeded at 7500 cells per 20 μL of medium per well on clear bottom 384-well plates (Corning, Corning, NY) in assay medium (DMEM low glucose medium (Wako, Osaka, Japan) containing 10% FBS, 100 U mL<sup>–1</sup> penicillin, and 100 μg mL<sup>–1</sup> streptomycin). After incubation for nearly 24 h at 37 °C/5% CO<sub>2</sub>, 5 μL of the assay medium containing 5-fold concentration of test compounds was added to each well, and the plate was further incubated for 24 h at 37 °C/5% CO<sub>2</sub>. To fix the cells, 25 μL of 4% paraformaldehyde phosphate buffer solution (Wako) was added into each well, and the plate was incubated for 30 min at room temperature. After removing the medium, the cells were washed with PBS 3 times, and 50 μL of PBS-T (PBS containing 1.5% (w/v) BSA and 0.1% (v/v) TritonX-100) was added to the plate for cell permeabilization and prevention of nonspecific antibody binding. After 1 h incubation at room temperature, the plate was washed with PBS 3 times, and the cells were incubated with 20 μL of PBS-T containing 250-fold diluted anti-α-tubulin antibody (TU-02) (ref no. sc-8035, Santa Cruz Biotechnology, Dallas, TX) followed by overnight incubation at 4 °C. After removal of the solution, the cells were washed with PBS 3 times, and 20 μL of 12.5 μM Hoechst 33342 (Thermo Fisher Scientific, Waltham, MA) and 400-fold diluted Alexa488-conjugated anti-mouse IgG antibody (ref no. A-11001, Thermo Fisher Scientific) in PBS-T was added to the plate. After 1 h incubation at room temperature, cells were washed 3 times, and fluorescence images were obtained using an INCell Analyzer 6500 (GE Healthcare UK Ltd., Amersham Place, England) with a 20× objective lens. The fluorescence images were quantified using INCell Developer (GE Healthcare UK Ltd.). In order to normalize the number of remaining cells in each well, fluorescence signal of Alexa488 (corresponding to tubulin) was corrected with number of nuclei stained with Hoechst 33342. Signals for 100% and 0% tubulin inhibition were obtained from the wells in the presence and absence of 2 μM colchicine, respectively. Relative Alexa488 fluorescence intensity in the presence of each concentration of compound was calculated by using <a class="ref internalNav" href="#eq2" aria-label="eq 2">eq 2</a>.<span class="NLM_disp-formula" id="eq2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/medium/jm9b01100_m002.gif" alt="" id="_i74" /></img><span class="labelSpan">(2)</span></span>where <i>T</i> is the value of the wells containing test compounds, and μ<sub>H</sub> and μ<sub>L</sub> are the mean values of the 0% and 100% inhibition control wells, respectively. The dose–response curve was fitted with <a class="ref internalNav" href="#eq3" aria-label="eq 3">eq 3</a><span class="NLM_disp-formula" id="eq3"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/medium/jm9b01100_m003.gif" alt="" id="_i75" /></img><span class="labelSpan">(3)</span></span>where IC<sub>50</sub>, [I], and <i>n</i> are half maximal inhibitory concentration, concentration of test compounds, and Hill slope, respectively. Minimal effective concentration (MEC) of each compound was calculated as the concentration where relative intensity corresponded to 100 – 3SD of 0% inhibition control wells by using <a class="ref internalNav" href="#eq3" aria-label="eq 3">eq 3</a>. All fits were performed using XLfit software. The structure, EC<sub>150</sub> value, and MEC value of tested compounds are shown in <a href="/doi/suppl/10.1021/acs.jmedchem.9b01100/suppl_file/jm9b01100_si_001.pdf" class="ext-link">Table S1</a>, Supporting Information.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> Computational Methods and Modeling</h3><div class="NLM_p last">The crystal structure of <i>Sus barbatus</i> tubulin α chain/<i>Gallus gallus</i> tubulin β-2 chain dimer in complex with nocodazole (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5CA1">5CA1</a>) was used as the template for docking. The identities of amino acids between human and <i>Sus barbatus</i> for tubulin α chain and between human and <i>Gallus gallus</i> for tubulin β-2 chain are 99.5% and 99.1%, respectively. In addition, as all the amino acids within 6 Å of nocodazole are conserved between human and <i>Sus barbatus</i> or <i>Gallus gallus</i>, docking models with the structure of <i>Sus barbatus</i> α and <i>Gallus gallus</i> β-2 tubulin dimer can be used to model the interactions between human tubulin dimer and its inhibitor. The protein structure for docking was prepared using Maestro version 11.6 protein preparation wizard [Schrödinger Release 2018-2, Maestro, version 11.6, Schrödinger, LLC, New York, NY, 2018]. The docking simulation was performed with Glide version 7.9 SP mode [Schrödinger Release 2018-2, Glide, version 7.9, Schrödinger, LLC, New York, NY, 2018]. The top conformation in GlideScore was selected as the docking model.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> Competitive Binding Assay with PAL probe</h3><div id="sec5_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> Materials and Method</h4><div class="NLM_p last">The following materials were used for photoaffinity labeling of α/β-tubulin: porcine tubulin (>99% pure, cytoskeleton, no. T240); TAMRA-azide (tetramethylrhodamine 5-carboxamido-(6-azidohexanyl); Lifetechnologies, no. T10182); tris[(1-benzyl-1<i>H</i>-1,2,3-triazol-4-yl)methyl]amine (TBTA) (Tokyo Chemical Industry, no. T2993); <i>tert</i>-butanol (<i>t</i>-BuOH; SIGMA, no. 360538); copper(II) sulfate (SIGMA, no. 451657); tris(2-carboxyethyl)phosphine (TCEP) (SIGMA, no. C4706); low protein binding 96 well plate (Sumitomo Bakelite Co. Ltd., Proteosave no. MS-8296V); Perfect NT Gel, 7.5–15%, 28 well (DRC, no. NTH-787HP).</div></div><div id="sec5_8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> Experimental Procedure</h4><div class="NLM_p last">Tubulin (25 μg/mL) in HEPES based isotonic buffer (20 mM HEPES, 140 mM NaCl, 10 mM KCl, 5% glycerol, pH 7.4), 196 μL, was mixed with 5 μL of DMSO or 1–10 mM compounds (compound <b>18</b>, compound <b>21</b>, nocodazole, vinblastine, colchicine, and paclitaxel) in DMSO for the competition study. The mixture was incubated for 30 min at room temperature, followed by addition of 2 μL of 0.01 mM PAL probe <b>28</b> and incubation on ice for 15 min. A portion of this solution, 40 μL, was transferred to a low protein binding 96 well plate and irradiated by UV cross-linker with CL-1000L lamp, 365 nm, 8 W (UVP, Inc., no. CL-100), for 5 min at 4 °C. To the solution, 5 μL of 10% SDS, 1 μL of 5 mM TAMRA-azide in DMSO, and 5 μL of catalyst mix for click reaction (1.7 mM TBTA in 80% <i>tert</i>-butanol and 20% DMSO/50 mM CuSO<sub>4</sub>/50 mM TCEP = 3:1:1) were added, and the mixture was incubated for 1 h at room temperature; catalyst mix was the prepared just before use. The obtained samples were mixed with Laemmli sample buffer including dithiothreitol (20 mM at the final concentration) and heated at 95 °C for 1 min, and 100 ng of tubulin for each condition was analyzed by SDS-PAGE (200 V, 50 min). The SDS-PAGE gel was scanned with Typhoon 9400 (Amersham Biosciences) to capture the image of PAL-probe-labeled tubulin and stained with Coomassie brilliant blue to observe the total tubulin, which was scanned with LAS4000 (Fujifilm).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i80"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01100" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36250" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36250" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b01100" class="ext-link">10.1021/acs.jmedchem.9b01100</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">The structure, EC<sub>150</sub> value, and MEC value of compounds tested in the tubulin depolymerization assay, preparation of compounds S1–S6, and results of TR-FRET based competitive binding assays against 337 kinases (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01100/suppl_file/jm9b01100_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01100/suppl_file/jm9b01100_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01100/suppl_file/jm9b01100_si_001.pdf">jm9b01100_si_001.pdf (747.97 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01100/suppl_file/jm9b01100_si_002.csv">jm9b01100_si_002.csv (1.96 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b01100" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62118" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62118" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hiroyuki Takada</span> - <span class="hlFld-Affiliation affiliation">Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6650-7902" title="Orcid link">http://orcid.org/0000-0001-6650-7902</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#117978637e68647a783f65707a707570205165707a7475703f727e7c"><span class="__cf_email__" data-cfemail="204849524f59554b490e54414b414441116054414b4544410e434f4d">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Akira Kaieda</span> - <span class="hlFld-Affiliation affiliation">Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1782-2345" title="Orcid link">http://orcid.org/0000-0003-1782-2345</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michiko Tawada</span> - <span class="hlFld-Affiliation affiliation">Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tomoko Nagino</span> - <span class="hlFld-Affiliation affiliation">T-CiRA
Discovery, Takeda Pharmaceutical Company
Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katsunori Sasa</span> - <span class="hlFld-Affiliation affiliation">T-CiRA
Discovery, Takeda Pharmaceutical Company
Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tatsuo Oikawa</span> - <span class="hlFld-Affiliation affiliation">T-CiRA
Discovery, Takeda Pharmaceutical Company
Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Akiko Oki</span> - <span class="hlFld-Affiliation affiliation">Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tomoya Sameshima</span> - <span class="hlFld-Affiliation affiliation">Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3580-3095" title="Orcid link">http://orcid.org/0000-0002-3580-3095</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kazumasa Miyamoto</span> - <span class="hlFld-Affiliation affiliation">Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Makoto Miyamoto</span> - <span class="hlFld-Affiliation affiliation">Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuko Kokubu</span> - <span class="hlFld-Affiliation affiliation">Center
for iPS Cell Research and Application, Kyoto
University, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ryuichi Tozawa</span> - <span class="hlFld-Affiliation affiliation">T-CiRA
Discovery, Takeda Pharmaceutical Company
Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hidetoshi Sakurai</span> - <span class="hlFld-Affiliation affiliation">Center
for iPS Cell Research and Application, Kyoto
University, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bunnai Saito</span> - <span class="hlFld-Affiliation affiliation">Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i82">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84001" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84001" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We are grateful to Masanori Okaniwa, Tsuneo Oda, Yasuhisa Kohara, Mika Inoue, and Hiroshi Imoto for their support to the synthesis study. We also thank Akiko Kume for the assistance with the dysferlin elevation assay. The kinase selectivity assay was carried out with the cooperation of Axcelead Drug Discovery Partners Inc.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AcOH</td><td class="NLM_def"><p class="first last">acetic acid</p></td></tr><tr><td class="NLM_term">AcONH<sub>4</sub></td><td class="NLM_def"><p class="first last">ammonium acetate</p></td></tr><tr><td class="NLM_term">BSA</td><td class="NLM_def"><p class="first last">bovine serum albumin</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DMAT</td><td class="NLM_def"><p class="first last">distal myopathy with anterior tibial onset</p></td></tr><tr><td class="NLM_term">DME</td><td class="NLM_def"><p class="first last">1,2-dimethoxyethane</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">DMSO-<i>d</i><sub>6</sub></td><td class="NLM_def"><p class="first last">deuterated dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">2-(7-aza-1<i>H</i>-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">iPSC</td><td class="NLM_def"><p class="first last">induced pluripotent stem cell</p></td></tr><tr><td class="NLM_term">LGMD2B</td><td class="NLM_def"><p class="first last">limb girdle muscular dystrophy 2B</p></td></tr><tr><td class="NLM_term">MeCN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">MEC</td><td class="NLM_def"><p class="first last">minimal effective concentration</p></td></tr><tr><td class="NLM_term">MM</td><td class="NLM_def"><p class="first last">Miyoshi myopathy</p></td></tr><tr><td class="NLM_term">PAL</td><td class="NLM_def"><p class="first last">photoaffinity labeling</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate buffered salts</p></td></tr><tr><td class="NLM_term">Pd(Amphos)Cl<sub>2</sub></td><td class="NLM_def"><p class="first last">bis(di-<i>tert</i>-butyl(4-dimethylaminophenyl)phosphine)dichloropalladium(II)</p></td></tr><tr><td class="NLM_term">PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub></td><td class="NLM_def"><p class="first last">bis(triphenylphosphine)dichloropalladium(II)</p></td></tr><tr><td class="NLM_term">PdCl<sub>2</sub>(dppf)</td><td class="NLM_def"><p class="first last">[1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II)</p></td></tr><tr><td class="NLM_term">Pd(PPh<sub>3</sub>)<sub>4</sub></td><td class="NLM_def"><p class="first last">tetrakis(triphenylphosphine)palladium(0)</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationships</p></td></tr><tr><td class="NLM_term">TAMRA</td><td class="NLM_def"><p class="first last">tetramethylrhodamine</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i84">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88736" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88736" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 25 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swinney, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anthony, J.</span></span> <span> </span><span class="NLM_article-title">How were new medicines discovered?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">507</span>– <span class="NLM_lpage">519</span>, <span class="refDoi"> DOI: 10.1038/nrd3480</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1038%2Fnrd3480" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=21701501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotlCmsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=507-519&author=D.+C.+Swinneyauthor=J.+Anthony&title=How+were+new+medicines+discovered%3F&doi=10.1038%2Fnrd3480"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">How were new medicines discovered?</span></div><div class="casAuthors">Swinney, David C.; Anthony, Jason</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">507-519</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Preclin. strategies that are used to identify potential drug candidates include target-based screening, phenotypic screening, modification of natural substances and biol.-based approaches.  To investigate whether some strategies have been more successful than others in the discovery of new drugs, we analyzed the discovery strategies and the mol. mechanism of action (MMOA) for new mol. entities and new biologics that were approved by the US Food and Drug Administration between 1999 and 2008.  Out of the 259 agents that were approved, 75 were first-in-class drugs with new MMOAs, and out of these, 50 (67%) were small mols. and 25 (33%) were biologics.  The results also show that the contribution of phenotypic screening to the discovery of first-in-class small-mol. drugs exceeded that of target-based approaches - with 28 and 17 of these drugs coming from the two approaches, resp. - in an era in which the major focus was on target-based approaches.  We postulate that a target-centric approach for first-in-class drugs, without consideration of an optimal MMOA, may contribute to the current high attrition rates and low productivity in pharmaceutical research and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE8Ah1iNz76bVg90H21EOLACvtfcHk0liE5LKcRXccmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotlCmsbs%253D&md5=7503620f8fbadb0a829f6ea2029936a2</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd3480&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3480%26sid%3Dliteratum%253Aachs%26aulast%3DSwinney%26aufirst%3DD.%2BC.%26aulast%3DAnthony%26aufirst%3DJ.%26atitle%3DHow%2520were%2520new%2520medicines%2520discovered%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D507%26epage%3D519%26doi%3D10.1038%2Fnrd3480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moffat, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eder, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prunotto, M.</span></span> <span> </span><span class="NLM_article-title">Opportunities and challenges in phenotypic drug discovery: an industry perspective</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">531</span>– <span class="NLM_lpage">543</span>, <span class="refDoi"> DOI: 10.1038/nrd.2017.111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1038%2Fnrd.2017.111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=28685762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFelsLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=531-543&author=J.+G.+Moffatauthor=F.+Vincentauthor=J.+A.+Leeauthor=J.+Ederauthor=M.+Prunotto&title=Opportunities+and+challenges+in+phenotypic+drug+discovery%3A+an+industry+perspective&doi=10.1038%2Fnrd.2017.111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Opportunities and challenges in phenotypic drug discovery: an industry perspective</span></div><div class="casAuthors">Moffat, John G.; Vincent, Fabien; Lee, Jonathan A.; Eder, Jorg; Prunotto, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">531-543</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Phenotypic drug discovery (PDD) approaches do not rely on knowledge of the identity of a specific drug target or a hypothesis about its role in disease, in contrast to the target-based strategies that have been widely used in the pharmaceutical industry in the past three decades.  However, in recent years, there has been a resurgence in interest in PDD approaches based on their potential to address the incompletely understood complexity of diseases and their promise of delivering first-in-class drugs, as well as major advances in the tools for cell-based phenotypic screening.  Nevertheless, PDD approaches also have considerable challenges, such as hit validation and target deconvolution.  This article focuses on the lessons learned by researchers engaged in PDD in the pharmaceutical industry and considers the impact of 'omics' knowledge in defining a cellular disease phenotype in the era of precision medicine, introducing the concept of a chain of translatability.  We particularly aim to identify features and areas in which PDD can best deliver value to drug discovery portfolios and can contribute to the identification and the development of novel medicines, and to illustrate the challenges and uncertainties that are assocd. with PDD in order to help set realistic expectations with regard to its benefits and costs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGrD5TsU8_kLVg90H21EOLACvtfcHk0ljtL5bEQsY6Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFelsLrJ&md5=d83196715c879a81d9eabcf544e303db</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2017.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2017.111%26sid%3Dliteratum%253Aachs%26aulast%3DMoffat%26aufirst%3DJ.%2BG.%26aulast%3DVincent%26aufirst%3DF.%26aulast%3DLee%26aufirst%3DJ.%2BA.%26aulast%3DEder%26aufirst%3DJ.%26aulast%3DPrunotto%26aufirst%3DM.%26atitle%3DOpportunities%2520and%2520challenges%2520in%2520phenotypic%2520drug%2520discovery%253A%2520an%2520industry%2520perspective%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26spage%3D531%26epage%3D543%26doi%3D10.1038%2Fnrd.2017.111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heilker, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traub, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinhardt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scholer, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sterneckert, J.</span></span> <span> </span><span class="NLM_article-title">iPS cell derived neuronal cells for drug discovery</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">510</span>– <span class="NLM_lpage">519</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2014.07.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1016%2Fj.tips.2014.07.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=25096281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1GktrzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=510-519&author=R.+Heilkerauthor=S.+Traubauthor=P.+Reinhardtauthor=H.+R.+Scholerauthor=J.+Sterneckert&title=iPS+cell+derived+neuronal+cells+for+drug+discovery&doi=10.1016%2Fj.tips.2014.07.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">iPS cell derived neuronal cells for drug discovery</span></div><div class="casAuthors">Heilker, Ralf; Traub, Stefanie; Reinhardt, Peter; Schoeler, Hans R.; Sterneckert, Jared</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">510-519</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Owing to the inherent disconnect between drug pharmacol. in heterologous cellular models and drug efficacy in vivo, the quest for more predictive in vitro systems is one of the most urgent challenges of modern drug discovery.  An improved pharmacol. in vitro profiling would employ primary samples of the proper drug-targeted human tissue or the bona fide human disease-relevant cells.  With the advent of induced pluripotent stem (iPS) cell technol. the facilitated access to a variety of disease-relevant target cells is now held out in prospect.  In this review, we focus on the use of human iPS cell derived neurons for high throughput pharmaceutical drug screening, employing detection technologies that are sufficiently sensitive to measure signaling in cells with physiol. target protein expression levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6UpEO1YZplbVg90H21EOLACvtfcHk0ljtL5bEQsY6Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1GktrzP&md5=6c178a3016f1cd8932bed7ece22def81</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2014.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2014.07.003%26sid%3Dliteratum%253Aachs%26aulast%3DHeilker%26aufirst%3DR.%26aulast%3DTraub%26aufirst%3DS.%26aulast%3DReinhardt%26aufirst%3DP.%26aulast%3DScholer%26aufirst%3DH.%2BR.%26aulast%3DSterneckert%26aufirst%3DJ.%26atitle%3DiPS%2520cell%2520derived%2520neuronal%2520cells%2520for%2520drug%2520discovery%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2014%26volume%3D35%26spage%3D510%26epage%3D519%26doi%3D10.1016%2Fj.tips.2014.07.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loria, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pregel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanton, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitching, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nocka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyonnas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steppan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroeter, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peakman, M. C.</span></span> <span> </span><span class="NLM_article-title">Developing predictive assays: the phenotypic screening ″rule of 3″</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">293ps15</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.aab1201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1126%2Fscitranslmed.aab1201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=26109101" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=293ps15&author=F.+Vincentauthor=P.+Loriaauthor=M.+Pregelauthor=R.+Stantonauthor=L.+Kitchingauthor=K.+Nockaauthor=R.+Doyonnasauthor=C.+Steppanauthor=A.+Gilbertauthor=T.+Schroeterauthor=M.+C.+Peakman&title=Developing+predictive+assays%3A+the+phenotypic+screening+%E2%80%B3rule+of+3%E2%80%B3&doi=10.1126%2Fscitranslmed.aab1201"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aab1201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aab1201%26sid%3Dliteratum%253Aachs%26aulast%3DVincent%26aufirst%3DF.%26aulast%3DLoria%26aufirst%3DP.%26aulast%3DPregel%26aufirst%3DM.%26aulast%3DStanton%26aufirst%3DR.%26aulast%3DKitching%26aufirst%3DL.%26aulast%3DNocka%26aufirst%3DK.%26aulast%3DDoyonnas%26aufirst%3DR.%26aulast%3DSteppan%26aufirst%3DC.%26aulast%3DGilbert%26aufirst%3DA.%26aulast%3DSchroeter%26aufirst%3DT.%26aulast%3DPeakman%26aufirst%3DM.%2BC.%26atitle%3DDeveloping%2520predictive%2520assays%253A%2520the%2520phenotypic%2520screening%2520%25E2%2580%25B3rule%2520of%25203%25E2%2580%25B3%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2015%26volume%3D7%26spage%3D293ps15%26doi%3D10.1126%2Fscitranslmed.aab1201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izumi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukita, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woltjen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hotta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitaoka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takuma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamaoka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunath, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wray, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furuya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Era, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makioka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujisawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishitoh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Homma, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichijo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Julien, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosokawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akiyama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaneko, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaji, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamanaka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, H.</span></span> <span> </span><span class="NLM_article-title">The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">eaaf3962</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.aaf3962</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1126%2Fscitranslmed.aaf3962" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=28539470" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=eaaf3962&author=K.+Imamuraauthor=Y.+Izumiauthor=A.+Watanabeauthor=K.+Tsukitaauthor=K.+Woltjenauthor=T.+Yamamotoauthor=A.+Hottaauthor=T.+Kondoauthor=S.+Kitaokaauthor=A.+Ohtaauthor=A.+Tanakaauthor=D.+Watanabeauthor=M.+Moritaauthor=H.+Takumaauthor=A.+Tamaokaauthor=T.+Kunathauthor=S.+Wrayauthor=H.+Furuyaauthor=T.+Eraauthor=K.+Makiokaauthor=K.+Okamotoauthor=T.+Fujisawaauthor=H.+Nishitohauthor=K.+Hommaauthor=H.+Ichijoauthor=J.+P.+Julienauthor=N.+Obataauthor=M.+Hosokawaauthor=H.+Akiyamaauthor=S.+Kanekoauthor=T.+Ayakiauthor=H.+Itoauthor=R.+Kajiauthor=R.+Takahashiauthor=S.+Yamanakaauthor=H.+Inoue&title=The+Src%2Fc-Abl+pathway+is+a+potential+therapeutic+target+in+amyotrophic+lateral+sclerosis&doi=10.1126%2Fscitranslmed.aaf3962"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aaf3962&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aaf3962%26sid%3Dliteratum%253Aachs%26aulast%3DImamura%26aufirst%3DK.%26aulast%3DIzumi%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DA.%26aulast%3DTsukita%26aufirst%3DK.%26aulast%3DWoltjen%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DHotta%26aufirst%3DA.%26aulast%3DKondo%26aufirst%3DT.%26aulast%3DKitaoka%26aufirst%3DS.%26aulast%3DOhta%26aufirst%3DA.%26aulast%3DTanaka%26aufirst%3DA.%26aulast%3DWatanabe%26aufirst%3DD.%26aulast%3DMorita%26aufirst%3DM.%26aulast%3DTakuma%26aufirst%3DH.%26aulast%3DTamaoka%26aufirst%3DA.%26aulast%3DKunath%26aufirst%3DT.%26aulast%3DWray%26aufirst%3DS.%26aulast%3DFuruya%26aufirst%3DH.%26aulast%3DEra%26aufirst%3DT.%26aulast%3DMakioka%26aufirst%3DK.%26aulast%3DOkamoto%26aufirst%3DK.%26aulast%3DFujisawa%26aufirst%3DT.%26aulast%3DNishitoh%26aufirst%3DH.%26aulast%3DHomma%26aufirst%3DK.%26aulast%3DIchijo%26aufirst%3DH.%26aulast%3DJulien%26aufirst%3DJ.%2BP.%26aulast%3DObata%26aufirst%3DN.%26aulast%3DHosokawa%26aufirst%3DM.%26aulast%3DAkiyama%26aufirst%3DH.%26aulast%3DKaneko%26aufirst%3DS.%26aulast%3DAyaki%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DKaji%26aufirst%3DR.%26aulast%3DTakahashi%26aufirst%3DR.%26aulast%3DYamanaka%26aufirst%3DS.%26aulast%3DInoue%26aufirst%3DH.%26atitle%3DThe%2520Src%252Fc-Abl%2520pathway%2520is%2520a%2520potential%2520therapeutic%2520target%2520in%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2017%26volume%3D9%26spage%3Deaaf3962%26doi%3D10.1126%2Fscitranslmed.aaf3962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horigome, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawakami, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toguchida, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeya, M.</span></span> <span> </span><span class="NLM_article-title">Activin-A enhances mTOR signaling to promote aberrant chondrogenesis in fibrodysplasia ossificans progressiva</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">3339</span>– <span class="NLM_lpage">3352</span>, <span class="refDoi"> DOI: 10.1172/JCI93521</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1172%2FJCI93521" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=28758906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A280%3ADC%252BC1cfis1Kiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2017&pages=3339-3352&author=K.+Hinoauthor=K.+Horigomeauthor=M.+Nishioauthor=S.+Komuraauthor=S.+Nagataauthor=C.+Zhaoauthor=Y.+Jinauthor=K.+Kawakamiauthor=Y.+Yamadaauthor=A.+Ohtaauthor=J.+Toguchidaauthor=M.+Ikeya&title=Activin-A+enhances+mTOR+signaling+to+promote+aberrant+chondrogenesis+in+fibrodysplasia+ossificans+progressiva&doi=10.1172%2FJCI93521"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Activin-A enhances mTOR signaling to promote aberrant chondrogenesis in fibrodysplasia ossificans progressiva</span></div><div class="casAuthors">Hino Kyosuke; Horigome Kazuhiko; Nagata Sanae; Toguchida Junya; Hino Kyosuke; Horigome Kazuhiko; Nishio Megumi; Jin Yonghui; Toguchida Junya; Komura Shingo; Zhao Chengzhu; Yamada Yasuhiro; Ikeya Makoto; Komura Shingo; Jin Yonghui; Toguchida Junya; Kawakami Koichi; Kawakami Koichi; Yamada Yasuhiro; Ohta Akira; Toguchida Junya</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical investigation</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3339-3352</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Fibrodysplasia ossificans progressiva (FOP) is a rare and intractable disease characterized by extraskeletal bone formation through endochondral ossification.  Patients with FOP harbor point mutations in ACVR1, a type I receptor for BMPs.  Although mutated ACVR1 (FOP-ACVR1) has been shown to render hyperactivity in BMP signaling, we and others have uncovered a mechanism by which FOP-ACVR1 mistransduces BMP signaling in response to Activin-A, a molecule that normally transduces TGF-β signaling.  Although Activin-A evokes enhanced chondrogenesis in vitro and heterotopic ossification (HO) in vivo, the underlying mechanisms have yet to be revealed.  To this end, we developed a high-throughput screening (HTS) system using FOP patient-derived induced pluripotent stem cells (FOP-iPSCs) to identify pivotal pathways in enhanced chondrogenesis that are initiated by Activin-A.  In a screen of 6,809 small-molecule compounds, we identified mTOR signaling as a critical pathway for the aberrant chondrogenesis of mesenchymal stromal cells derived from FOP-iPSCs (FOP-iMSCs).  Two different HO mouse models, an FOP model mouse expressing FOP-ACVR1 and an FOP-iPSC-based HO model mouse, revealed critical roles for mTOR signaling in vivo.  Moreover, we identified ENPP2, an enzyme that generates lysophosphatidic acid, as a linker of FOP-ACVR1 and mTOR signaling in chondrogenesis.  These results uncovered the crucial role of the Activin-A/FOP-ACVR1/ENPP2/mTOR axis in FOP pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRpSiQmce1M_3O4gDb7JggCfW6udTcc2ebo6-U8ekrrK7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cfis1Kiuw%253D%253D&md5=0dc58b47256454b55b1587b62dfb959c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1172%2FJCI93521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI93521%26sid%3Dliteratum%253Aachs%26aulast%3DHino%26aufirst%3DK.%26aulast%3DHorigome%26aufirst%3DK.%26aulast%3DNishio%26aufirst%3DM.%26aulast%3DKomura%26aufirst%3DS.%26aulast%3DNagata%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DKawakami%26aufirst%3DK.%26aulast%3DYamada%26aufirst%3DY.%26aulast%3DOhta%26aufirst%3DA.%26aulast%3DToguchida%26aufirst%3DJ.%26aulast%3DIkeya%26aufirst%3DM.%26atitle%3DActivin-A%2520enhances%2520mTOR%2520signaling%2520to%2520promote%2520aberrant%2520chondrogenesis%2520in%2520fibrodysplasia%2520ossificans%2520progressiva%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2017%26volume%3D127%26spage%3D3339%26epage%3D3352%26doi%3D10.1172%2FJCI93521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Illa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fardeau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angelini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serrano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urtizberea, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hentati, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamida, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohlega, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culper, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amato, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bossie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oeltjen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bejaoui, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenna-Yasek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosler, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schurr, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arahata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jong, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, R. H.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">31</span>– <span class="NLM_lpage">36</span>, <span class="refDoi"> DOI: 10.1038/1682</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1038%2F1682" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=9731526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A528%3ADyaK1cXmtVOmt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1998&pages=31-36&author=J.+Liuauthor=M.+Aokiauthor=I.+Illaauthor=C.+Wuauthor=M.+Fardeauauthor=C.+Angeliniauthor=C.+Serranoauthor=J.+A.+Urtizbereaauthor=F.+Hentatiauthor=M.+B.+Hamidaauthor=S.+Bohlegaauthor=E.+J.+Culperauthor=A.+A.+Amatoauthor=K.+Bossieauthor=J.+Oeltjenauthor=K.+Bejaouiauthor=D.+McKenna-Yasekauthor=B.+A.+Hoslerauthor=E.+Schurrauthor=K.+Arahataauthor=P.+J.+de+Jongauthor=R.+H.+Brown&title=Dysferlin%2C+a+novel+skeletal+muscle+gene%2C+is+mutated+in+Miyoshi+myopathy+and+limb+girdle+muscular+dystrophy&doi=10.1038%2F1682"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy</span></div><div class="casAuthors">Liu, Jing; Aoki, Masashi; Illa, Isabel; Wu, Chenyan; Fardeau, Michel; Angelini, Corrado; Serrano, Carmen; Urtizberea, J. Andoni; Hentati, Faycal; Ben Hamida, Mongi; Bohlega, Saeed; Culper, Edward J.; Amato, Anthony A.; Bossie, Karen; Oeltjen, Joshua; Bejaoui, Khemissa; McKenna-Yasek, Diane; Hosler, Betsy A.; Schurr, Erwin; Arahata, Kiichi; De Jong, Pieter J.; Brown, Robert H., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-36</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">Miyoshi myopathy (MM) is an adult onset, recessive inherited distal muscular dystrophy that the authors have mapped to human chromosome 2p13.  The authors recently constructed a 3-Mb P1-derived artificial chromosome (PAC) contig spanning the MM candidate region.  This clarified the order of genetic markers across the MM locus, provided five new polymorphic markers within it and narrowed the locus to approx. 2 Mb.  Five skeletal muscle expressed sequence tags (ESTs) map in this region.  The authors report that one of these is located in a novel, full-length 6.9-kb muscle cDNA, and the authors designate the corresponding protein "dysferlin".  The authors describe nine mutations in the dysferlin gene in nine families; five are predicted to prevent dysferlin expression.  Identical mutations in the dysferlin gene can produce more than one myopathy phenotype (MM, limb girdle dystrophy, distal myopathy with anterior tibial onset).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxkyGFM7tI27Vg90H21EOLACvtfcHk0lgtl1-3bqXJKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmtVOmt7s%253D&md5=f0339b67ae4a42804c7154b466f08e72</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2F1682&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F1682%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DAoki%26aufirst%3DM.%26aulast%3DIlla%26aufirst%3DI.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DFardeau%26aufirst%3DM.%26aulast%3DAngelini%26aufirst%3DC.%26aulast%3DSerrano%26aufirst%3DC.%26aulast%3DUrtizberea%26aufirst%3DJ.%2BA.%26aulast%3DHentati%26aufirst%3DF.%26aulast%3DHamida%26aufirst%3DM.%2BB.%26aulast%3DBohlega%26aufirst%3DS.%26aulast%3DCulper%26aufirst%3DE.%2BJ.%26aulast%3DAmato%26aufirst%3DA.%2BA.%26aulast%3DBossie%26aufirst%3DK.%26aulast%3DOeltjen%26aufirst%3DJ.%26aulast%3DBejaoui%26aufirst%3DK.%26aulast%3DMcKenna-Yasek%26aufirst%3DD.%26aulast%3DHosler%26aufirst%3DB.%2BA.%26aulast%3DSchurr%26aufirst%3DE.%26aulast%3DArahata%26aufirst%3DK.%26aulast%3Dde%2BJong%26aufirst%3DP.%2BJ.%26aulast%3DBrown%26aufirst%3DR.%2BH.%26atitle%3DDysferlin%252C%2520a%2520novel%2520skeletal%2520muscle%2520gene%252C%2520is%2520mutated%2520in%2520Miyoshi%2520myopathy%2520and%2520limb%2520girdle%2520muscular%2520dystrophy%26jtitle%3DNat.%2520Genet.%26date%3D1998%26volume%3D20%26spage%3D31%26epage%3D36%26doi%3D10.1038%2F1682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bashir, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Britton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strachan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keers, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vafiadaki, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lako, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richard, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourg, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argov, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadeh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahjneh, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marconi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passos-Bueno, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreira, E. d. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zatz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckmann, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bushby, K.</span></span> <span> </span><span class="NLM_article-title">A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">42</span>, <span class="refDoi"> DOI: 10.1038/1689</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1038%2F1689" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=9731527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A528%3ADyaK1cXmtVOmt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1998&pages=37-42&author=R.+Bashirauthor=S.+Brittonauthor=T.+Strachanauthor=S.+Keersauthor=E.+Vafiadakiauthor=M.+Lakoauthor=I.+Richardauthor=S.+Marchandauthor=N.+Bourgauthor=Z.+Argovauthor=M.+Sadehauthor=I.+Mahjnehauthor=G.+Marconiauthor=M.+R.+Passos-Buenoauthor=E.+d.+S.+Moreiraauthor=M.+Zatzauthor=J.+S.+Beckmannauthor=K.+Bushby&title=A+gene+related+to+Caenorhabditis+elegans+spermatogenesis+factor+fer-1+is+mutated+in+limb-girdle+muscular+dystrophy+type+2B&doi=10.1038%2F1689"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B</span></div><div class="casAuthors">Bashir, Rumaisa; Britton, Stephen; Strachan, Tom; Keers, Sharon; Vafiadaki, Elizabeth; Lako, Majlinda; Richard, Isabelle; Marchand, Sylvie; Bourg, Nathalie; Argov, Zohar; Sadeh, Menachem; Mahjneh, Ibrahim; Marconi, Giampiero; Passos-Bueno, Maria Rita; De S Moreira, Eloisa; Zatz, Mayana; Beckmann, Jacques S.; Bushby, Kate</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-42</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">The limb-girdle muscular dystrophies are a genetically heterogeneous group of inherited progressive muscle disorders that affect mainly the proximal musculature, with evidence for at least three autosomal dominant and eight autosomal recessive loci.  The latter mostly involve mutations in genes encoding components of the dystrophin-assocd. complex; another form is caused by mutations in the gene for the muscle-specific protease calpain 3.  Using a positional cloning approach, the authors have identified the gene for a form of limb-girdle muscular dystrophy that the authors previously mapped to chromosome 2p13 (LGMD2B).  This gene shows no homol. to any known mammalian gene, but its predicted product is related to the C. elegans spermatogenesis factor fer-1.  The authors have identified two homozygous frameshift mutations in this gene, resulting in muscular dystrophy of either proximal or distal onset in nine families.  The proposed name "dysferlin" combines the role of the gene in producing muscular dystrophy with its C. elegans homol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq896TElAHNpbVg90H21EOLACvtfcHk0lg3JhbjeEp1Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmtVOmt7Y%253D&md5=bce328e4f8ce30f015f6bfdca829aeab</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2F1689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F1689%26sid%3Dliteratum%253Aachs%26aulast%3DBashir%26aufirst%3DR.%26aulast%3DBritton%26aufirst%3DS.%26aulast%3DStrachan%26aufirst%3DT.%26aulast%3DKeers%26aufirst%3DS.%26aulast%3DVafiadaki%26aufirst%3DE.%26aulast%3DLako%26aufirst%3DM.%26aulast%3DRichard%26aufirst%3DI.%26aulast%3DMarchand%26aufirst%3DS.%26aulast%3DBourg%26aufirst%3DN.%26aulast%3DArgov%26aufirst%3DZ.%26aulast%3DSadeh%26aufirst%3DM.%26aulast%3DMahjneh%26aufirst%3DI.%26aulast%3DMarconi%26aufirst%3DG.%26aulast%3DPassos-Bueno%26aufirst%3DM.%2BR.%26aulast%3DMoreira%26aufirst%3DE.%2Bd.%2BS.%26aulast%3DZatz%26aufirst%3DM.%26aulast%3DBeckmann%26aufirst%3DJ.%2BS.%26aulast%3DBushby%26aufirst%3DK.%26atitle%3DA%2520gene%2520related%2520to%2520Caenorhabditis%2520elegans%2520spermatogenesis%2520factor%2520fer-1%2520is%2520mutated%2520in%2520limb-girdle%2520muscular%2520dystrophy%2520type%25202B%26jtitle%3DNat.%2520Genet.%26date%3D1998%26volume%3D20%26spage%3D37%26epage%3D42%26doi%3D10.1038%2F1689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davison, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moss, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cullen, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bashir, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Britton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keers, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argov, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahjneh, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fougerousse, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckmann, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bushby, K. M.</span></span> <span> </span><span class="NLM_article-title">Dysferlin is a plasma membrane protein and is expressed early in human development</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">855</span>– <span class="NLM_lpage">861</span>, <span class="refDoi"> DOI: 10.1093/hmg/8.5.855</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1093%2Fhmg%2F8.5.855" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10196375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A528%3ADyaK1MXivFamtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1999&pages=855-861&author=L.+V.+Andersonauthor=K.+Davisonauthor=J.+A.+Mossauthor=C.+Youngauthor=M.+J.+Cullenauthor=J.+Walshauthor=M.+A.+Johnsonauthor=R.+Bashirauthor=S.+Brittonauthor=S.+Keersauthor=Z.+Argovauthor=I.+Mahjnehauthor=F.+Fougerousseauthor=J.+S.+Beckmannauthor=K.+M.+Bushby&title=Dysferlin+is+a+plasma+membrane+protein+and+is+expressed+early+in+human+development&doi=10.1093%2Fhmg%2F8.5.855"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Dysferlin is a plasma membrane protein and is expressed early in human development</span></div><div class="casAuthors">Anderson, Louise V. B.; Davison, Keith; Moss, Jennifer A.; Young, Carol; Cullen, Michael J.; Walsh, John; Johnson, Margaret A.; Bashir, Rumaisa; Britton, Stephen; Keers, Sharon; Argov, Zohar; Mahjneh, Ibrahim; Fougerousse, Francoise; Beckmann, Jacques S.; Bushby, Kate M. D.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">855-861</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Recently, a single gene, DYSF, has been identified which is mutated in patients with limb-girdle muscular dystrophy type 2B (LGMD2B) and with Miyoshi myopathy (MM).  This is of interest because these diseases have been considered as two distinct clin. conditions since different muscle groups are the initial targets.  Dysferlin, the protein product of the gene, is a novel mol. without homol. to any known mammalian protein.  The authors have now raised a monoclonal antibody to dysferlin and report on the expression of this new protein: immunolabeling with the antibody (designated NCL-hamlet) demonstrated a polypeptide of ∼230 kDa on western blots of skeletal muscle, with localization to the muscle fiber membrane by microscopy at both the light and electron microscopic level.  A specific loss of dysferlin labeling was obsd. in patients with mutations in the LGMD2B/MM gene.  Furthermore, patients with two different frame-shifting mutations demonstrated very low levels of immunoreactive protein in a manner reminiscent of the dystrophin expressed in many Duchenne patients.  Anal. of human fetal tissue showed that dysferlin was expressed at the earliest stages of development examd., at Carnegie stage 15 or 16 (embryonic age 5-6 wk).  Dysferlin is present, therefore, at a time when the limbs start to show regional differentiation.  Lack of dysferlin at this crit. time may contribute to the pattern of muscle involvement that develops later, with the onset of a muscular dystrophy primarily affecting proximal or distal muscles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp98wlh5OkKDbVg90H21EOLACvtfcHk0lg3JhbjeEp1Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXivFamtro%253D&md5=2b82ecf5074c538ff7f302e7697c1fea</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2F8.5.855&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252F8.5.855%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DL.%2BV.%26aulast%3DDavison%26aufirst%3DK.%26aulast%3DMoss%26aufirst%3DJ.%2BA.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DCullen%26aufirst%3DM.%2BJ.%26aulast%3DWalsh%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DM.%2BA.%26aulast%3DBashir%26aufirst%3DR.%26aulast%3DBritton%26aufirst%3DS.%26aulast%3DKeers%26aufirst%3DS.%26aulast%3DArgov%26aufirst%3DZ.%26aulast%3DMahjneh%26aufirst%3DI.%26aulast%3DFougerousse%26aufirst%3DF.%26aulast%3DBeckmann%26aufirst%3DJ.%2BS.%26aulast%3DBushby%26aufirst%3DK.%2BM.%26atitle%3DDysferlin%2520is%2520a%2520plasma%2520membrane%2520protein%2520and%2520is%2520expressed%2520early%2520in%2520human%2520development%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D1999%26volume%3D8%26spage%3D855%26epage%3D861%26doi%3D10.1093%2Fhmg%2F8.5.855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bansal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, K. P.</span></span> <span> </span><span class="NLM_article-title">Dysferlin and the plasma membrane repair in muscular dystrophy</span>. <i>Trends Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">206</span>– <span class="NLM_lpage">213</span>, <span class="refDoi"> DOI: 10.1016/j.tcb.2004.03.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1016%2Fj.tcb.2004.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=15066638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivVGjt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=206-213&author=D.+Bansalauthor=K.+P.+Campbell&title=Dysferlin+and+the+plasma+membrane+repair+in+muscular+dystrophy&doi=10.1016%2Fj.tcb.2004.03.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Dysferlin and the plasma membrane repair in muscular dystrophy</span></div><div class="casAuthors">Bansal, Dimple; Campbell, Kevin P.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">206-213</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Muscular dystrophy covers a group of genetically detd. disorders that cause progressive weakness and wasting of the skeletal muscles.  Dysferlin was identified as a gene mutated in limb-girdle muscular dystrophy (type 2B) and Miyoshi myopathy.  The discovery of dysferlin revealed a new family of proteins, known as the ferlin family, which includes four different genes.  Recent work suggests the function of dysferlin in membrane repair and demonstrates that defective membrane repair is a novel mechanism of muscle degeneration.  These findings reveal the importance of a basic cellular function in skeletal muscle and a new class of muscular dystrophy where the defect lies in the maintenance, not the structure, of the plasma membrane.  Here, the authors discuss the current knowledge of dysferlin function in the repair of the plasma membrane of the skeletal muscle cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdlPn75UrLC7Vg90H21EOLACvtfcHk0lg3JhbjeEp1Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivVGjt7g%253D&md5=7fd91f6e34aea84f5b45e75777bc0244</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.tcb.2004.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tcb.2004.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DBansal%26aufirst%3DD.%26aulast%3DCampbell%26aufirst%3DK.%2BP.%26atitle%3DDysferlin%2520and%2520the%2520plasma%2520membrane%2520repair%2520in%2520muscular%2520dystrophy%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2004%26volume%3D14%26spage%3D206%26epage%3D213%26doi%3D10.1016%2Fj.tcb.2004.03.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, R.</span></span> <span> </span><span class="NLM_article-title">Muscle membrane repair and inflammatory attack in dysferlinopathy</span>. <i>Skeletal Muscle</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">10</span>, <span class="refDoi"> DOI: 10.1186/2044-5040-1-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1186%2F2044-5040-1-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=21798087" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A280%3ADC%252BC3MjitV2quw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=10&author=R.+Han&title=Muscle+membrane+repair+and+inflammatory+attack+in+dysferlinopathy&doi=10.1186%2F2044-5040-1-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Muscle membrane repair and inflammatory attack in dysferlinopathy</span></div><div class="casAuthors">Han Renzhi</div><div class="citationInfo"><span class="NLM_cas:title">Skeletal muscle</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">10</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Repair of plasma membrane tears is an important normal physiological process that enables the cells to survive a variety of physiological and pathological membrane lesions.  Dysferlin was the first protein reported to play a crucial role in this repair process in muscle, and recently, several other proteins including Mitsugumin 53 (MG53), annexin and calpain were also found to participate.  These findings have now established the framework of the membrane repair mechanism.  Defective membrane repair in dysferlin-deficient muscle leads to the development of muscular dystrophy associated with remarkable muscle inflammation.  Recent studies have demonstrated a crosstalk between defective membrane repair and immunological attack, thus unveiling a new pathophysiological mechanism of dysferlinopathy.  Here I summarize and discuss the latest progress in the molecular mechanisms of membrane repair and the pathogenesis of dysferlinopathy.  Discussion about potential therapeutic applications of these findings is also provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRZh8qbcSd5LYxhnOQkIHOxfW6udTcc2eYOrdiWr775prntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MjitV2quw%253D%253D&md5=ea5d3bb8795de5b63ff593522a92fcfc</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1186%2F2044-5040-1-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2044-5040-1-10%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DR.%26atitle%3DMuscle%2520membrane%2520repair%2520and%2520inflammatory%2520attack%2520in%2520dysferlinopathy%26jtitle%3DSkeletal%2520Muscle%26date%3D2011%26volume%3D1%26spage%3D10%26doi%3D10.1186%2F2044-5040-1-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiyosue, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishino, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, Y. K.</span></span> <span> </span><span class="NLM_article-title">Dysferlinopathy fibroblasts are defective in plasma membrane repair</span>. <i>PLoS Curr.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>, <span class="refDoi"> DOI: 10.1371/currents.md.5865add2d766f39a0e0411d38a7ba09c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1371%2Fcurrents.md.5865add2d766f39a0e0411d38a7ba09c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=26579332" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=C.+Matsudaauthor=K.+Kiyosueauthor=I.+Nishinoauthor=Y.+Gotoauthor=Y.+K.+Hayashi&title=Dysferlinopathy+fibroblasts+are+defective+in+plasma+membrane+repair&doi=10.1371%2Fcurrents.md.5865add2d766f39a0e0411d38a7ba09c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1371%2Fcurrents.md.5865add2d766f39a0e0411d38a7ba09c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fcurrents.md.5865add2d766f39a0e0411d38a7ba09c%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuda%26aufirst%3DC.%26aulast%3DKiyosue%26aufirst%3DK.%26aulast%3DNishino%26aufirst%3DI.%26aulast%3DGoto%26aufirst%3DY.%26aulast%3DHayashi%26aufirst%3DY.%2BK.%26atitle%3DDysferlinopathy%2520fibroblasts%2520are%2520defective%2520in%2520plasma%2520membrane%2520repair%26jtitle%3DPLoS%2520Curr.%26date%3D2015%26doi%3D10.1371%2Fcurrents.md.5865add2d766f39a0e0411d38a7ba09c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tateyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yaginuma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayasaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugawara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abe-Kondo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimakura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuru, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakayama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sobue, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funakawa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukai, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawanami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuji, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuzuhara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshioka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konno, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onodera, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoyama, Y.</span></span> <span> </span><span class="NLM_article-title">Clinical features and a mutation with late onset of limb girdle muscular dystrophy 2B</span>. <i>J. Neurol., Neurosurg. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">433</span>– <span class="NLM_lpage">440</span>, <span class="refDoi"> DOI: 10.1136/jnnp-2011-301339</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1136%2Fjnnp-2011-301339" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=23243261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A280%3ADC%252BC3s3itlSjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2013&pages=433-440&author=T.+Takahashiauthor=M.+Aokiauthor=N.+Suzukiauthor=M.+Tateyamaauthor=C.+Yaginumaauthor=H.+Satoauthor=M.+Hayasakaauthor=H.+Sugawaraauthor=M.+Itoauthor=E.+Abe-Kondoauthor=N.+Shimakuraauthor=T.+Ibiauthor=S.+Kuruauthor=T.+Wakayamaauthor=G.+Sobueauthor=N.+Fujiiauthor=T.+Saitoauthor=T.+Matsumuraauthor=I.+Funakawaauthor=E.+Mukaiauthor=T.+Kawanamiauthor=M.+Moritaauthor=M.+Yamazakiauthor=T.+Hasegawaauthor=J.+Shimizuauthor=S.+Tsujiauthor=S.+Kuzuharaauthor=H.+Tanakaauthor=M.+Yoshiokaauthor=H.+Konnoauthor=H.+Onoderaauthor=Y.+Itoyama&title=Clinical+features+and+a+mutation+with+late+onset+of+limb+girdle+muscular+dystrophy+2B&doi=10.1136%2Fjnnp-2011-301339"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical features and a mutation with late onset of limb girdle muscular dystrophy 2B</span></div><div class="casAuthors">Takahashi Toshiaki; Aoki Masashi; Suzuki Naoki; Tateyama Maki; Yaginuma Chikako; Sato Hitomi; Hayasaka Miho; Sugawara Hitomi; Ito Mariko; Abe-Kondo Emi; Shimakura Naoko; Ibi Tohru; Kuru Satoshi; Wakayama Tadashi; Sobue Gen; Fujii Naoki; Saito Toshio; Matsumura Tsuyoshi; Funakawa Itaru; Mukai Eiichiro; Kawanami Toru; Morita Mitsuya; Yamazaki Mineo; Hasegawa Takashi; Shimizu Jun; Tsuji Shoji; Kuzuhara Shigeki; Tanaka Hiroyasu; Yoshioka Masaru; Konno Hidehiko; Onodera Hiroshi; Itoyama Yasuto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurology, neurosurgery, and psychiatry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">433-40</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE AND METHODS:  Dysferlin encoded by DYSF deficiency leads to two main phenotypes, limb girdle muscular dystrophy (LGMD) 2B and Miyoshi myopathy.  To reveal in detail the mutational and clinical features of LGMD2B in Japan, we observed 40 Japanese patients in 36 families with LGMD2B in whom dysferlin mutations were confirmed.  RESULTS AND CONCLUSIONS:  Three mutations (c.1566C>G, c.2997G>T and c.4497delT) were relatively more prevalent.  The c.2997G>T mutation was associated with late onset, proximal dominant forms of dysferlinopathy, a high probability that muscle weakness started in an upper limb and lower serum creatine kinase (CK) levels.  The clinical features of LGMD2B are as follows: (1) onset in the late teens or early adulthood, except patients homozygous for the c.2997G>T mutation; (2) lower limb weakness at onset; (3) distal change of lower limbs on muscle CT at an early stage; (4) impairment of lumbar erector spinal muscles on muscle CT at an early stage; (5) predominant involvement of proximal upper limbs; (6) preservation of function of the hands at late stage; (7) preservation of strength in neck muscles at late stage; (8) lack of facial weakness or dysphagia; (9) avoidance of scoliosis; (10) hyper-Ckaemia; (11) preservation of cardiac function; and (12) a tendency for respiratory function to decline with disease duration.  It is important that the late onset phenotype is found with prevalent mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQIECvdOWcgRKcY7HFp97qMfW6udTcc2eYOrdiWr775prntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s3itlSjuw%253D%253D&md5=5e6664b74e698a33a08095f932343b9d</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1136%2Fjnnp-2011-301339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjnnp-2011-301339%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DT.%26aulast%3DAoki%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DTateyama%26aufirst%3DM.%26aulast%3DYaginuma%26aufirst%3DC.%26aulast%3DSato%26aufirst%3DH.%26aulast%3DHayasaka%26aufirst%3DM.%26aulast%3DSugawara%26aufirst%3DH.%26aulast%3DIto%26aufirst%3DM.%26aulast%3DAbe-Kondo%26aufirst%3DE.%26aulast%3DShimakura%26aufirst%3DN.%26aulast%3DIbi%26aufirst%3DT.%26aulast%3DKuru%26aufirst%3DS.%26aulast%3DWakayama%26aufirst%3DT.%26aulast%3DSobue%26aufirst%3DG.%26aulast%3DFujii%26aufirst%3DN.%26aulast%3DSaito%26aufirst%3DT.%26aulast%3DMatsumura%26aufirst%3DT.%26aulast%3DFunakawa%26aufirst%3DI.%26aulast%3DMukai%26aufirst%3DE.%26aulast%3DKawanami%26aufirst%3DT.%26aulast%3DMorita%26aufirst%3DM.%26aulast%3DYamazaki%26aufirst%3DM.%26aulast%3DHasegawa%26aufirst%3DT.%26aulast%3DShimizu%26aufirst%3DJ.%26aulast%3DTsuji%26aufirst%3DS.%26aulast%3DKuzuhara%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DH.%26aulast%3DYoshioka%26aufirst%3DM.%26aulast%3DKonno%26aufirst%3DH.%26aulast%3DOnodera%26aufirst%3DH.%26aulast%3DItoyama%26aufirst%3DY.%26atitle%3DClinical%2520features%2520and%2520a%2520mutation%2520with%2520late%2520onset%2520of%2520limb%2520girdle%2520muscular%2520dystrophy%25202B%26jtitle%3DJ.%2520Neurol.%252C%2520Neurosurg.%2520Psychiatry%26date%3D2013%26volume%3D84%26spage%3D433%26epage%3D440%26doi%3D10.1136%2Fjnnp-2011-301339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woltjen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyake, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hotta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishino, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoji, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehara-Fujisawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manabe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanaoka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Era, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isobe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, H.</span></span> <span> </span><span class="NLM_article-title">Efficient and reproducible myogenic differentiation from human iPS cells: prospects for modeling Miyoshi myopathy in vitro</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e61540</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0061540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1371%2Fjournal.pone.0061540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=23626698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVKrurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&author=A.+Tanakaauthor=K.+Woltjenauthor=K.+Miyakeauthor=A.+Hottaauthor=M.+Ikeyaauthor=T.+Yamamotoauthor=T.+Nishinoauthor=E.+Shojiauthor=A.+Sehara-Fujisawaauthor=Y.+Manabeauthor=N.+Fujiiauthor=K.+Hanaokaauthor=T.+Eraauthor=S.+Yamashitaauthor=K.+Isobeauthor=E.+Kimuraauthor=H.+Sakurai&title=Efficient+and+reproducible+myogenic+differentiation+from+human+iPS+cells%3A+prospects+for+modeling+Miyoshi+myopathy+in+vitro&doi=10.1371%2Fjournal.pone.0061540"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient and reproducible myogenic differentiation from human iPS cells: prospects for modeling Miyoshi Myopathy in vitro</span></div><div class="casAuthors">Tanaka, Akihito; Woltjen, Knut; Miyake, Katsuya; Hotta, Akitsu; Ikeya, Makoto; Yamamoto, Takuya; Nishino, Tokiko; Shoji, Emi; Sehara-Fujisawa, Atsuko; Manabe, Yasuko; Fujii, Nobuharu; Hanaoka, Kazunori; Era, Takumi; Yamashita, Satoshi; Isobe, Ken-ichi; Kimura, En; Sakurai, Hidetoshi</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e61540</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The establishment of human induced pluripotent stem cells (hiPSCs) has enabled the prodn. of in vitro, patient-specific cell models of human disease.  In vitro recreation of disease pathol. from patient-derived hiPSCs depends on efficient differentiation protocols producing relevant adult cell types.  However, myogenic differentiation of hiPSCs has faced obstacles, namely, low efficiency and/or poor reproducibility.  Here, we report the rapid, efficient and reproducible differentiation of hiPSCs into mature myocytes.  We demonstrated that inducible expression of myogenic differentiation 1 (MYOD1) in immature hiPSCs for at least 5 days drives cells along the myogenic lineage, with efficiencies reaching 70-90 %.  Myogenic differentiation driven by MYOD1 occurred even in immature, almost completely undifferentiated hiPSCs, without mesodermal transition.  Myocytes induced in this manner reach maturity within 2 wk of differentiation as assessed by marker gene expression and functional properties, including in vitro and in vivo cell fusion and twitching in response to elec. stimulation.  Miyoshi Myopathy (MM) is a congenital distal myopathy caused by defective muscle membrane repair due to mutations in DYSFERLIN.  Using our induced differentiation technique, we successfully recreated the pathol. condition of MM in vitro, demonstrating defective membrane repair in hiPSC-derived myotubes from an MM patient and phenotypic rescue by expression of full-length DYSFERLIN (DYSF).  These findings not only facilitate the pathol. investigation of MM, but could potentially be applied in modeling of other human muscular diseases by using patient-derived hiPSCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpMwgyF8EPb7Vg90H21EOLACvtfcHk0lgl1tr5I_r6hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVKrurk%253D&md5=36a81c807e35702243066b9896ba9dfb</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0061540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0061540%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DA.%26aulast%3DWoltjen%26aufirst%3DK.%26aulast%3DMiyake%26aufirst%3DK.%26aulast%3DHotta%26aufirst%3DA.%26aulast%3DIkeya%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DNishino%26aufirst%3DT.%26aulast%3DShoji%26aufirst%3DE.%26aulast%3DSehara-Fujisawa%26aufirst%3DA.%26aulast%3DManabe%26aufirst%3DY.%26aulast%3DFujii%26aufirst%3DN.%26aulast%3DHanaoka%26aufirst%3DK.%26aulast%3DEra%26aufirst%3DT.%26aulast%3DYamashita%26aufirst%3DS.%26aulast%3DIsobe%26aufirst%3DK.%26aulast%3DKimura%26aufirst%3DE.%26aulast%3DSakurai%26aufirst%3DH.%26atitle%3DEfficient%2520and%2520reproducible%2520myogenic%2520differentiation%2520from%2520human%2520iPS%2520cells%253A%2520prospects%2520for%2520modeling%2520Miyoshi%2520myopathy%2520in%2520vitro%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26doi%3D10.1371%2Fjournal.pone.0061540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kokubu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagino, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oikawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyake, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kume, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuse, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tozawa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, H.</span></span> <span> </span><span class="NLM_article-title">Phenotypic drug screening for dysferlinopathy using patient-derived induced pluripotent stem cells</span>. <i>Stem Cells Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1017</span>, <span class="refDoi"> DOI: 10.1002/sctm.18-0280</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1002%2Fsctm.18-0280" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=31250983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A280%3ADC%252BB3MzhvFWgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&pages=1017&author=Y.+Kokubuauthor=T.+Naginoauthor=K.+Sasaauthor=T.+Oikawaauthor=K.+Miyakeauthor=A.+Kumeauthor=M.+Fukudaauthor=H.+Fuseauthor=R.+Tozawaauthor=H.+Sakurai&title=Phenotypic+drug+screening+for+dysferlinopathy+using+patient-derived+induced+pluripotent+stem+cells&doi=10.1002%2Fsctm.18-0280"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Phenotypic Drug Screening for Dysferlinopathy Using Patient-Derived Induced Pluripotent Stem Cells</span></div><div class="casAuthors">Kokubu Yuko; Fukuda Mikiko; Sakurai Hidetoshi; Nagino Tomoko; Sasa Katsunori; Oikawa Tatsuo; Kume Akiko; Fuse Hiromitsu; Tozawa Ryuichi; Miyake Katsuya</div><div class="citationInfo"><span class="NLM_cas:title">Stem cells translational medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1017-1029</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dysferlinopathy is a progressive muscle disorder that includes limb-girdle muscular dystrophy type 2B and Miyoshi myopathy (MM).  It is caused by mutations in the dysferlin (DYSF) gene, whose function is to reseal the muscular membrane.  Treatment with proteasome inhibitor MG-132 has been shown to increase misfolded dysferlin in fibroblasts, allowing them to recover their membrane resealing function.  Here, we developed a screening system based on myocytes from MM patient-derived induced pluripotent stem cells.  According to the screening, nocodazole was found to effectively increase the level of dysferlin in cells, which, in turn, enhanced membrane resealing following injury by laser irradiation.  Moreover, the increase was due to microtubule disorganization and involved autophagy rather than the proteasome degradation pathway.  These findings suggest that increasing the amount of misfolded dysferlin using small molecules could represent an effective future clinical treatment for dysferlinopathy.  Stem Cells Translational Medicine 2019;8:1017-1029.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTmeHYKxCnC5IHWj6b1v8uTfW6udTcc2eY5lAgmM3N3wLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MzhvFWgtA%253D%253D&md5=4c5cb7828405980ec6d77bee4f188355</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fsctm.18-0280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsctm.18-0280%26sid%3Dliteratum%253Aachs%26aulast%3DKokubu%26aufirst%3DY.%26aulast%3DNagino%26aufirst%3DT.%26aulast%3DSasa%26aufirst%3DK.%26aulast%3DOikawa%26aufirst%3DT.%26aulast%3DMiyake%26aufirst%3DK.%26aulast%3DKume%26aufirst%3DA.%26aulast%3DFukuda%26aufirst%3DM.%26aulast%3DFuse%26aufirst%3DH.%26aulast%3DTozawa%26aufirst%3DR.%26aulast%3DSakurai%26aufirst%3DH.%26atitle%3DPhenotypic%2520drug%2520screening%2520for%2520dysferlinopathy%2520using%2520patient-derived%2520induced%2520pluripotent%2520stem%2520cells%26jtitle%3DStem%2520Cells%2520Transl.%2520Med.%26date%3D2019%26volume%3D8%26spage%3D1017%26doi%3D10.1002%2Fsctm.18-0280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oda, T.</span>; <span class="NLM_string-name">Imada, T.</span>; <span class="NLM_string-name">Naito, K.</span>; <span class="NLM_string-name">Tamura, T.</span>; <span class="NLM_string-name">Furuya, S.</span></span> <span> </span><span class="NLM_article-title">Bicyclic Derivative, Process for Producing the Same, and Use</span>. PCT Int. Appl. <span class="NLM_patent">WO 03/045929 A1</span>, <span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=T.+Oda&author=T.+Imada&author=K.+Naito&author=T.+Tamura&author=S.+Furuya&title=Bicyclic+Derivative%2C+Process+for+Producing+the+Same%2C+and+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DOda%26aufirst%3DT.%26atitle%3DBicyclic%2520Derivative%252C%2520Process%2520for%2520Producing%2520the%2520Same%252C%2520and%2520Use%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ziegler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pries, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedberg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldmann, H.</span></span> <span> </span><span class="NLM_article-title">Target identification for small bioactive molecules: finding the needle in the haystack</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">2744</span>– <span class="NLM_lpage">2792</span>, <span class="refDoi"> DOI: 10.1002/anie.201208749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1002%2Fanie.201208749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=23418026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A528%3ADC%252BC3sXislSksLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=2744-2792&author=S.+Zieglerauthor=V.+Priesauthor=C.+Hedbergauthor=H.+Waldmann&title=Target+identification+for+small+bioactive+molecules%3A+finding+the+needle+in+the+haystack&doi=10.1002%2Fanie.201208749"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Target Identification for Small Bioactive Molecules: Finding the Needle in the Haystack</span></div><div class="casAuthors">Ziegler, Slava; Pries, Verena; Hedberg, Christian; Waldmann, Herbert</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2744-2792</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Identification and confirmation of bioactive small-mol. targets is a crucial, often decisive step both in academic and pharmaceutical research.  Through the development and availability of several new exptl. techniques, target identification is, in principle, feasible, and the no. of successful examples steadily grows.  However, a generic methodol. that can successfully be applied in the majority of the cases has not yet been established.  Herein we summarize current methods for target identification of small mols., primarily for a chem. audience but also the biol. community, for example, the chemist or biologist attempting to identify the target of a given bioactive compd.  We describe the most frequently employed exptl. approaches for target identification and provide several representative examples illustrating the state-of-the-art.  Among the techniques currently available, protein affinity isolation using suitable small-mol. probes (pulldown) and subsequent mass spectrometric anal. of the isolated proteins appears to be most powerful and most frequently applied.  To provide guidance for rapid entry into the field and based on our own experience we propose a typical workflow for target identification, which centers on the application of chem. proteomics as the key step to generate hypotheses for potential target proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYC9-7L3abMrVg90H21EOLACvtfcHk0lgl1tr5I_r6hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXislSksLk%253D&md5=3a124205e3a57a53f479b889073bda76</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fanie.201208749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201208749%26sid%3Dliteratum%253Aachs%26aulast%3DZiegler%26aufirst%3DS.%26aulast%3DPries%26aufirst%3DV.%26aulast%3DHedberg%26aufirst%3DC.%26aulast%3DWaldmann%26aufirst%3DH.%26atitle%3DTarget%2520identification%2520for%2520small%2520bioactive%2520molecules%253A%2520finding%2520the%2520needle%2520in%2520the%2520haystack%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2013%26volume%3D52%26spage%3D2744%26epage%3D2792%26doi%3D10.1002%2Fanie.201208749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Comess, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLoughlin, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyer, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasudevan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warder, S. E.</span></span> <span> </span><span class="NLM_article-title">Emerging approaches for the identification of protein targets of small molecules - a practitioners’ perspective</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">8504</span>– <span class="NLM_lpage">8535</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01921</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01921" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A528%3ADC%252BC1cXovVCht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=8504-8535&author=K.+M.+Comessauthor=S.+M.+McLoughlinauthor=J.+A.+Oyerauthor=P.+L.+Richardsonauthor=H.+Stockmannauthor=A.+Vasudevanauthor=S.+E.+Warder&title=Emerging+approaches+for+the+identification+of+protein+targets+of+small+molecules+-+a+practitioners%E2%80%99+perspective&doi=10.1021%2Facs.jmedchem.7b01921"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging Approaches for the Identification of Protein Targets of Small Molecules - A Practitioners' Perspective</span></div><div class="casAuthors">Comess, Kenneth M.; McLoughlin, Shaun M.; Oyer, Jon A.; Richardson, Paul L.; Stockmann, Henning; Vasudevan, Anil; Warder, Scott E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8504-8535</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Small-mol. (SM) leads in the early drug discovery pipeline are progressed primarily based on potency against the intended target(s) and selectivity against a very narrow slice of the proteome.  So, why is there a tendency to wait until SMs are matured before probing for a deeper mechanistic understanding.  For one, there is a concern about the interpretation of complex -omic data outputs and the resources needed to test these hypotheses.  However, with recent advances in broad endpoint profiling assays that have companion ref. databases and refined technol. integration strategies, we argue that data complexity can translate into meaningful decision-making.  This same strategy can also prioritize phenotypic screening hits to increase the likelihood of accessing unprecedented target space.  In this Perspective. we will highlight a cohesive process that supports SM hit prosecution, providing a data-driven rationale and a suite of methods for direct identification of SM targets driving relevant biol. end points.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTl79BgUlfjbVg90H21EOLACvtfcHk0liAWFT-PrpgGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXovVCht7Y%253D&md5=7c051edc4cc8e8603a46ed927a6a08c3</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01921%26sid%3Dliteratum%253Aachs%26aulast%3DComess%26aufirst%3DK.%2BM.%26aulast%3DMcLoughlin%26aufirst%3DS.%2BM.%26aulast%3DOyer%26aufirst%3DJ.%2BA.%26aulast%3DRichardson%26aufirst%3DP.%2BL.%26aulast%3DStockmann%26aufirst%3DH.%26aulast%3DVasudevan%26aufirst%3DA.%26aulast%3DWarder%26aufirst%3DS.%2BE.%26atitle%3DEmerging%2520approaches%2520for%2520the%2520identification%2520of%2520protein%2520targets%2520of%2520small%2520molecules%2520-%2520a%2520practitioners%25E2%2580%2599%2520perspective%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D8504%26epage%3D8535%26doi%3D10.1021%2Facs.jmedchem.7b01921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. D.</span></span> <span> </span><span class="NLM_article-title">An overview of tubulin inhibitors that interact with the colchicine binding site</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">2943</span>– <span class="NLM_lpage">2971</span>, <span class="refDoi"> DOI: 10.1007/s11095-012-0828-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1007%2Fs11095-012-0828-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=22814904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOis7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2012&pages=2943-2971&author=Y.+Luauthor=J.+Chenauthor=M.+Xiaoauthor=W.+Liauthor=D.+D.+Miller&title=An+overview+of+tubulin+inhibitors+that+interact+with+the+colchicine+binding+site&doi=10.1007%2Fs11095-012-0828-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">An Overview of Tubulin Inhibitors That Interact with the Colchicine Binding Site</span></div><div class="casAuthors">Lu, Yan; Chen, Jianjun; Xiao, Min; Li, Wei; Miller, Duane D.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2943-2971</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Tubulin dynamics is a promising target for new chemotherapeutic agents.  The colchicine binding site is one of the most important pockets for potential tubulin polymn. destabilizers.  Colchicine binding site inhibitors (CBSI) exert their biol. effects by inhibiting tubulin assembly and suppressing microtubule formation.  A large no. of mols. interacting with the colchicine binding site have been designed and synthesized with significant structural diversity.  CBSIs have been modified as to chem. structure as well as pharmacokinetic properties, and tested in order to find a highly potent, low toxicity agent for treatment of cancers.  CBSIs are believed to act by a common mechanism via binding to the colchicine site on tubulin.  The present review is a synopsis of compds. that have been reported in the past decade that have provided an increase in our understanding of the actions of CBSIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFrFQVgeCbBbVg90H21EOLACvtfcHk0liAWFT-PrpgGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOis7vN&md5=dfe42e8eb1f0ff22b256641aaa8c17ab</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1007%2Fs11095-012-0828-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-012-0828-z%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DXiao%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DMiller%26aufirst%3DD.%2BD.%26atitle%3DAn%2520overview%2520of%2520tubulin%2520inhibitors%2520that%2520interact%2520with%2520the%2520colchicine%2520binding%2520site%26jtitle%3DPharm.%2520Res.%26date%3D2012%26volume%3D29%26spage%3D2943%26epage%3D2971%26doi%3D10.1007%2Fs11095-012-0828-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gigant, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span> <span> </span><span class="NLM_article-title">Structures of a diverse set of colchicine binding site inhibitors in complex with tubulin provide a rationale for drug discovery</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">102</span>– <span class="NLM_lpage">111</span>, <span class="refDoi"> DOI: 10.1111/febs.13555</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1111%2Ffebs.13555" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=26462166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslKktrzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2016&pages=102-111&author=Y.+Wangauthor=H.+Zhangauthor=B.+Gigantauthor=Y.+Yuauthor=Y.+Wuauthor=X.+Chenauthor=Q.+Laiauthor=Z.+Yangauthor=Q.+Chenauthor=J.+Yang&title=Structures+of+a+diverse+set+of+colchicine+binding+site+inhibitors+in+complex+with+tubulin+provide+a+rationale+for+drug+discovery&doi=10.1111%2Ffebs.13555"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of a diverse set of colchicine binding site inhibitors in complex with tubulin provide a rationale for drug discovery</span></div><div class="casAuthors">Wang, Yuxi; Zhang, Hang; Gigant, Benoit; Yu, Yamei; Wu, Yangping; Chen, Xiangzheng; Lai, Qinhuai; Yang, Zhaoya; Chen, Qiang; Yang, Jinliang</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">102-111</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Microtubules are dynamic assemblies of αβ-tubulin heterodimers and have been recognized as highly attractive targets for cancer chemotherapy.  A broad range of agents bind to tubulin and interfere with microtubule assembly.  Despite having a long history of characterization, colchicine binding site inhibitors (CBSIs) have not yet reached the com. phase as anti-cancer drugs to date.  We detd. the structures of tubulin complexed with a set of structurally diverse CBSIs (lexibulin, nocodazole, plinabulin and tivantinib), among which nocodazole and tivantinib are both binary-function inhibitors targeting cancer-related kinases and microtubules simultaneously.  High resoln. structures revealed the detailed interactions between these ligands and tubulin.  Our results showed that the binding modes of the CBSIs were different from previous docking models, highlighting the importance of crystal structure information in structure-based drug design.  A real structure-based pharmacophore was proposed to rationalize key common interactions of the CBSIs at the colchicine domain.  Our studies provide a solid structural basis for developing new anti-cancer agents for the colchicine binding site.  Database : The at. coordinates and structure factors for tubulin complexed with lexibulin, nocodazole, plinabulin and tivantinib have been deposited in the Protein Data Bank under accession codes , , and , resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSIAVSS_EsIbVg90H21EOLACvtfcHk0lgZR9Uq83ZExg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslKktrzP&md5=d5a17d9a3ac54d8eda44d0543ffa5fbd</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1111%2Ffebs.13555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.13555%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DGigant%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DLai%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DJ.%26atitle%3DStructures%2520of%2520a%2520diverse%2520set%2520of%2520colchicine%2520binding%2520site%2520inhibitors%2520in%2520complex%2520with%2520tubulin%2520provide%2520a%2520rationale%2520for%2520drug%2520discovery%26jtitle%3DFEBS%2520J.%26date%3D2016%26volume%3D283%26spage%3D102%26epage%3D111%26doi%3D10.1111%2Ffebs.13555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murale, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haque, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. S.</span></span> <span> </span><span class="NLM_article-title">Photo-affinity labeling (PAL) in chemical proteomics: a handy tool to investigate protein-protein interactions (PPIs)</span>. <i>Proteome Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">14</span>, <span class="refDoi"> DOI: 10.1186/s12953-017-0123-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1186%2Fs12953-017-0123-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=28652856" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A280%3ADC%252BC1cjitV2ksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=14&author=D.+P.+Muraleauthor=S.+C.+Hongauthor=M.+M.+Haqueauthor=J.+S.+Lee&title=Photo-affinity+labeling+%28PAL%29+in+chemical+proteomics%3A+a+handy+tool+to+investigate+protein-protein+interactions+%28PPIs%29&doi=10.1186%2Fs12953-017-0123-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Photo-affinity labeling (PAL) in chemical proteomics: a handy tool to investigate protein-protein interactions (PPIs)</span></div><div class="casAuthors">Murale Dhiraj P; Hong Seong Cheol; Haque Md Mamunul; Lee Jun-Seok; Hong Seong Cheol; Lee Jun-Seok</div><div class="citationInfo"><span class="NLM_cas:title">Proteome science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">14</span>
        ISSN:<span class="NLM_cas:issn">1477-5956</span>.
    </div><div class="casAbstract">Protein-protein interactions (PPIs) trigger a wide range of biological signaling pathways that are crucial for biomedical research and drug discovery.  Various techniques have been used to study specific proteins, including affinity chromatography, activity-based probes, affinity-based probes and photo-affinity labeling (PAL).  PAL has become one of the most powerful strategies to study PPIs.  Traditional photocrosslinkers are used in PAL, including benzophenone, aryl azide, and diazirine.  Upon photoirradiation, these photocrosslinkers (Pls) generate highly reactive species that react with adjacent molecules, resulting in a direct covalent modification.  This review introduces recent examples of chemical proteomics study using PAL for PPIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRaiDChB3xtDcjl5L8hwNX0fW6udTcc2eafZyHu8LeWc7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cjitV2ksA%253D%253D&md5=d6ef0d08db66c5d4b74caa24e5b97a94</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1186%2Fs12953-017-0123-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12953-017-0123-3%26sid%3Dliteratum%253Aachs%26aulast%3DMurale%26aufirst%3DD.%2BP.%26aulast%3DHong%26aufirst%3DS.%2BC.%26aulast%3DHaque%26aufirst%3DM.%2BM.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26atitle%3DPhoto-affinity%2520labeling%2520%2528PAL%2529%2520in%2520chemical%2520proteomics%253A%2520a%2520handy%2520tool%2520to%2520investigate%2520protein-protein%2520interactions%2520%2528PPIs%2529%26jtitle%3DProteome%2520Sci.%26date%3D2016%26volume%3D15%26spage%3D14%26doi%3D10.1186%2Fs12953-017-0123-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dominguez-Brauer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thu, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaser, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bray, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span> <span> </span><span class="NLM_article-title">Targeting mitosis in cancer: emerging strategies</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">524</span>– <span class="NLM_lpage">536</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2015.11.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1016%2Fj.molcel.2015.11.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=26590712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVyqtbrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2015&pages=524-536&author=C.+Dominguez-Brauerauthor=K.+L.+Thuauthor=J.+M.+Masonauthor=H.+Blaserauthor=M.+R.+Brayauthor=T.+W.+Mak&title=Targeting+mitosis+in+cancer%3A+emerging+strategies&doi=10.1016%2Fj.molcel.2015.11.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Mitosis in Cancer: Emerging Strategies</span></div><div class="casAuthors">Dominguez-Brauer, Carmen; Thu, Kelsie L.; Mason, Jacqueline M.; Blaser, Heiko; Bray, Mark R.; Mak, Tak W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">524-536</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The cell cycle is an evolutionarily conserved process necessary for mammalian cell growth and development.  Because cell-cycle aberrations are a hallmark of cancer, this process has been the target of anti-cancer therapeutics for decades.  However, despite numerous clin. trials, cell-cycle-targeting agents have generally failed in the clinic.  This review briefly examines past cell-cycle-targeted therapeutics and outlines how experience with these agents has provided valuable insight to refine and improve anti-mitotic strategies.  An overview of emerging anti-mitotic approaches with promising pre-clin. results is provided, and the concept of exploiting the genomic instability of tumor cells through therapeutic inhibition of mitotic checkpoints is discussed.  We believe this strategy has a high likelihood of success given its potential to enhance therapeutic index by targeting tumor-specific vulnerabilities.  This reasoning stimulated our development of novel inhibitors targeting the crit. regulators of genomic stability and the mitotic checkpoint: AURKA, PLK4, and Mps1/TTK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr5RAGZ9XTCLVg90H21EOLACvtfcHk0lgZR9Uq83ZExg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVyqtbrJ&md5=3f4b6d0a92a2ea8c1ef0b7c0b5824b2d</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2015.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2015.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DDominguez-Brauer%26aufirst%3DC.%26aulast%3DThu%26aufirst%3DK.%2BL.%26aulast%3DMason%26aufirst%3DJ.%2BM.%26aulast%3DBlaser%26aufirst%3DH.%26aulast%3DBray%26aufirst%3DM.%2BR.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DTargeting%2520mitosis%2520in%2520cancer%253A%2520emerging%2520strategies%26jtitle%3DMol.%2520Cell%26date%3D2015%26volume%3D60%26spage%3D524%26epage%3D536%26doi%3D10.1016%2Fj.molcel.2015.11.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okita, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamakawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amano, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goshima, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamanaka, S.</span></span> <span> </span><span class="NLM_article-title">An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells</span>. <i>Stem Cells</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">458</span>– <span class="NLM_lpage">466</span>, <span class="refDoi"> DOI: 10.1002/stem.1293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1002%2Fstem.1293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=23193063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksFWqtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=458-466&author=K.+Okitaauthor=T.+Yamakawaauthor=Y.+Matsumuraauthor=Y.+Satoauthor=N.+Amanoauthor=A.+Watanabeauthor=N.+Goshimaauthor=S.+Yamanaka&title=An+efficient+nonviral+method+to+generate+integration-free+human-induced+pluripotent+stem+cells+from+cord+blood+and+peripheral+blood+cells&doi=10.1002%2Fstem.1293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells</span></div><div class="casAuthors">Okita, Keisuke; Yamakawa, Tatsuya; Matsumura, Yasuko; Sato, Yoshiko; Amano, Naoki; Watanabe, Akira; Goshima, Naoki; Yamanaka, Shinya</div><div class="citationInfo"><span class="NLM_cas:title">Stem Cells (Durham, NC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">458-466</span>CODEN:
                <span class="NLM_cas:coden">STCEEJ</span>;
        ISSN:<span class="NLM_cas:issn">1066-5099</span>.
    
            (<span class="NLM_cas:orgname">AlphaMed Press</span>)
        </div><div class="casAbstract">The generation of induced pluripotent stem cells (iPSCs) provides the opportunity to use patient-specific somatic cells, which are a valuable source for disease modeling and drug discovery.  To promote research involving these cells, it is important to make iPSCs from easily accessible and less invasive tissues, like blood.  We have recently reported the efficient generation of human iPSCs from adult fibroblasts using a combination of plasmids encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, and shRNA for TP53.  We herein report a modified protocol enabling efficient iPSC induction from CD34+ cord blood cells and from peripheral blood isolated from healthy donors using these plasmid vectors.  The original plasmid mixt. could induce iPSCs; however, the efficiency was low.  The addn. of EBNA1, an essential factor for episomal amplification of the vectors, by an extra plasmid greatly increased the efficiency of iPSC induction, esp. when the induction was performed from αβT cells.  This improvement enabled the establishment of blood-derived iPSCs from seven healthy donors ranging in age from their 20s to their 60s.  This induction method will be useful for the derivation of patient-specific integration-free iPSCs and would also be applicable to the generation of clin.-grade iPSCs in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm06NKan_SNbVg90H21EOLACvtfcHk0lgZR9Uq83ZExg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksFWqtLk%253D&md5=3c38a6bbb47c7f00d32936ed40a5fdec</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fstem.1293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fstem.1293%26sid%3Dliteratum%253Aachs%26aulast%3DOkita%26aufirst%3DK.%26aulast%3DYamakawa%26aufirst%3DT.%26aulast%3DMatsumura%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DAmano%26aufirst%3DN.%26aulast%3DWatanabe%26aufirst%3DA.%26aulast%3DGoshima%26aufirst%3DN.%26aulast%3DYamanaka%26aufirst%3DS.%26atitle%3DAn%2520efficient%2520nonviral%2520method%2520to%2520generate%2520integration-free%2520human-induced%2520pluripotent%2520stem%2520cells%2520from%2520cord%2520blood%2520and%2520peripheral%2520blood%2520cells%26jtitle%3DStem%2520Cells%26date%3D2013%26volume%3D31%26spage%3D458%26epage%3D466%26doi%3D10.1002%2Fstem.1293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takizawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichisaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morizane, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishizawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyoda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osafune, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sekiguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamanaka, S.</span></span> <span> </span><span class="NLM_article-title">A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">3594</span>, <span class="refDoi"> DOI: 10.1038/srep03594</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1038%2Fsrep03594" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=24399248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A280%3ADC%252BC2czivVeksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=3594&author=M.+Nakagawaauthor=Y.+Taniguchiauthor=S.+Sendaauthor=N.+Takizawaauthor=T.+Ichisakaauthor=K.+Asanoauthor=A.+Morizaneauthor=D.+Doiauthor=J.+Takahashiauthor=M.+Nishizawaauthor=Y.+Yoshidaauthor=T.+Toyodaauthor=K.+Osafuneauthor=K.+Sekiguchiauthor=S.+Yamanaka&title=A+novel+efficient+feeder-free+culture+system+for+the+derivation+of+human+induced+pluripotent+stem+cells&doi=10.1038%2Fsrep03594"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells</span></div><div class="casAuthors">Nakagawa Masato; Takizawa Nanako; Ichisaka Tomoko; Asano Kanako; Morizane Asuka; Doi Daisuke; Takahashi Jun; Nishizawa Masatoshi; Yoshida Yoshinori; Toyoda Taro; Osafune Kenji; Taniguchi Yukimasa; Sekiguchi Kiyotoshi; Senda Sho; Yamanaka Shinya</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3594</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In order to apply human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) to regenerative medicine, the cells should be produced under restricted conditions conforming to GMP guidelines.  Since the conventional culture system has some issues that need to be addressed to achieve this goal, we developed a novel culture system.  We found that recombinant laminin-511 E8 fragments are useful matrices for maintaining hESCs and hiPSCs when used in combination with a completely xeno-free (Xf) medium, StemFit®.  Using this system, hESCs and hiPSCs can be easily and stably passaged by dissociating the cells into single cells for long periods, without any karyotype abnormalities.  Human iPSCs could be generated under feeder-free (Ff) and Xf culture systems from human primary fibroblasts and blood cells, and they possessed differentiation abilities.  These results indicate that hiPSCs can be generated and maintained under this novel Ff and Xf culture system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS-Kp3h4bu0WUQ0lWbKiCflfW6udTcc2ebb6_gExu-PTLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2czivVeksQ%253D%253D&md5=4c7945358bb242a13783bc10cc649482</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fsrep03594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep03594%26sid%3Dliteratum%253Aachs%26aulast%3DNakagawa%26aufirst%3DM.%26aulast%3DTaniguchi%26aufirst%3DY.%26aulast%3DSenda%26aufirst%3DS.%26aulast%3DTakizawa%26aufirst%3DN.%26aulast%3DIchisaka%26aufirst%3DT.%26aulast%3DAsano%26aufirst%3DK.%26aulast%3DMorizane%26aufirst%3DA.%26aulast%3DDoi%26aufirst%3DD.%26aulast%3DTakahashi%26aufirst%3DJ.%26aulast%3DNishizawa%26aufirst%3DM.%26aulast%3DYoshida%26aufirst%3DY.%26aulast%3DToyoda%26aufirst%3DT.%26aulast%3DOsafune%26aufirst%3DK.%26aulast%3DSekiguchi%26aufirst%3DK.%26aulast%3DYamanaka%26aufirst%3DS.%26atitle%3DA%2520novel%2520efficient%2520feeder-free%2520culture%2520system%2520for%2520the%2520derivation%2520of%2520human%2520induced%2520pluripotent%2520stem%2520cells%26jtitle%3DSci.%2520Rep.%26date%3D2014%26volume%3D4%26spage%3D3594%26doi%3D10.1038%2Fsrep03594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uchimura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otomo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, H.</span></span> <span> </span><span class="NLM_article-title">A human iPS cell myogenic differentiation system permitting high-throughput drug screening</span>. <i>Stem Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">98</span>– <span class="NLM_lpage">106</span>, <span class="refDoi"> DOI: 10.1016/j.scr.2017.10.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1016%2Fj.scr.2017.10.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=29125995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslyksL7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=98-106&author=T.+Uchimuraauthor=J.+Otomoauthor=M.+Satoauthor=H.+Sakurai&title=A+human+iPS+cell+myogenic+differentiation+system+permitting+high-throughput+drug+screening&doi=10.1016%2Fj.scr.2017.10.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A human iPS cell myogenic differentiation system permitting high-throughput drug screening</span></div><div class="casAuthors">Uchimura, Tomoya; Otomo, Jun; Sato, Masae; Sakurai, Hidetoshi</div><div class="citationInfo"><span class="NLM_cas:title">Stem Cell Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">98-106</span>CODEN:
                <span class="NLM_cas:coden">SCRTDJ</span>;
        ISSN:<span class="NLM_cas:issn">1873-5061</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Muscular dystrophy is a disease characterized by progressive muscle weakness and degeneration.  There are currently no available treatments for most muscular diseases, such as muscular dystrophy.  Moreover, current therapeutics are focused on improving the quality of life of patients by relieving the symptoms or stress caused by the disease.  Although the causative genes for many muscular diseases have been identified, the mechanisms underlying their pathogenesis remain unclear.  Patient-derived induced pluripotent stem cells (iPSCs) have become a powerful tool for understanding the pathogenesis of intractable diseases, as well as for phenotype screening, which can serve as the basis for developing new drugs.  However, it is necessary to develop an efficient and reproducible myogenic differentiation system.  Previously, we reported a tetracycline-inducible MyoD overexpression model of myogenic differentiation using human iPSCs (hiPSCs).  However, this model has certain disadvantages that limit its use in various applications, such as a drug screening.  In this study, we developed an efficient and reproducible myogenic differentiation system by further modifying our previous protocol.  The new protocol achieves efficient differentiation of feeder-free hiPSCs to myogenic cells via small-scale culture in six-well microplates to large-scale culture in 384-well microplates for high-throughput applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqREjRCcfo_fbVg90H21EOLACvtfcHk0lhgAywExoYnXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslyksL7P&md5=e03af6a36fa0d931f92ecf20cde2befb</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.scr.2017.10.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.scr.2017.10.023%26sid%3Dliteratum%253Aachs%26aulast%3DUchimura%26aufirst%3DT.%26aulast%3DOtomo%26aufirst%3DJ.%26aulast%3DSato%26aufirst%3DM.%26aulast%3DSakurai%26aufirst%3DH.%26atitle%3DA%2520human%2520iPS%2520cell%2520myogenic%2520differentiation%2520system%2520permitting%2520high-throughput%2520drug%2520screening%26jtitle%3DStem%2520Cell%2520Res.%26date%3D2017%26volume%3D25%26spage%3D98%26epage%3D106%26doi%3D10.1016%2Fj.scr.2017.10.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 3 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J. Jeya  Vandana</span>, <span class="hlFld-ContribAuthor ">Lauretta A.  Lacko</span>, <span class="hlFld-ContribAuthor ">Shuibing  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Phenotypic technologies in stem cell biology. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2021,</strong> <em>28 </em>
                                    (3)
                                     , 257-270. <a href="https://doi.org/10.1016/j.chembiol.2021.02.001" title="DOI URL">https://doi.org/10.1016/j.chembiol.2021.02.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2021.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2021.02.001%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DPhenotypic%252Btechnologies%252Bin%252Bstem%252Bcell%252Bbiology%26aulast%3DVandana%26aufirst%3DJ.%2BJeya%26date%3D2021%26volume%3D28%26issue%3D3%26spage%3D257%26epage%3D270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabien  Vincent</span>, <span class="hlFld-ContribAuthor ">Paula M.  Loria</span>, <span class="hlFld-ContribAuthor ">Andrea D.  Weston</span>, <span class="hlFld-ContribAuthor ">Claire M.  Steppan</span>, <span class="hlFld-ContribAuthor ">Regis  Doyonnas</span>, <span class="hlFld-ContribAuthor ">Yue-Ming  Wang</span>, <span class="hlFld-ContribAuthor ">Kristin L.  Rockwell</span>, <span class="hlFld-ContribAuthor ">Marie-Claire  Peakman</span>. </span><span class="cited-content_cbyCitation_article-title">Hit Triage and Validation in Phenotypic Screening: Considerations and Strategies. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2020,</strong> <em>27 </em>
                                    (11)
                                     , 1332-1346. <a href="https://doi.org/10.1016/j.chembiol.2020.08.009" title="DOI URL">https://doi.org/10.1016/j.chembiol.2020.08.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2020.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2020.08.009%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DHit%252BTriage%252Band%252BValidation%252Bin%252BPhenotypic%252BScreening%25253A%252BConsiderations%252Band%252BStrategies%26aulast%3DVincent%26aufirst%3DFabien%26date%3D2020%26volume%3D27%26issue%3D11%26spage%3D1332%26epage%3D1346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zainab  Jabri</span>, <span class="hlFld-ContribAuthor ">Nada Kheira  Sebbar</span>, <span class="hlFld-ContribAuthor ">Tuncer  Hökelek</span>, <span class="hlFld-ContribAuthor ">Joel T.  Mague</span>, <span class="hlFld-ContribAuthor ">Safia  Sabir</span>, <span class="hlFld-ContribAuthor ">Youssef Kandri  Rodi</span>, <span class="hlFld-ContribAuthor ">Khalid  Misbahi</span>. </span><span class="cited-content_cbyCitation_article-title">Crystal structure, Hirshfeld surface analysis and DFT study of 6-bromo-3-(5-bromohexyl)-2-[4-(dimethylamino)phenyl]-3
              H
              -imidazo[4,5-
              b
              ]pyridine. </span><span class="cited-content_cbyCitation_journal-name">Acta Crystallographica Section E Crystallographic Communications</span><span> <strong>2020,</strong> <em>76 </em>
                                    (8)
                                     , 1234-1238. <a href="https://doi.org/10.1107/S2056989020008889" title="DOI URL">https://doi.org/10.1107/S2056989020008889</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1107/S2056989020008889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1107%2FS2056989020008889%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Crystallographica%2520Section%2520E%2520Crystallographic%2520Communications%26atitle%3DCrystal%252Bstructure%25252C%252BHirshfeld%252Bsurface%252Banalysis%252Band%252BDFT%252Bstudy%252Bof%252B6-bromo-3-%2525285-bromohexyl%252529-2-%25255B4-%252528dimethylamino%252529phenyl%25255D-3%252BH%252B-imidazo%25255B4%25252C5-%252Bb%252B%25255Dpyridine%26aulast%3DJabri%26aufirst%3DZainab%26date%3D2020%26date%3D2020%26volume%3D76%26issue%3D8%26spage%3D1234%26epage%3D1238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/medium/jm9b01100_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/large/jm9b01100_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01100&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/medium/jm9b01100_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/large/jm9b01100_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of hit compound <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/large/jm9b01100_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01100&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/medium/jm9b01100_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/large/jm9b01100_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Correlation plot of pEC<sub>150</sub> with tubulin depolymerization pMEC. MEC, minimal effective concentration; <i>R</i>, correlation coefficient. The EC<sub>150</sub> value of compounds represented as square or triangle is >10 μM. The MEC value of compounds represented as circle or square is <0.080 μM or >50 μM, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/large/jm9b01100_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01100&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/medium/jm9b01100_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/large/jm9b01100_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (a) Structure and cellular activity of nocodazole and compound <b>19</b>. (b) Docking model of <b>19</b> with an α/β-tubulin heterodimer. Compound <b>19</b> is light blue, α-tubulin is black, and β-tubulin is gray. (c) The binding site of <b>19</b>. Residues that form hydrogen bonds or hydrophobic interactions with <b>19</b> are shown as sticks and are labeled. (d) X-ray cocrystal of nocodazole with tubulin (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5CA1">5CA1</a>). Residues that form hydrogen bonds with the ligand are shown as sticks and are labeled. (e) Surface of residues within 4.0 Å of <b>19</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/large/jm9b01100_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01100&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/medium/jm9b01100_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/large/jm9b01100_0004.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Image of SDS-PAGE for PAL probe-labeled tubulins. The tubulins were labeled with PAL probe <b>28</b> after preincubation with nonlabeled active or inactive compound (compound <b>18</b> or <b>21</b>, respectively) or known tubulin binders. PAL probe <b>28</b>, which has an acetylene group, was probed with TAMRA-azide by click reaction. (a) The samples were analyzed by SDS-PAGE, and the fluorescence images were captured to detect the PAL-probe-labeled tubulins. (b) Subsequently, the gel was stained with Coomassie brilliant blue to visualize the total tubulin. (c) Structure and cellular activity of nocodazole and vinblastine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/large/jm9b01100_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01100&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/medium/jm9b01100_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/large/jm9b01100_0005.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compound <b>17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/large/jm9b01100_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01100&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) HATU, DIPEA, 2-(4-fluorophenoxy)acetic acid, DMF; (ii) AcOH, reflux, 70% (2 steps); (b) Pd(Amphos)Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, thiophen-2-ylboronic acid, DME, water, microwave 120 °C, 17%.</p></p></figure><figure data-id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/medium/jm9b01100_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/large/jm9b01100_0006.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compound <b>21</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/large/jm9b01100_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01100&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) (COCl)<sub>2</sub>, DMF (cat), CHCl<sub>3</sub>; (ii) NH<sub>3</sub>, CHCl<sub>3</sub>, 0 °C to RT, 76% (2 steps); (b) trifluoroacetic anhydride, 90%; (c) (i) HCl gas, MeOH, Et<sub>2</sub>O, 0–4 °C; (ii) MeOH, hexane; (d) PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, thiophen-2-ylboronic acid, 1,4-dioxane, water, 110 °C, 59%; (e) <b>32</b>, AcOH, toluene, reflux, 73%.</p></p></figure><figure data-id="sch3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/medium/jm9b01100_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/large/jm9b01100_0007.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compound <b>28</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01100/20191018/images/large/jm9b01100_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01100&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaOH aq., MeOH, THF, 86%; (b) HATU, DIPEA, 2-(3-(but-3-yn-1-yl)-3H-diazirin-3-yl)ethan-1-amine, DMF, 65%.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i84">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82641" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82641" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 25 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swinney, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anthony, J.</span></span> <span> </span><span class="NLM_article-title">How were new medicines discovered?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">507</span>– <span class="NLM_lpage">519</span>, <span class="refDoi"> DOI: 10.1038/nrd3480</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1038%2Fnrd3480" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=21701501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotlCmsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=507-519&author=D.+C.+Swinneyauthor=J.+Anthony&title=How+were+new+medicines+discovered%3F&doi=10.1038%2Fnrd3480"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">How were new medicines discovered?</span></div><div class="casAuthors">Swinney, David C.; Anthony, Jason</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">507-519</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Preclin. strategies that are used to identify potential drug candidates include target-based screening, phenotypic screening, modification of natural substances and biol.-based approaches.  To investigate whether some strategies have been more successful than others in the discovery of new drugs, we analyzed the discovery strategies and the mol. mechanism of action (MMOA) for new mol. entities and new biologics that were approved by the US Food and Drug Administration between 1999 and 2008.  Out of the 259 agents that were approved, 75 were first-in-class drugs with new MMOAs, and out of these, 50 (67%) were small mols. and 25 (33%) were biologics.  The results also show that the contribution of phenotypic screening to the discovery of first-in-class small-mol. drugs exceeded that of target-based approaches - with 28 and 17 of these drugs coming from the two approaches, resp. - in an era in which the major focus was on target-based approaches.  We postulate that a target-centric approach for first-in-class drugs, without consideration of an optimal MMOA, may contribute to the current high attrition rates and low productivity in pharmaceutical research and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE8Ah1iNz76bVg90H21EOLACvtfcHk0liAu5a9lFBeWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotlCmsbs%253D&md5=7503620f8fbadb0a829f6ea2029936a2</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd3480&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3480%26sid%3Dliteratum%253Aachs%26aulast%3DSwinney%26aufirst%3DD.%2BC.%26aulast%3DAnthony%26aufirst%3DJ.%26atitle%3DHow%2520were%2520new%2520medicines%2520discovered%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D507%26epage%3D519%26doi%3D10.1038%2Fnrd3480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moffat, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eder, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prunotto, M.</span></span> <span> </span><span class="NLM_article-title">Opportunities and challenges in phenotypic drug discovery: an industry perspective</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">531</span>– <span class="NLM_lpage">543</span>, <span class="refDoi"> DOI: 10.1038/nrd.2017.111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1038%2Fnrd.2017.111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=28685762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFelsLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=531-543&author=J.+G.+Moffatauthor=F.+Vincentauthor=J.+A.+Leeauthor=J.+Ederauthor=M.+Prunotto&title=Opportunities+and+challenges+in+phenotypic+drug+discovery%3A+an+industry+perspective&doi=10.1038%2Fnrd.2017.111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Opportunities and challenges in phenotypic drug discovery: an industry perspective</span></div><div class="casAuthors">Moffat, John G.; Vincent, Fabien; Lee, Jonathan A.; Eder, Jorg; Prunotto, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">531-543</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Phenotypic drug discovery (PDD) approaches do not rely on knowledge of the identity of a specific drug target or a hypothesis about its role in disease, in contrast to the target-based strategies that have been widely used in the pharmaceutical industry in the past three decades.  However, in recent years, there has been a resurgence in interest in PDD approaches based on their potential to address the incompletely understood complexity of diseases and their promise of delivering first-in-class drugs, as well as major advances in the tools for cell-based phenotypic screening.  Nevertheless, PDD approaches also have considerable challenges, such as hit validation and target deconvolution.  This article focuses on the lessons learned by researchers engaged in PDD in the pharmaceutical industry and considers the impact of 'omics' knowledge in defining a cellular disease phenotype in the era of precision medicine, introducing the concept of a chain of translatability.  We particularly aim to identify features and areas in which PDD can best deliver value to drug discovery portfolios and can contribute to the identification and the development of novel medicines, and to illustrate the challenges and uncertainties that are assocd. with PDD in order to help set realistic expectations with regard to its benefits and costs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGrD5TsU8_kLVg90H21EOLACvtfcHk0liAu5a9lFBeWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFelsLrJ&md5=d83196715c879a81d9eabcf544e303db</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2017.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2017.111%26sid%3Dliteratum%253Aachs%26aulast%3DMoffat%26aufirst%3DJ.%2BG.%26aulast%3DVincent%26aufirst%3DF.%26aulast%3DLee%26aufirst%3DJ.%2BA.%26aulast%3DEder%26aufirst%3DJ.%26aulast%3DPrunotto%26aufirst%3DM.%26atitle%3DOpportunities%2520and%2520challenges%2520in%2520phenotypic%2520drug%2520discovery%253A%2520an%2520industry%2520perspective%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26spage%3D531%26epage%3D543%26doi%3D10.1038%2Fnrd.2017.111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heilker, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traub, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinhardt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scholer, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sterneckert, J.</span></span> <span> </span><span class="NLM_article-title">iPS cell derived neuronal cells for drug discovery</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">510</span>– <span class="NLM_lpage">519</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2014.07.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1016%2Fj.tips.2014.07.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=25096281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1GktrzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=510-519&author=R.+Heilkerauthor=S.+Traubauthor=P.+Reinhardtauthor=H.+R.+Scholerauthor=J.+Sterneckert&title=iPS+cell+derived+neuronal+cells+for+drug+discovery&doi=10.1016%2Fj.tips.2014.07.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">iPS cell derived neuronal cells for drug discovery</span></div><div class="casAuthors">Heilker, Ralf; Traub, Stefanie; Reinhardt, Peter; Schoeler, Hans R.; Sterneckert, Jared</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">510-519</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Owing to the inherent disconnect between drug pharmacol. in heterologous cellular models and drug efficacy in vivo, the quest for more predictive in vitro systems is one of the most urgent challenges of modern drug discovery.  An improved pharmacol. in vitro profiling would employ primary samples of the proper drug-targeted human tissue or the bona fide human disease-relevant cells.  With the advent of induced pluripotent stem (iPS) cell technol. the facilitated access to a variety of disease-relevant target cells is now held out in prospect.  In this review, we focus on the use of human iPS cell derived neurons for high throughput pharmaceutical drug screening, employing detection technologies that are sufficiently sensitive to measure signaling in cells with physiol. target protein expression levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6UpEO1YZplbVg90H21EOLACvtfcHk0liAu5a9lFBeWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1GktrzP&md5=6c178a3016f1cd8932bed7ece22def81</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2014.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2014.07.003%26sid%3Dliteratum%253Aachs%26aulast%3DHeilker%26aufirst%3DR.%26aulast%3DTraub%26aufirst%3DS.%26aulast%3DReinhardt%26aufirst%3DP.%26aulast%3DScholer%26aufirst%3DH.%2BR.%26aulast%3DSterneckert%26aufirst%3DJ.%26atitle%3DiPS%2520cell%2520derived%2520neuronal%2520cells%2520for%2520drug%2520discovery%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2014%26volume%3D35%26spage%3D510%26epage%3D519%26doi%3D10.1016%2Fj.tips.2014.07.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loria, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pregel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanton, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitching, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nocka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyonnas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steppan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroeter, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peakman, M. C.</span></span> <span> </span><span class="NLM_article-title">Developing predictive assays: the phenotypic screening ″rule of 3″</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">293ps15</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.aab1201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1126%2Fscitranslmed.aab1201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=26109101" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=293ps15&author=F.+Vincentauthor=P.+Loriaauthor=M.+Pregelauthor=R.+Stantonauthor=L.+Kitchingauthor=K.+Nockaauthor=R.+Doyonnasauthor=C.+Steppanauthor=A.+Gilbertauthor=T.+Schroeterauthor=M.+C.+Peakman&title=Developing+predictive+assays%3A+the+phenotypic+screening+%E2%80%B3rule+of+3%E2%80%B3&doi=10.1126%2Fscitranslmed.aab1201"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aab1201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aab1201%26sid%3Dliteratum%253Aachs%26aulast%3DVincent%26aufirst%3DF.%26aulast%3DLoria%26aufirst%3DP.%26aulast%3DPregel%26aufirst%3DM.%26aulast%3DStanton%26aufirst%3DR.%26aulast%3DKitching%26aufirst%3DL.%26aulast%3DNocka%26aufirst%3DK.%26aulast%3DDoyonnas%26aufirst%3DR.%26aulast%3DSteppan%26aufirst%3DC.%26aulast%3DGilbert%26aufirst%3DA.%26aulast%3DSchroeter%26aufirst%3DT.%26aulast%3DPeakman%26aufirst%3DM.%2BC.%26atitle%3DDeveloping%2520predictive%2520assays%253A%2520the%2520phenotypic%2520screening%2520%25E2%2580%25B3rule%2520of%25203%25E2%2580%25B3%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2015%26volume%3D7%26spage%3D293ps15%26doi%3D10.1126%2Fscitranslmed.aab1201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izumi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukita, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woltjen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hotta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitaoka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takuma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamaoka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunath, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wray, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furuya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Era, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makioka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujisawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishitoh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Homma, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichijo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Julien, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosokawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akiyama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaneko, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaji, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamanaka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, H.</span></span> <span> </span><span class="NLM_article-title">The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">eaaf3962</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.aaf3962</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1126%2Fscitranslmed.aaf3962" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=28539470" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=eaaf3962&author=K.+Imamuraauthor=Y.+Izumiauthor=A.+Watanabeauthor=K.+Tsukitaauthor=K.+Woltjenauthor=T.+Yamamotoauthor=A.+Hottaauthor=T.+Kondoauthor=S.+Kitaokaauthor=A.+Ohtaauthor=A.+Tanakaauthor=D.+Watanabeauthor=M.+Moritaauthor=H.+Takumaauthor=A.+Tamaokaauthor=T.+Kunathauthor=S.+Wrayauthor=H.+Furuyaauthor=T.+Eraauthor=K.+Makiokaauthor=K.+Okamotoauthor=T.+Fujisawaauthor=H.+Nishitohauthor=K.+Hommaauthor=H.+Ichijoauthor=J.+P.+Julienauthor=N.+Obataauthor=M.+Hosokawaauthor=H.+Akiyamaauthor=S.+Kanekoauthor=T.+Ayakiauthor=H.+Itoauthor=R.+Kajiauthor=R.+Takahashiauthor=S.+Yamanakaauthor=H.+Inoue&title=The+Src%2Fc-Abl+pathway+is+a+potential+therapeutic+target+in+amyotrophic+lateral+sclerosis&doi=10.1126%2Fscitranslmed.aaf3962"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aaf3962&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aaf3962%26sid%3Dliteratum%253Aachs%26aulast%3DImamura%26aufirst%3DK.%26aulast%3DIzumi%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DA.%26aulast%3DTsukita%26aufirst%3DK.%26aulast%3DWoltjen%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DHotta%26aufirst%3DA.%26aulast%3DKondo%26aufirst%3DT.%26aulast%3DKitaoka%26aufirst%3DS.%26aulast%3DOhta%26aufirst%3DA.%26aulast%3DTanaka%26aufirst%3DA.%26aulast%3DWatanabe%26aufirst%3DD.%26aulast%3DMorita%26aufirst%3DM.%26aulast%3DTakuma%26aufirst%3DH.%26aulast%3DTamaoka%26aufirst%3DA.%26aulast%3DKunath%26aufirst%3DT.%26aulast%3DWray%26aufirst%3DS.%26aulast%3DFuruya%26aufirst%3DH.%26aulast%3DEra%26aufirst%3DT.%26aulast%3DMakioka%26aufirst%3DK.%26aulast%3DOkamoto%26aufirst%3DK.%26aulast%3DFujisawa%26aufirst%3DT.%26aulast%3DNishitoh%26aufirst%3DH.%26aulast%3DHomma%26aufirst%3DK.%26aulast%3DIchijo%26aufirst%3DH.%26aulast%3DJulien%26aufirst%3DJ.%2BP.%26aulast%3DObata%26aufirst%3DN.%26aulast%3DHosokawa%26aufirst%3DM.%26aulast%3DAkiyama%26aufirst%3DH.%26aulast%3DKaneko%26aufirst%3DS.%26aulast%3DAyaki%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DKaji%26aufirst%3DR.%26aulast%3DTakahashi%26aufirst%3DR.%26aulast%3DYamanaka%26aufirst%3DS.%26aulast%3DInoue%26aufirst%3DH.%26atitle%3DThe%2520Src%252Fc-Abl%2520pathway%2520is%2520a%2520potential%2520therapeutic%2520target%2520in%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2017%26volume%3D9%26spage%3Deaaf3962%26doi%3D10.1126%2Fscitranslmed.aaf3962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hino, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horigome, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawakami, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toguchida, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeya, M.</span></span> <span> </span><span class="NLM_article-title">Activin-A enhances mTOR signaling to promote aberrant chondrogenesis in fibrodysplasia ossificans progressiva</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">3339</span>– <span class="NLM_lpage">3352</span>, <span class="refDoi"> DOI: 10.1172/JCI93521</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1172%2FJCI93521" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=28758906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A280%3ADC%252BC1cfis1Kiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2017&pages=3339-3352&author=K.+Hinoauthor=K.+Horigomeauthor=M.+Nishioauthor=S.+Komuraauthor=S.+Nagataauthor=C.+Zhaoauthor=Y.+Jinauthor=K.+Kawakamiauthor=Y.+Yamadaauthor=A.+Ohtaauthor=J.+Toguchidaauthor=M.+Ikeya&title=Activin-A+enhances+mTOR+signaling+to+promote+aberrant+chondrogenesis+in+fibrodysplasia+ossificans+progressiva&doi=10.1172%2FJCI93521"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Activin-A enhances mTOR signaling to promote aberrant chondrogenesis in fibrodysplasia ossificans progressiva</span></div><div class="casAuthors">Hino Kyosuke; Horigome Kazuhiko; Nagata Sanae; Toguchida Junya; Hino Kyosuke; Horigome Kazuhiko; Nishio Megumi; Jin Yonghui; Toguchida Junya; Komura Shingo; Zhao Chengzhu; Yamada Yasuhiro; Ikeya Makoto; Komura Shingo; Jin Yonghui; Toguchida Junya; Kawakami Koichi; Kawakami Koichi; Yamada Yasuhiro; Ohta Akira; Toguchida Junya</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical investigation</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3339-3352</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Fibrodysplasia ossificans progressiva (FOP) is a rare and intractable disease characterized by extraskeletal bone formation through endochondral ossification.  Patients with FOP harbor point mutations in ACVR1, a type I receptor for BMPs.  Although mutated ACVR1 (FOP-ACVR1) has been shown to render hyperactivity in BMP signaling, we and others have uncovered a mechanism by which FOP-ACVR1 mistransduces BMP signaling in response to Activin-A, a molecule that normally transduces TGF-β signaling.  Although Activin-A evokes enhanced chondrogenesis in vitro and heterotopic ossification (HO) in vivo, the underlying mechanisms have yet to be revealed.  To this end, we developed a high-throughput screening (HTS) system using FOP patient-derived induced pluripotent stem cells (FOP-iPSCs) to identify pivotal pathways in enhanced chondrogenesis that are initiated by Activin-A.  In a screen of 6,809 small-molecule compounds, we identified mTOR signaling as a critical pathway for the aberrant chondrogenesis of mesenchymal stromal cells derived from FOP-iPSCs (FOP-iMSCs).  Two different HO mouse models, an FOP model mouse expressing FOP-ACVR1 and an FOP-iPSC-based HO model mouse, revealed critical roles for mTOR signaling in vivo.  Moreover, we identified ENPP2, an enzyme that generates lysophosphatidic acid, as a linker of FOP-ACVR1 and mTOR signaling in chondrogenesis.  These results uncovered the crucial role of the Activin-A/FOP-ACVR1/ENPP2/mTOR axis in FOP pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRpSiQmce1M_3O4gDb7JggCfW6udTcc2eY_nQkzgDec1bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cfis1Kiuw%253D%253D&md5=0dc58b47256454b55b1587b62dfb959c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1172%2FJCI93521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI93521%26sid%3Dliteratum%253Aachs%26aulast%3DHino%26aufirst%3DK.%26aulast%3DHorigome%26aufirst%3DK.%26aulast%3DNishio%26aufirst%3DM.%26aulast%3DKomura%26aufirst%3DS.%26aulast%3DNagata%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DKawakami%26aufirst%3DK.%26aulast%3DYamada%26aufirst%3DY.%26aulast%3DOhta%26aufirst%3DA.%26aulast%3DToguchida%26aufirst%3DJ.%26aulast%3DIkeya%26aufirst%3DM.%26atitle%3DActivin-A%2520enhances%2520mTOR%2520signaling%2520to%2520promote%2520aberrant%2520chondrogenesis%2520in%2520fibrodysplasia%2520ossificans%2520progressiva%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2017%26volume%3D127%26spage%3D3339%26epage%3D3352%26doi%3D10.1172%2FJCI93521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Illa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fardeau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angelini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serrano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urtizberea, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hentati, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamida, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohlega, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culper, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amato, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bossie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oeltjen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bejaoui, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenna-Yasek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosler, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schurr, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arahata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jong, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, R. H.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">31</span>– <span class="NLM_lpage">36</span>, <span class="refDoi"> DOI: 10.1038/1682</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1038%2F1682" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=9731526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A528%3ADyaK1cXmtVOmt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1998&pages=31-36&author=J.+Liuauthor=M.+Aokiauthor=I.+Illaauthor=C.+Wuauthor=M.+Fardeauauthor=C.+Angeliniauthor=C.+Serranoauthor=J.+A.+Urtizbereaauthor=F.+Hentatiauthor=M.+B.+Hamidaauthor=S.+Bohlegaauthor=E.+J.+Culperauthor=A.+A.+Amatoauthor=K.+Bossieauthor=J.+Oeltjenauthor=K.+Bejaouiauthor=D.+McKenna-Yasekauthor=B.+A.+Hoslerauthor=E.+Schurrauthor=K.+Arahataauthor=P.+J.+de+Jongauthor=R.+H.+Brown&title=Dysferlin%2C+a+novel+skeletal+muscle+gene%2C+is+mutated+in+Miyoshi+myopathy+and+limb+girdle+muscular+dystrophy&doi=10.1038%2F1682"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy</span></div><div class="casAuthors">Liu, Jing; Aoki, Masashi; Illa, Isabel; Wu, Chenyan; Fardeau, Michel; Angelini, Corrado; Serrano, Carmen; Urtizberea, J. Andoni; Hentati, Faycal; Ben Hamida, Mongi; Bohlega, Saeed; Culper, Edward J.; Amato, Anthony A.; Bossie, Karen; Oeltjen, Joshua; Bejaoui, Khemissa; McKenna-Yasek, Diane; Hosler, Betsy A.; Schurr, Erwin; Arahata, Kiichi; De Jong, Pieter J.; Brown, Robert H., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-36</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">Miyoshi myopathy (MM) is an adult onset, recessive inherited distal muscular dystrophy that the authors have mapped to human chromosome 2p13.  The authors recently constructed a 3-Mb P1-derived artificial chromosome (PAC) contig spanning the MM candidate region.  This clarified the order of genetic markers across the MM locus, provided five new polymorphic markers within it and narrowed the locus to approx. 2 Mb.  Five skeletal muscle expressed sequence tags (ESTs) map in this region.  The authors report that one of these is located in a novel, full-length 6.9-kb muscle cDNA, and the authors designate the corresponding protein "dysferlin".  The authors describe nine mutations in the dysferlin gene in nine families; five are predicted to prevent dysferlin expression.  Identical mutations in the dysferlin gene can produce more than one myopathy phenotype (MM, limb girdle dystrophy, distal myopathy with anterior tibial onset).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxkyGFM7tI27Vg90H21EOLACvtfcHk0lhzSGev4RlXlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmtVOmt7s%253D&md5=f0339b67ae4a42804c7154b466f08e72</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2F1682&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F1682%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DAoki%26aufirst%3DM.%26aulast%3DIlla%26aufirst%3DI.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DFardeau%26aufirst%3DM.%26aulast%3DAngelini%26aufirst%3DC.%26aulast%3DSerrano%26aufirst%3DC.%26aulast%3DUrtizberea%26aufirst%3DJ.%2BA.%26aulast%3DHentati%26aufirst%3DF.%26aulast%3DHamida%26aufirst%3DM.%2BB.%26aulast%3DBohlega%26aufirst%3DS.%26aulast%3DCulper%26aufirst%3DE.%2BJ.%26aulast%3DAmato%26aufirst%3DA.%2BA.%26aulast%3DBossie%26aufirst%3DK.%26aulast%3DOeltjen%26aufirst%3DJ.%26aulast%3DBejaoui%26aufirst%3DK.%26aulast%3DMcKenna-Yasek%26aufirst%3DD.%26aulast%3DHosler%26aufirst%3DB.%2BA.%26aulast%3DSchurr%26aufirst%3DE.%26aulast%3DArahata%26aufirst%3DK.%26aulast%3Dde%2BJong%26aufirst%3DP.%2BJ.%26aulast%3DBrown%26aufirst%3DR.%2BH.%26atitle%3DDysferlin%252C%2520a%2520novel%2520skeletal%2520muscle%2520gene%252C%2520is%2520mutated%2520in%2520Miyoshi%2520myopathy%2520and%2520limb%2520girdle%2520muscular%2520dystrophy%26jtitle%3DNat.%2520Genet.%26date%3D1998%26volume%3D20%26spage%3D31%26epage%3D36%26doi%3D10.1038%2F1682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bashir, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Britton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strachan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keers, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vafiadaki, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lako, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richard, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourg, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argov, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadeh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahjneh, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marconi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passos-Bueno, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreira, E. d. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zatz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckmann, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bushby, K.</span></span> <span> </span><span class="NLM_article-title">A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">42</span>, <span class="refDoi"> DOI: 10.1038/1689</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1038%2F1689" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=9731527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A528%3ADyaK1cXmtVOmt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1998&pages=37-42&author=R.+Bashirauthor=S.+Brittonauthor=T.+Strachanauthor=S.+Keersauthor=E.+Vafiadakiauthor=M.+Lakoauthor=I.+Richardauthor=S.+Marchandauthor=N.+Bourgauthor=Z.+Argovauthor=M.+Sadehauthor=I.+Mahjnehauthor=G.+Marconiauthor=M.+R.+Passos-Buenoauthor=E.+d.+S.+Moreiraauthor=M.+Zatzauthor=J.+S.+Beckmannauthor=K.+Bushby&title=A+gene+related+to+Caenorhabditis+elegans+spermatogenesis+factor+fer-1+is+mutated+in+limb-girdle+muscular+dystrophy+type+2B&doi=10.1038%2F1689"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B</span></div><div class="casAuthors">Bashir, Rumaisa; Britton, Stephen; Strachan, Tom; Keers, Sharon; Vafiadaki, Elizabeth; Lako, Majlinda; Richard, Isabelle; Marchand, Sylvie; Bourg, Nathalie; Argov, Zohar; Sadeh, Menachem; Mahjneh, Ibrahim; Marconi, Giampiero; Passos-Bueno, Maria Rita; De S Moreira, Eloisa; Zatz, Mayana; Beckmann, Jacques S.; Bushby, Kate</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-42</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">The limb-girdle muscular dystrophies are a genetically heterogeneous group of inherited progressive muscle disorders that affect mainly the proximal musculature, with evidence for at least three autosomal dominant and eight autosomal recessive loci.  The latter mostly involve mutations in genes encoding components of the dystrophin-assocd. complex; another form is caused by mutations in the gene for the muscle-specific protease calpain 3.  Using a positional cloning approach, the authors have identified the gene for a form of limb-girdle muscular dystrophy that the authors previously mapped to chromosome 2p13 (LGMD2B).  This gene shows no homol. to any known mammalian gene, but its predicted product is related to the C. elegans spermatogenesis factor fer-1.  The authors have identified two homozygous frameshift mutations in this gene, resulting in muscular dystrophy of either proximal or distal onset in nine families.  The proposed name "dysferlin" combines the role of the gene in producing muscular dystrophy with its C. elegans homol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq896TElAHNpbVg90H21EOLACvtfcHk0lhdPQGh--bGXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmtVOmt7Y%253D&md5=bce328e4f8ce30f015f6bfdca829aeab</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2F1689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F1689%26sid%3Dliteratum%253Aachs%26aulast%3DBashir%26aufirst%3DR.%26aulast%3DBritton%26aufirst%3DS.%26aulast%3DStrachan%26aufirst%3DT.%26aulast%3DKeers%26aufirst%3DS.%26aulast%3DVafiadaki%26aufirst%3DE.%26aulast%3DLako%26aufirst%3DM.%26aulast%3DRichard%26aufirst%3DI.%26aulast%3DMarchand%26aufirst%3DS.%26aulast%3DBourg%26aufirst%3DN.%26aulast%3DArgov%26aufirst%3DZ.%26aulast%3DSadeh%26aufirst%3DM.%26aulast%3DMahjneh%26aufirst%3DI.%26aulast%3DMarconi%26aufirst%3DG.%26aulast%3DPassos-Bueno%26aufirst%3DM.%2BR.%26aulast%3DMoreira%26aufirst%3DE.%2Bd.%2BS.%26aulast%3DZatz%26aufirst%3DM.%26aulast%3DBeckmann%26aufirst%3DJ.%2BS.%26aulast%3DBushby%26aufirst%3DK.%26atitle%3DA%2520gene%2520related%2520to%2520Caenorhabditis%2520elegans%2520spermatogenesis%2520factor%2520fer-1%2520is%2520mutated%2520in%2520limb-girdle%2520muscular%2520dystrophy%2520type%25202B%26jtitle%3DNat.%2520Genet.%26date%3D1998%26volume%3D20%26spage%3D37%26epage%3D42%26doi%3D10.1038%2F1689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davison, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moss, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cullen, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bashir, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Britton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keers, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argov, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahjneh, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fougerousse, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckmann, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bushby, K. M.</span></span> <span> </span><span class="NLM_article-title">Dysferlin is a plasma membrane protein and is expressed early in human development</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">855</span>– <span class="NLM_lpage">861</span>, <span class="refDoi"> DOI: 10.1093/hmg/8.5.855</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1093%2Fhmg%2F8.5.855" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10196375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A528%3ADyaK1MXivFamtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1999&pages=855-861&author=L.+V.+Andersonauthor=K.+Davisonauthor=J.+A.+Mossauthor=C.+Youngauthor=M.+J.+Cullenauthor=J.+Walshauthor=M.+A.+Johnsonauthor=R.+Bashirauthor=S.+Brittonauthor=S.+Keersauthor=Z.+Argovauthor=I.+Mahjnehauthor=F.+Fougerousseauthor=J.+S.+Beckmannauthor=K.+M.+Bushby&title=Dysferlin+is+a+plasma+membrane+protein+and+is+expressed+early+in+human+development&doi=10.1093%2Fhmg%2F8.5.855"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Dysferlin is a plasma membrane protein and is expressed early in human development</span></div><div class="casAuthors">Anderson, Louise V. B.; Davison, Keith; Moss, Jennifer A.; Young, Carol; Cullen, Michael J.; Walsh, John; Johnson, Margaret A.; Bashir, Rumaisa; Britton, Stephen; Keers, Sharon; Argov, Zohar; Mahjneh, Ibrahim; Fougerousse, Francoise; Beckmann, Jacques S.; Bushby, Kate M. D.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">855-861</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Recently, a single gene, DYSF, has been identified which is mutated in patients with limb-girdle muscular dystrophy type 2B (LGMD2B) and with Miyoshi myopathy (MM).  This is of interest because these diseases have been considered as two distinct clin. conditions since different muscle groups are the initial targets.  Dysferlin, the protein product of the gene, is a novel mol. without homol. to any known mammalian protein.  The authors have now raised a monoclonal antibody to dysferlin and report on the expression of this new protein: immunolabeling with the antibody (designated NCL-hamlet) demonstrated a polypeptide of ∼230 kDa on western blots of skeletal muscle, with localization to the muscle fiber membrane by microscopy at both the light and electron microscopic level.  A specific loss of dysferlin labeling was obsd. in patients with mutations in the LGMD2B/MM gene.  Furthermore, patients with two different frame-shifting mutations demonstrated very low levels of immunoreactive protein in a manner reminiscent of the dystrophin expressed in many Duchenne patients.  Anal. of human fetal tissue showed that dysferlin was expressed at the earliest stages of development examd., at Carnegie stage 15 or 16 (embryonic age 5-6 wk).  Dysferlin is present, therefore, at a time when the limbs start to show regional differentiation.  Lack of dysferlin at this crit. time may contribute to the pattern of muscle involvement that develops later, with the onset of a muscular dystrophy primarily affecting proximal or distal muscles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp98wlh5OkKDbVg90H21EOLACvtfcHk0lhdPQGh--bGXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXivFamtro%253D&md5=2b82ecf5074c538ff7f302e7697c1fea</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2F8.5.855&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252F8.5.855%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DL.%2BV.%26aulast%3DDavison%26aufirst%3DK.%26aulast%3DMoss%26aufirst%3DJ.%2BA.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DCullen%26aufirst%3DM.%2BJ.%26aulast%3DWalsh%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DM.%2BA.%26aulast%3DBashir%26aufirst%3DR.%26aulast%3DBritton%26aufirst%3DS.%26aulast%3DKeers%26aufirst%3DS.%26aulast%3DArgov%26aufirst%3DZ.%26aulast%3DMahjneh%26aufirst%3DI.%26aulast%3DFougerousse%26aufirst%3DF.%26aulast%3DBeckmann%26aufirst%3DJ.%2BS.%26aulast%3DBushby%26aufirst%3DK.%2BM.%26atitle%3DDysferlin%2520is%2520a%2520plasma%2520membrane%2520protein%2520and%2520is%2520expressed%2520early%2520in%2520human%2520development%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D1999%26volume%3D8%26spage%3D855%26epage%3D861%26doi%3D10.1093%2Fhmg%2F8.5.855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bansal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, K. P.</span></span> <span> </span><span class="NLM_article-title">Dysferlin and the plasma membrane repair in muscular dystrophy</span>. <i>Trends Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">206</span>– <span class="NLM_lpage">213</span>, <span class="refDoi"> DOI: 10.1016/j.tcb.2004.03.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1016%2Fj.tcb.2004.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=15066638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivVGjt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=206-213&author=D.+Bansalauthor=K.+P.+Campbell&title=Dysferlin+and+the+plasma+membrane+repair+in+muscular+dystrophy&doi=10.1016%2Fj.tcb.2004.03.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Dysferlin and the plasma membrane repair in muscular dystrophy</span></div><div class="casAuthors">Bansal, Dimple; Campbell, Kevin P.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">206-213</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Muscular dystrophy covers a group of genetically detd. disorders that cause progressive weakness and wasting of the skeletal muscles.  Dysferlin was identified as a gene mutated in limb-girdle muscular dystrophy (type 2B) and Miyoshi myopathy.  The discovery of dysferlin revealed a new family of proteins, known as the ferlin family, which includes four different genes.  Recent work suggests the function of dysferlin in membrane repair and demonstrates that defective membrane repair is a novel mechanism of muscle degeneration.  These findings reveal the importance of a basic cellular function in skeletal muscle and a new class of muscular dystrophy where the defect lies in the maintenance, not the structure, of the plasma membrane.  Here, the authors discuss the current knowledge of dysferlin function in the repair of the plasma membrane of the skeletal muscle cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdlPn75UrLC7Vg90H21EOLACvtfcHk0lhdPQGh--bGXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivVGjt7g%253D&md5=7fd91f6e34aea84f5b45e75777bc0244</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.tcb.2004.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tcb.2004.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DBansal%26aufirst%3DD.%26aulast%3DCampbell%26aufirst%3DK.%2BP.%26atitle%3DDysferlin%2520and%2520the%2520plasma%2520membrane%2520repair%2520in%2520muscular%2520dystrophy%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2004%26volume%3D14%26spage%3D206%26epage%3D213%26doi%3D10.1016%2Fj.tcb.2004.03.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, R.</span></span> <span> </span><span class="NLM_article-title">Muscle membrane repair and inflammatory attack in dysferlinopathy</span>. <i>Skeletal Muscle</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">10</span>, <span class="refDoi"> DOI: 10.1186/2044-5040-1-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1186%2F2044-5040-1-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=21798087" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A280%3ADC%252BC3MjitV2quw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=10&author=R.+Han&title=Muscle+membrane+repair+and+inflammatory+attack+in+dysferlinopathy&doi=10.1186%2F2044-5040-1-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Muscle membrane repair and inflammatory attack in dysferlinopathy</span></div><div class="casAuthors">Han Renzhi</div><div class="citationInfo"><span class="NLM_cas:title">Skeletal muscle</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">10</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Repair of plasma membrane tears is an important normal physiological process that enables the cells to survive a variety of physiological and pathological membrane lesions.  Dysferlin was the first protein reported to play a crucial role in this repair process in muscle, and recently, several other proteins including Mitsugumin 53 (MG53), annexin and calpain were also found to participate.  These findings have now established the framework of the membrane repair mechanism.  Defective membrane repair in dysferlin-deficient muscle leads to the development of muscular dystrophy associated with remarkable muscle inflammation.  Recent studies have demonstrated a crosstalk between defective membrane repair and immunological attack, thus unveiling a new pathophysiological mechanism of dysferlinopathy.  Here I summarize and discuss the latest progress in the molecular mechanisms of membrane repair and the pathogenesis of dysferlinopathy.  Discussion about potential therapeutic applications of these findings is also provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRZh8qbcSd5LYxhnOQkIHOxfW6udTcc2eafgQYdjucs9rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MjitV2quw%253D%253D&md5=ea5d3bb8795de5b63ff593522a92fcfc</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1186%2F2044-5040-1-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2044-5040-1-10%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DR.%26atitle%3DMuscle%2520membrane%2520repair%2520and%2520inflammatory%2520attack%2520in%2520dysferlinopathy%26jtitle%3DSkeletal%2520Muscle%26date%3D2011%26volume%3D1%26spage%3D10%26doi%3D10.1186%2F2044-5040-1-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiyosue, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishino, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, Y. K.</span></span> <span> </span><span class="NLM_article-title">Dysferlinopathy fibroblasts are defective in plasma membrane repair</span>. <i>PLoS Curr.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>, <span class="refDoi"> DOI: 10.1371/currents.md.5865add2d766f39a0e0411d38a7ba09c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1371%2Fcurrents.md.5865add2d766f39a0e0411d38a7ba09c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=26579332" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=C.+Matsudaauthor=K.+Kiyosueauthor=I.+Nishinoauthor=Y.+Gotoauthor=Y.+K.+Hayashi&title=Dysferlinopathy+fibroblasts+are+defective+in+plasma+membrane+repair&doi=10.1371%2Fcurrents.md.5865add2d766f39a0e0411d38a7ba09c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1371%2Fcurrents.md.5865add2d766f39a0e0411d38a7ba09c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fcurrents.md.5865add2d766f39a0e0411d38a7ba09c%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuda%26aufirst%3DC.%26aulast%3DKiyosue%26aufirst%3DK.%26aulast%3DNishino%26aufirst%3DI.%26aulast%3DGoto%26aufirst%3DY.%26aulast%3DHayashi%26aufirst%3DY.%2BK.%26atitle%3DDysferlinopathy%2520fibroblasts%2520are%2520defective%2520in%2520plasma%2520membrane%2520repair%26jtitle%3DPLoS%2520Curr.%26date%3D2015%26doi%3D10.1371%2Fcurrents.md.5865add2d766f39a0e0411d38a7ba09c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tateyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yaginuma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayasaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugawara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abe-Kondo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimakura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuru, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakayama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sobue, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funakawa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukai, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawanami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuji, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuzuhara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshioka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konno, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onodera, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoyama, Y.</span></span> <span> </span><span class="NLM_article-title">Clinical features and a mutation with late onset of limb girdle muscular dystrophy 2B</span>. <i>J. Neurol., Neurosurg. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">433</span>– <span class="NLM_lpage">440</span>, <span class="refDoi"> DOI: 10.1136/jnnp-2011-301339</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1136%2Fjnnp-2011-301339" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=23243261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A280%3ADC%252BC3s3itlSjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2013&pages=433-440&author=T.+Takahashiauthor=M.+Aokiauthor=N.+Suzukiauthor=M.+Tateyamaauthor=C.+Yaginumaauthor=H.+Satoauthor=M.+Hayasakaauthor=H.+Sugawaraauthor=M.+Itoauthor=E.+Abe-Kondoauthor=N.+Shimakuraauthor=T.+Ibiauthor=S.+Kuruauthor=T.+Wakayamaauthor=G.+Sobueauthor=N.+Fujiiauthor=T.+Saitoauthor=T.+Matsumuraauthor=I.+Funakawaauthor=E.+Mukaiauthor=T.+Kawanamiauthor=M.+Moritaauthor=M.+Yamazakiauthor=T.+Hasegawaauthor=J.+Shimizuauthor=S.+Tsujiauthor=S.+Kuzuharaauthor=H.+Tanakaauthor=M.+Yoshiokaauthor=H.+Konnoauthor=H.+Onoderaauthor=Y.+Itoyama&title=Clinical+features+and+a+mutation+with+late+onset+of+limb+girdle+muscular+dystrophy+2B&doi=10.1136%2Fjnnp-2011-301339"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical features and a mutation with late onset of limb girdle muscular dystrophy 2B</span></div><div class="casAuthors">Takahashi Toshiaki; Aoki Masashi; Suzuki Naoki; Tateyama Maki; Yaginuma Chikako; Sato Hitomi; Hayasaka Miho; Sugawara Hitomi; Ito Mariko; Abe-Kondo Emi; Shimakura Naoko; Ibi Tohru; Kuru Satoshi; Wakayama Tadashi; Sobue Gen; Fujii Naoki; Saito Toshio; Matsumura Tsuyoshi; Funakawa Itaru; Mukai Eiichiro; Kawanami Toru; Morita Mitsuya; Yamazaki Mineo; Hasegawa Takashi; Shimizu Jun; Tsuji Shoji; Kuzuhara Shigeki; Tanaka Hiroyasu; Yoshioka Masaru; Konno Hidehiko; Onodera Hiroshi; Itoyama Yasuto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurology, neurosurgery, and psychiatry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">433-40</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE AND METHODS:  Dysferlin encoded by DYSF deficiency leads to two main phenotypes, limb girdle muscular dystrophy (LGMD) 2B and Miyoshi myopathy.  To reveal in detail the mutational and clinical features of LGMD2B in Japan, we observed 40 Japanese patients in 36 families with LGMD2B in whom dysferlin mutations were confirmed.  RESULTS AND CONCLUSIONS:  Three mutations (c.1566C>G, c.2997G>T and c.4497delT) were relatively more prevalent.  The c.2997G>T mutation was associated with late onset, proximal dominant forms of dysferlinopathy, a high probability that muscle weakness started in an upper limb and lower serum creatine kinase (CK) levels.  The clinical features of LGMD2B are as follows: (1) onset in the late teens or early adulthood, except patients homozygous for the c.2997G>T mutation; (2) lower limb weakness at onset; (3) distal change of lower limbs on muscle CT at an early stage; (4) impairment of lumbar erector spinal muscles on muscle CT at an early stage; (5) predominant involvement of proximal upper limbs; (6) preservation of function of the hands at late stage; (7) preservation of strength in neck muscles at late stage; (8) lack of facial weakness or dysphagia; (9) avoidance of scoliosis; (10) hyper-Ckaemia; (11) preservation of cardiac function; and (12) a tendency for respiratory function to decline with disease duration.  It is important that the late onset phenotype is found with prevalent mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQIECvdOWcgRKcY7HFp97qMfW6udTcc2eafgQYdjucs9rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s3itlSjuw%253D%253D&md5=5e6664b74e698a33a08095f932343b9d</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1136%2Fjnnp-2011-301339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjnnp-2011-301339%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DT.%26aulast%3DAoki%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DTateyama%26aufirst%3DM.%26aulast%3DYaginuma%26aufirst%3DC.%26aulast%3DSato%26aufirst%3DH.%26aulast%3DHayasaka%26aufirst%3DM.%26aulast%3DSugawara%26aufirst%3DH.%26aulast%3DIto%26aufirst%3DM.%26aulast%3DAbe-Kondo%26aufirst%3DE.%26aulast%3DShimakura%26aufirst%3DN.%26aulast%3DIbi%26aufirst%3DT.%26aulast%3DKuru%26aufirst%3DS.%26aulast%3DWakayama%26aufirst%3DT.%26aulast%3DSobue%26aufirst%3DG.%26aulast%3DFujii%26aufirst%3DN.%26aulast%3DSaito%26aufirst%3DT.%26aulast%3DMatsumura%26aufirst%3DT.%26aulast%3DFunakawa%26aufirst%3DI.%26aulast%3DMukai%26aufirst%3DE.%26aulast%3DKawanami%26aufirst%3DT.%26aulast%3DMorita%26aufirst%3DM.%26aulast%3DYamazaki%26aufirst%3DM.%26aulast%3DHasegawa%26aufirst%3DT.%26aulast%3DShimizu%26aufirst%3DJ.%26aulast%3DTsuji%26aufirst%3DS.%26aulast%3DKuzuhara%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DH.%26aulast%3DYoshioka%26aufirst%3DM.%26aulast%3DKonno%26aufirst%3DH.%26aulast%3DOnodera%26aufirst%3DH.%26aulast%3DItoyama%26aufirst%3DY.%26atitle%3DClinical%2520features%2520and%2520a%2520mutation%2520with%2520late%2520onset%2520of%2520limb%2520girdle%2520muscular%2520dystrophy%25202B%26jtitle%3DJ.%2520Neurol.%252C%2520Neurosurg.%2520Psychiatry%26date%3D2013%26volume%3D84%26spage%3D433%26epage%3D440%26doi%3D10.1136%2Fjnnp-2011-301339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woltjen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyake, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hotta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishino, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoji, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehara-Fujisawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manabe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanaoka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Era, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isobe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, H.</span></span> <span> </span><span class="NLM_article-title">Efficient and reproducible myogenic differentiation from human iPS cells: prospects for modeling Miyoshi myopathy in vitro</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e61540</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0061540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1371%2Fjournal.pone.0061540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=23626698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVKrurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&author=A.+Tanakaauthor=K.+Woltjenauthor=K.+Miyakeauthor=A.+Hottaauthor=M.+Ikeyaauthor=T.+Yamamotoauthor=T.+Nishinoauthor=E.+Shojiauthor=A.+Sehara-Fujisawaauthor=Y.+Manabeauthor=N.+Fujiiauthor=K.+Hanaokaauthor=T.+Eraauthor=S.+Yamashitaauthor=K.+Isobeauthor=E.+Kimuraauthor=H.+Sakurai&title=Efficient+and+reproducible+myogenic+differentiation+from+human+iPS+cells%3A+prospects+for+modeling+Miyoshi+myopathy+in+vitro&doi=10.1371%2Fjournal.pone.0061540"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient and reproducible myogenic differentiation from human iPS cells: prospects for modeling Miyoshi Myopathy in vitro</span></div><div class="casAuthors">Tanaka, Akihito; Woltjen, Knut; Miyake, Katsuya; Hotta, Akitsu; Ikeya, Makoto; Yamamoto, Takuya; Nishino, Tokiko; Shoji, Emi; Sehara-Fujisawa, Atsuko; Manabe, Yasuko; Fujii, Nobuharu; Hanaoka, Kazunori; Era, Takumi; Yamashita, Satoshi; Isobe, Ken-ichi; Kimura, En; Sakurai, Hidetoshi</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e61540</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The establishment of human induced pluripotent stem cells (hiPSCs) has enabled the prodn. of in vitro, patient-specific cell models of human disease.  In vitro recreation of disease pathol. from patient-derived hiPSCs depends on efficient differentiation protocols producing relevant adult cell types.  However, myogenic differentiation of hiPSCs has faced obstacles, namely, low efficiency and/or poor reproducibility.  Here, we report the rapid, efficient and reproducible differentiation of hiPSCs into mature myocytes.  We demonstrated that inducible expression of myogenic differentiation 1 (MYOD1) in immature hiPSCs for at least 5 days drives cells along the myogenic lineage, with efficiencies reaching 70-90 %.  Myogenic differentiation driven by MYOD1 occurred even in immature, almost completely undifferentiated hiPSCs, without mesodermal transition.  Myocytes induced in this manner reach maturity within 2 wk of differentiation as assessed by marker gene expression and functional properties, including in vitro and in vivo cell fusion and twitching in response to elec. stimulation.  Miyoshi Myopathy (MM) is a congenital distal myopathy caused by defective muscle membrane repair due to mutations in DYSFERLIN.  Using our induced differentiation technique, we successfully recreated the pathol. condition of MM in vitro, demonstrating defective membrane repair in hiPSC-derived myotubes from an MM patient and phenotypic rescue by expression of full-length DYSFERLIN (DYSF).  These findings not only facilitate the pathol. investigation of MM, but could potentially be applied in modeling of other human muscular diseases by using patient-derived hiPSCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpMwgyF8EPb7Vg90H21EOLACvtfcHk0lgbeWf0sCMJxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVKrurk%253D&md5=36a81c807e35702243066b9896ba9dfb</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0061540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0061540%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DA.%26aulast%3DWoltjen%26aufirst%3DK.%26aulast%3DMiyake%26aufirst%3DK.%26aulast%3DHotta%26aufirst%3DA.%26aulast%3DIkeya%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DNishino%26aufirst%3DT.%26aulast%3DShoji%26aufirst%3DE.%26aulast%3DSehara-Fujisawa%26aufirst%3DA.%26aulast%3DManabe%26aufirst%3DY.%26aulast%3DFujii%26aufirst%3DN.%26aulast%3DHanaoka%26aufirst%3DK.%26aulast%3DEra%26aufirst%3DT.%26aulast%3DYamashita%26aufirst%3DS.%26aulast%3DIsobe%26aufirst%3DK.%26aulast%3DKimura%26aufirst%3DE.%26aulast%3DSakurai%26aufirst%3DH.%26atitle%3DEfficient%2520and%2520reproducible%2520myogenic%2520differentiation%2520from%2520human%2520iPS%2520cells%253A%2520prospects%2520for%2520modeling%2520Miyoshi%2520myopathy%2520in%2520vitro%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26doi%3D10.1371%2Fjournal.pone.0061540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kokubu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagino, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oikawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyake, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kume, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuse, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tozawa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, H.</span></span> <span> </span><span class="NLM_article-title">Phenotypic drug screening for dysferlinopathy using patient-derived induced pluripotent stem cells</span>. <i>Stem Cells Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1017</span>, <span class="refDoi"> DOI: 10.1002/sctm.18-0280</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1002%2Fsctm.18-0280" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=31250983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A280%3ADC%252BB3MzhvFWgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&pages=1017&author=Y.+Kokubuauthor=T.+Naginoauthor=K.+Sasaauthor=T.+Oikawaauthor=K.+Miyakeauthor=A.+Kumeauthor=M.+Fukudaauthor=H.+Fuseauthor=R.+Tozawaauthor=H.+Sakurai&title=Phenotypic+drug+screening+for+dysferlinopathy+using+patient-derived+induced+pluripotent+stem+cells&doi=10.1002%2Fsctm.18-0280"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Phenotypic Drug Screening for Dysferlinopathy Using Patient-Derived Induced Pluripotent Stem Cells</span></div><div class="casAuthors">Kokubu Yuko; Fukuda Mikiko; Sakurai Hidetoshi; Nagino Tomoko; Sasa Katsunori; Oikawa Tatsuo; Kume Akiko; Fuse Hiromitsu; Tozawa Ryuichi; Miyake Katsuya</div><div class="citationInfo"><span class="NLM_cas:title">Stem cells translational medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1017-1029</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dysferlinopathy is a progressive muscle disorder that includes limb-girdle muscular dystrophy type 2B and Miyoshi myopathy (MM).  It is caused by mutations in the dysferlin (DYSF) gene, whose function is to reseal the muscular membrane.  Treatment with proteasome inhibitor MG-132 has been shown to increase misfolded dysferlin in fibroblasts, allowing them to recover their membrane resealing function.  Here, we developed a screening system based on myocytes from MM patient-derived induced pluripotent stem cells.  According to the screening, nocodazole was found to effectively increase the level of dysferlin in cells, which, in turn, enhanced membrane resealing following injury by laser irradiation.  Moreover, the increase was due to microtubule disorganization and involved autophagy rather than the proteasome degradation pathway.  These findings suggest that increasing the amount of misfolded dysferlin using small molecules could represent an effective future clinical treatment for dysferlinopathy.  Stem Cells Translational Medicine 2019;8:1017-1029.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTmeHYKxCnC5IHWj6b1v8uTfW6udTcc2eYbECzjW5x7drntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MzhvFWgtA%253D%253D&md5=4c5cb7828405980ec6d77bee4f188355</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fsctm.18-0280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsctm.18-0280%26sid%3Dliteratum%253Aachs%26aulast%3DKokubu%26aufirst%3DY.%26aulast%3DNagino%26aufirst%3DT.%26aulast%3DSasa%26aufirst%3DK.%26aulast%3DOikawa%26aufirst%3DT.%26aulast%3DMiyake%26aufirst%3DK.%26aulast%3DKume%26aufirst%3DA.%26aulast%3DFukuda%26aufirst%3DM.%26aulast%3DFuse%26aufirst%3DH.%26aulast%3DTozawa%26aufirst%3DR.%26aulast%3DSakurai%26aufirst%3DH.%26atitle%3DPhenotypic%2520drug%2520screening%2520for%2520dysferlinopathy%2520using%2520patient-derived%2520induced%2520pluripotent%2520stem%2520cells%26jtitle%3DStem%2520Cells%2520Transl.%2520Med.%26date%3D2019%26volume%3D8%26spage%3D1017%26doi%3D10.1002%2Fsctm.18-0280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oda, T.</span>; <span class="NLM_string-name">Imada, T.</span>; <span class="NLM_string-name">Naito, K.</span>; <span class="NLM_string-name">Tamura, T.</span>; <span class="NLM_string-name">Furuya, S.</span></span> <span> </span><span class="NLM_article-title">Bicyclic Derivative, Process for Producing the Same, and Use</span>. PCT Int. Appl. <span class="NLM_patent">WO 03/045929 A1</span>, <span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=T.+Oda&author=T.+Imada&author=K.+Naito&author=T.+Tamura&author=S.+Furuya&title=Bicyclic+Derivative%2C+Process+for+Producing+the+Same%2C+and+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DOda%26aufirst%3DT.%26atitle%3DBicyclic%2520Derivative%252C%2520Process%2520for%2520Producing%2520the%2520Same%252C%2520and%2520Use%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ziegler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pries, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedberg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldmann, H.</span></span> <span> </span><span class="NLM_article-title">Target identification for small bioactive molecules: finding the needle in the haystack</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">2744</span>– <span class="NLM_lpage">2792</span>, <span class="refDoi"> DOI: 10.1002/anie.201208749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1002%2Fanie.201208749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=23418026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A528%3ADC%252BC3sXislSksLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=2744-2792&author=S.+Zieglerauthor=V.+Priesauthor=C.+Hedbergauthor=H.+Waldmann&title=Target+identification+for+small+bioactive+molecules%3A+finding+the+needle+in+the+haystack&doi=10.1002%2Fanie.201208749"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Target Identification for Small Bioactive Molecules: Finding the Needle in the Haystack</span></div><div class="casAuthors">Ziegler, Slava; Pries, Verena; Hedberg, Christian; Waldmann, Herbert</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2744-2792</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Identification and confirmation of bioactive small-mol. targets is a crucial, often decisive step both in academic and pharmaceutical research.  Through the development and availability of several new exptl. techniques, target identification is, in principle, feasible, and the no. of successful examples steadily grows.  However, a generic methodol. that can successfully be applied in the majority of the cases has not yet been established.  Herein we summarize current methods for target identification of small mols., primarily for a chem. audience but also the biol. community, for example, the chemist or biologist attempting to identify the target of a given bioactive compd.  We describe the most frequently employed exptl. approaches for target identification and provide several representative examples illustrating the state-of-the-art.  Among the techniques currently available, protein affinity isolation using suitable small-mol. probes (pulldown) and subsequent mass spectrometric anal. of the isolated proteins appears to be most powerful and most frequently applied.  To provide guidance for rapid entry into the field and based on our own experience we propose a typical workflow for target identification, which centers on the application of chem. proteomics as the key step to generate hypotheses for potential target proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYC9-7L3abMrVg90H21EOLACvtfcHk0lgbeWf0sCMJxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXislSksLk%253D&md5=3a124205e3a57a53f479b889073bda76</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fanie.201208749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201208749%26sid%3Dliteratum%253Aachs%26aulast%3DZiegler%26aufirst%3DS.%26aulast%3DPries%26aufirst%3DV.%26aulast%3DHedberg%26aufirst%3DC.%26aulast%3DWaldmann%26aufirst%3DH.%26atitle%3DTarget%2520identification%2520for%2520small%2520bioactive%2520molecules%253A%2520finding%2520the%2520needle%2520in%2520the%2520haystack%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2013%26volume%3D52%26spage%3D2744%26epage%3D2792%26doi%3D10.1002%2Fanie.201208749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Comess, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLoughlin, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyer, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasudevan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warder, S. E.</span></span> <span> </span><span class="NLM_article-title">Emerging approaches for the identification of protein targets of small molecules - a practitioners’ perspective</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">8504</span>– <span class="NLM_lpage">8535</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01921</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01921" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A528%3ADC%252BC1cXovVCht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=8504-8535&author=K.+M.+Comessauthor=S.+M.+McLoughlinauthor=J.+A.+Oyerauthor=P.+L.+Richardsonauthor=H.+Stockmannauthor=A.+Vasudevanauthor=S.+E.+Warder&title=Emerging+approaches+for+the+identification+of+protein+targets+of+small+molecules+-+a+practitioners%E2%80%99+perspective&doi=10.1021%2Facs.jmedchem.7b01921"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging Approaches for the Identification of Protein Targets of Small Molecules - A Practitioners' Perspective</span></div><div class="casAuthors">Comess, Kenneth M.; McLoughlin, Shaun M.; Oyer, Jon A.; Richardson, Paul L.; Stockmann, Henning; Vasudevan, Anil; Warder, Scott E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8504-8535</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Small-mol. (SM) leads in the early drug discovery pipeline are progressed primarily based on potency against the intended target(s) and selectivity against a very narrow slice of the proteome.  So, why is there a tendency to wait until SMs are matured before probing for a deeper mechanistic understanding.  For one, there is a concern about the interpretation of complex -omic data outputs and the resources needed to test these hypotheses.  However, with recent advances in broad endpoint profiling assays that have companion ref. databases and refined technol. integration strategies, we argue that data complexity can translate into meaningful decision-making.  This same strategy can also prioritize phenotypic screening hits to increase the likelihood of accessing unprecedented target space.  In this Perspective. we will highlight a cohesive process that supports SM hit prosecution, providing a data-driven rationale and a suite of methods for direct identification of SM targets driving relevant biol. end points.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTl79BgUlfjbVg90H21EOLACvtfcHk0lhfv6A3gZ6D9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXovVCht7Y%253D&md5=7c051edc4cc8e8603a46ed927a6a08c3</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01921%26sid%3Dliteratum%253Aachs%26aulast%3DComess%26aufirst%3DK.%2BM.%26aulast%3DMcLoughlin%26aufirst%3DS.%2BM.%26aulast%3DOyer%26aufirst%3DJ.%2BA.%26aulast%3DRichardson%26aufirst%3DP.%2BL.%26aulast%3DStockmann%26aufirst%3DH.%26aulast%3DVasudevan%26aufirst%3DA.%26aulast%3DWarder%26aufirst%3DS.%2BE.%26atitle%3DEmerging%2520approaches%2520for%2520the%2520identification%2520of%2520protein%2520targets%2520of%2520small%2520molecules%2520-%2520a%2520practitioners%25E2%2580%2599%2520perspective%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D8504%26epage%3D8535%26doi%3D10.1021%2Facs.jmedchem.7b01921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. D.</span></span> <span> </span><span class="NLM_article-title">An overview of tubulin inhibitors that interact with the colchicine binding site</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">2943</span>– <span class="NLM_lpage">2971</span>, <span class="refDoi"> DOI: 10.1007/s11095-012-0828-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1007%2Fs11095-012-0828-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=22814904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOis7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2012&pages=2943-2971&author=Y.+Luauthor=J.+Chenauthor=M.+Xiaoauthor=W.+Liauthor=D.+D.+Miller&title=An+overview+of+tubulin+inhibitors+that+interact+with+the+colchicine+binding+site&doi=10.1007%2Fs11095-012-0828-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">An Overview of Tubulin Inhibitors That Interact with the Colchicine Binding Site</span></div><div class="casAuthors">Lu, Yan; Chen, Jianjun; Xiao, Min; Li, Wei; Miller, Duane D.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2943-2971</span>CODEN:
                <span class="NLM_cas:coden">PHREEB</span>;
        ISSN:<span class="NLM_cas:issn">0724-8741</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Tubulin dynamics is a promising target for new chemotherapeutic agents.  The colchicine binding site is one of the most important pockets for potential tubulin polymn. destabilizers.  Colchicine binding site inhibitors (CBSI) exert their biol. effects by inhibiting tubulin assembly and suppressing microtubule formation.  A large no. of mols. interacting with the colchicine binding site have been designed and synthesized with significant structural diversity.  CBSIs have been modified as to chem. structure as well as pharmacokinetic properties, and tested in order to find a highly potent, low toxicity agent for treatment of cancers.  CBSIs are believed to act by a common mechanism via binding to the colchicine site on tubulin.  The present review is a synopsis of compds. that have been reported in the past decade that have provided an increase in our understanding of the actions of CBSIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFrFQVgeCbBbVg90H21EOLACvtfcHk0lhfv6A3gZ6D9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOis7vN&md5=dfe42e8eb1f0ff22b256641aaa8c17ab</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1007%2Fs11095-012-0828-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-012-0828-z%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DXiao%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DMiller%26aufirst%3DD.%2BD.%26atitle%3DAn%2520overview%2520of%2520tubulin%2520inhibitors%2520that%2520interact%2520with%2520the%2520colchicine%2520binding%2520site%26jtitle%3DPharm.%2520Res.%26date%3D2012%26volume%3D29%26spage%3D2943%26epage%3D2971%26doi%3D10.1007%2Fs11095-012-0828-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gigant, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span> <span> </span><span class="NLM_article-title">Structures of a diverse set of colchicine binding site inhibitors in complex with tubulin provide a rationale for drug discovery</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">102</span>– <span class="NLM_lpage">111</span>, <span class="refDoi"> DOI: 10.1111/febs.13555</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1111%2Ffebs.13555" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=26462166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslKktrzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2016&pages=102-111&author=Y.+Wangauthor=H.+Zhangauthor=B.+Gigantauthor=Y.+Yuauthor=Y.+Wuauthor=X.+Chenauthor=Q.+Laiauthor=Z.+Yangauthor=Q.+Chenauthor=J.+Yang&title=Structures+of+a+diverse+set+of+colchicine+binding+site+inhibitors+in+complex+with+tubulin+provide+a+rationale+for+drug+discovery&doi=10.1111%2Ffebs.13555"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of a diverse set of colchicine binding site inhibitors in complex with tubulin provide a rationale for drug discovery</span></div><div class="casAuthors">Wang, Yuxi; Zhang, Hang; Gigant, Benoit; Yu, Yamei; Wu, Yangping; Chen, Xiangzheng; Lai, Qinhuai; Yang, Zhaoya; Chen, Qiang; Yang, Jinliang</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">102-111</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Microtubules are dynamic assemblies of αβ-tubulin heterodimers and have been recognized as highly attractive targets for cancer chemotherapy.  A broad range of agents bind to tubulin and interfere with microtubule assembly.  Despite having a long history of characterization, colchicine binding site inhibitors (CBSIs) have not yet reached the com. phase as anti-cancer drugs to date.  We detd. the structures of tubulin complexed with a set of structurally diverse CBSIs (lexibulin, nocodazole, plinabulin and tivantinib), among which nocodazole and tivantinib are both binary-function inhibitors targeting cancer-related kinases and microtubules simultaneously.  High resoln. structures revealed the detailed interactions between these ligands and tubulin.  Our results showed that the binding modes of the CBSIs were different from previous docking models, highlighting the importance of crystal structure information in structure-based drug design.  A real structure-based pharmacophore was proposed to rationalize key common interactions of the CBSIs at the colchicine domain.  Our studies provide a solid structural basis for developing new anti-cancer agents for the colchicine binding site.  Database : The at. coordinates and structure factors for tubulin complexed with lexibulin, nocodazole, plinabulin and tivantinib have been deposited in the Protein Data Bank under accession codes , , and , resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSIAVSS_EsIbVg90H21EOLACvtfcHk0lhfv6A3gZ6D9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslKktrzP&md5=d5a17d9a3ac54d8eda44d0543ffa5fbd</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1111%2Ffebs.13555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.13555%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DGigant%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DLai%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DJ.%26atitle%3DStructures%2520of%2520a%2520diverse%2520set%2520of%2520colchicine%2520binding%2520site%2520inhibitors%2520in%2520complex%2520with%2520tubulin%2520provide%2520a%2520rationale%2520for%2520drug%2520discovery%26jtitle%3DFEBS%2520J.%26date%3D2016%26volume%3D283%26spage%3D102%26epage%3D111%26doi%3D10.1111%2Ffebs.13555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murale, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haque, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. S.</span></span> <span> </span><span class="NLM_article-title">Photo-affinity labeling (PAL) in chemical proteomics: a handy tool to investigate protein-protein interactions (PPIs)</span>. <i>Proteome Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">14</span>, <span class="refDoi"> DOI: 10.1186/s12953-017-0123-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1186%2Fs12953-017-0123-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=28652856" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A280%3ADC%252BC1cjitV2ksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=14&author=D.+P.+Muraleauthor=S.+C.+Hongauthor=M.+M.+Haqueauthor=J.+S.+Lee&title=Photo-affinity+labeling+%28PAL%29+in+chemical+proteomics%3A+a+handy+tool+to+investigate+protein-protein+interactions+%28PPIs%29&doi=10.1186%2Fs12953-017-0123-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Photo-affinity labeling (PAL) in chemical proteomics: a handy tool to investigate protein-protein interactions (PPIs)</span></div><div class="casAuthors">Murale Dhiraj P; Hong Seong Cheol; Haque Md Mamunul; Lee Jun-Seok; Hong Seong Cheol; Lee Jun-Seok</div><div class="citationInfo"><span class="NLM_cas:title">Proteome science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">14</span>
        ISSN:<span class="NLM_cas:issn">1477-5956</span>.
    </div><div class="casAbstract">Protein-protein interactions (PPIs) trigger a wide range of biological signaling pathways that are crucial for biomedical research and drug discovery.  Various techniques have been used to study specific proteins, including affinity chromatography, activity-based probes, affinity-based probes and photo-affinity labeling (PAL).  PAL has become one of the most powerful strategies to study PPIs.  Traditional photocrosslinkers are used in PAL, including benzophenone, aryl azide, and diazirine.  Upon photoirradiation, these photocrosslinkers (Pls) generate highly reactive species that react with adjacent molecules, resulting in a direct covalent modification.  This review introduces recent examples of chemical proteomics study using PAL for PPIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRaiDChB3xtDcjl5L8hwNX0fW6udTcc2eZHe8MhmVeYpLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cjitV2ksA%253D%253D&md5=d6ef0d08db66c5d4b74caa24e5b97a94</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1186%2Fs12953-017-0123-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12953-017-0123-3%26sid%3Dliteratum%253Aachs%26aulast%3DMurale%26aufirst%3DD.%2BP.%26aulast%3DHong%26aufirst%3DS.%2BC.%26aulast%3DHaque%26aufirst%3DM.%2BM.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26atitle%3DPhoto-affinity%2520labeling%2520%2528PAL%2529%2520in%2520chemical%2520proteomics%253A%2520a%2520handy%2520tool%2520to%2520investigate%2520protein-protein%2520interactions%2520%2528PPIs%2529%26jtitle%3DProteome%2520Sci.%26date%3D2016%26volume%3D15%26spage%3D14%26doi%3D10.1186%2Fs12953-017-0123-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dominguez-Brauer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thu, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaser, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bray, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span> <span> </span><span class="NLM_article-title">Targeting mitosis in cancer: emerging strategies</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">524</span>– <span class="NLM_lpage">536</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2015.11.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1016%2Fj.molcel.2015.11.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=26590712" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVyqtbrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2015&pages=524-536&author=C.+Dominguez-Brauerauthor=K.+L.+Thuauthor=J.+M.+Masonauthor=H.+Blaserauthor=M.+R.+Brayauthor=T.+W.+Mak&title=Targeting+mitosis+in+cancer%3A+emerging+strategies&doi=10.1016%2Fj.molcel.2015.11.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Mitosis in Cancer: Emerging Strategies</span></div><div class="casAuthors">Dominguez-Brauer, Carmen; Thu, Kelsie L.; Mason, Jacqueline M.; Blaser, Heiko; Bray, Mark R.; Mak, Tak W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">524-536</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The cell cycle is an evolutionarily conserved process necessary for mammalian cell growth and development.  Because cell-cycle aberrations are a hallmark of cancer, this process has been the target of anti-cancer therapeutics for decades.  However, despite numerous clin. trials, cell-cycle-targeting agents have generally failed in the clinic.  This review briefly examines past cell-cycle-targeted therapeutics and outlines how experience with these agents has provided valuable insight to refine and improve anti-mitotic strategies.  An overview of emerging anti-mitotic approaches with promising pre-clin. results is provided, and the concept of exploiting the genomic instability of tumor cells through therapeutic inhibition of mitotic checkpoints is discussed.  We believe this strategy has a high likelihood of success given its potential to enhance therapeutic index by targeting tumor-specific vulnerabilities.  This reasoning stimulated our development of novel inhibitors targeting the crit. regulators of genomic stability and the mitotic checkpoint: AURKA, PLK4, and Mps1/TTK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr5RAGZ9XTCLVg90H21EOLACvtfcHk0ljC0u8E5PY9mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVyqtbrJ&md5=3f4b6d0a92a2ea8c1ef0b7c0b5824b2d</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2015.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2015.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DDominguez-Brauer%26aufirst%3DC.%26aulast%3DThu%26aufirst%3DK.%2BL.%26aulast%3DMason%26aufirst%3DJ.%2BM.%26aulast%3DBlaser%26aufirst%3DH.%26aulast%3DBray%26aufirst%3DM.%2BR.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DTargeting%2520mitosis%2520in%2520cancer%253A%2520emerging%2520strategies%26jtitle%3DMol.%2520Cell%26date%3D2015%26volume%3D60%26spage%3D524%26epage%3D536%26doi%3D10.1016%2Fj.molcel.2015.11.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okita, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamakawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amano, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goshima, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamanaka, S.</span></span> <span> </span><span class="NLM_article-title">An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells</span>. <i>Stem Cells</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">458</span>– <span class="NLM_lpage">466</span>, <span class="refDoi"> DOI: 10.1002/stem.1293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1002%2Fstem.1293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=23193063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksFWqtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=458-466&author=K.+Okitaauthor=T.+Yamakawaauthor=Y.+Matsumuraauthor=Y.+Satoauthor=N.+Amanoauthor=A.+Watanabeauthor=N.+Goshimaauthor=S.+Yamanaka&title=An+efficient+nonviral+method+to+generate+integration-free+human-induced+pluripotent+stem+cells+from+cord+blood+and+peripheral+blood+cells&doi=10.1002%2Fstem.1293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells</span></div><div class="casAuthors">Okita, Keisuke; Yamakawa, Tatsuya; Matsumura, Yasuko; Sato, Yoshiko; Amano, Naoki; Watanabe, Akira; Goshima, Naoki; Yamanaka, Shinya</div><div class="citationInfo"><span class="NLM_cas:title">Stem Cells (Durham, NC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">458-466</span>CODEN:
                <span class="NLM_cas:coden">STCEEJ</span>;
        ISSN:<span class="NLM_cas:issn">1066-5099</span>.
    
            (<span class="NLM_cas:orgname">AlphaMed Press</span>)
        </div><div class="casAbstract">The generation of induced pluripotent stem cells (iPSCs) provides the opportunity to use patient-specific somatic cells, which are a valuable source for disease modeling and drug discovery.  To promote research involving these cells, it is important to make iPSCs from easily accessible and less invasive tissues, like blood.  We have recently reported the efficient generation of human iPSCs from adult fibroblasts using a combination of plasmids encoding OCT3/4, SOX2, KLF4, L-MYC, LIN28, and shRNA for TP53.  We herein report a modified protocol enabling efficient iPSC induction from CD34+ cord blood cells and from peripheral blood isolated from healthy donors using these plasmid vectors.  The original plasmid mixt. could induce iPSCs; however, the efficiency was low.  The addn. of EBNA1, an essential factor for episomal amplification of the vectors, by an extra plasmid greatly increased the efficiency of iPSC induction, esp. when the induction was performed from αβT cells.  This improvement enabled the establishment of blood-derived iPSCs from seven healthy donors ranging in age from their 20s to their 60s.  This induction method will be useful for the derivation of patient-specific integration-free iPSCs and would also be applicable to the generation of clin.-grade iPSCs in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm06NKan_SNbVg90H21EOLACvtfcHk0ljC0u8E5PY9mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksFWqtLk%253D&md5=3c38a6bbb47c7f00d32936ed40a5fdec</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fstem.1293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fstem.1293%26sid%3Dliteratum%253Aachs%26aulast%3DOkita%26aufirst%3DK.%26aulast%3DYamakawa%26aufirst%3DT.%26aulast%3DMatsumura%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DAmano%26aufirst%3DN.%26aulast%3DWatanabe%26aufirst%3DA.%26aulast%3DGoshima%26aufirst%3DN.%26aulast%3DYamanaka%26aufirst%3DS.%26atitle%3DAn%2520efficient%2520nonviral%2520method%2520to%2520generate%2520integration-free%2520human-induced%2520pluripotent%2520stem%2520cells%2520from%2520cord%2520blood%2520and%2520peripheral%2520blood%2520cells%26jtitle%3DStem%2520Cells%26date%3D2013%26volume%3D31%26spage%3D458%26epage%3D466%26doi%3D10.1002%2Fstem.1293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takizawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichisaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morizane, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishizawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyoda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osafune, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sekiguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamanaka, S.</span></span> <span> </span><span class="NLM_article-title">A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">3594</span>, <span class="refDoi"> DOI: 10.1038/srep03594</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1038%2Fsrep03594" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=24399248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A280%3ADC%252BC2czivVeksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=3594&author=M.+Nakagawaauthor=Y.+Taniguchiauthor=S.+Sendaauthor=N.+Takizawaauthor=T.+Ichisakaauthor=K.+Asanoauthor=A.+Morizaneauthor=D.+Doiauthor=J.+Takahashiauthor=M.+Nishizawaauthor=Y.+Yoshidaauthor=T.+Toyodaauthor=K.+Osafuneauthor=K.+Sekiguchiauthor=S.+Yamanaka&title=A+novel+efficient+feeder-free+culture+system+for+the+derivation+of+human+induced+pluripotent+stem+cells&doi=10.1038%2Fsrep03594"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells</span></div><div class="casAuthors">Nakagawa Masato; Takizawa Nanako; Ichisaka Tomoko; Asano Kanako; Morizane Asuka; Doi Daisuke; Takahashi Jun; Nishizawa Masatoshi; Yoshida Yoshinori; Toyoda Taro; Osafune Kenji; Taniguchi Yukimasa; Sekiguchi Kiyotoshi; Senda Sho; Yamanaka Shinya</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3594</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In order to apply human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) to regenerative medicine, the cells should be produced under restricted conditions conforming to GMP guidelines.  Since the conventional culture system has some issues that need to be addressed to achieve this goal, we developed a novel culture system.  We found that recombinant laminin-511 E8 fragments are useful matrices for maintaining hESCs and hiPSCs when used in combination with a completely xeno-free (Xf) medium, StemFit®.  Using this system, hESCs and hiPSCs can be easily and stably passaged by dissociating the cells into single cells for long periods, without any karyotype abnormalities.  Human iPSCs could be generated under feeder-free (Ff) and Xf culture systems from human primary fibroblasts and blood cells, and they possessed differentiation abilities.  These results indicate that hiPSCs can be generated and maintained under this novel Ff and Xf culture system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS-Kp3h4bu0WUQ0lWbKiCflfW6udTcc2eZHe8MhmVeYpLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2czivVeksQ%253D%253D&md5=4c7945358bb242a13783bc10cc649482</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fsrep03594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep03594%26sid%3Dliteratum%253Aachs%26aulast%3DNakagawa%26aufirst%3DM.%26aulast%3DTaniguchi%26aufirst%3DY.%26aulast%3DSenda%26aufirst%3DS.%26aulast%3DTakizawa%26aufirst%3DN.%26aulast%3DIchisaka%26aufirst%3DT.%26aulast%3DAsano%26aufirst%3DK.%26aulast%3DMorizane%26aufirst%3DA.%26aulast%3DDoi%26aufirst%3DD.%26aulast%3DTakahashi%26aufirst%3DJ.%26aulast%3DNishizawa%26aufirst%3DM.%26aulast%3DYoshida%26aufirst%3DY.%26aulast%3DToyoda%26aufirst%3DT.%26aulast%3DOsafune%26aufirst%3DK.%26aulast%3DSekiguchi%26aufirst%3DK.%26aulast%3DYamanaka%26aufirst%3DS.%26atitle%3DA%2520novel%2520efficient%2520feeder-free%2520culture%2520system%2520for%2520the%2520derivation%2520of%2520human%2520induced%2520pluripotent%2520stem%2520cells%26jtitle%3DSci.%2520Rep.%26date%3D2014%26volume%3D4%26spage%3D3594%26doi%3D10.1038%2Fsrep03594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uchimura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otomo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, H.</span></span> <span> </span><span class="NLM_article-title">A human iPS cell myogenic differentiation system permitting high-throughput drug screening</span>. <i>Stem Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">98</span>– <span class="NLM_lpage">106</span>, <span class="refDoi"> DOI: 10.1016/j.scr.2017.10.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=10.1016%2Fj.scr.2017.10.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=29125995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslyksL7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=98-106&author=T.+Uchimuraauthor=J.+Otomoauthor=M.+Satoauthor=H.+Sakurai&title=A+human+iPS+cell+myogenic+differentiation+system+permitting+high-throughput+drug+screening&doi=10.1016%2Fj.scr.2017.10.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A human iPS cell myogenic differentiation system permitting high-throughput drug screening</span></div><div class="casAuthors">Uchimura, Tomoya; Otomo, Jun; Sato, Masae; Sakurai, Hidetoshi</div><div class="citationInfo"><span class="NLM_cas:title">Stem Cell Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">98-106</span>CODEN:
                <span class="NLM_cas:coden">SCRTDJ</span>;
        ISSN:<span class="NLM_cas:issn">1873-5061</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Muscular dystrophy is a disease characterized by progressive muscle weakness and degeneration.  There are currently no available treatments for most muscular diseases, such as muscular dystrophy.  Moreover, current therapeutics are focused on improving the quality of life of patients by relieving the symptoms or stress caused by the disease.  Although the causative genes for many muscular diseases have been identified, the mechanisms underlying their pathogenesis remain unclear.  Patient-derived induced pluripotent stem cells (iPSCs) have become a powerful tool for understanding the pathogenesis of intractable diseases, as well as for phenotype screening, which can serve as the basis for developing new drugs.  However, it is necessary to develop an efficient and reproducible myogenic differentiation system.  Previously, we reported a tetracycline-inducible MyoD overexpression model of myogenic differentiation using human iPSCs (hiPSCs).  However, this model has certain disadvantages that limit its use in various applications, such as a drug screening.  In this study, we developed an efficient and reproducible myogenic differentiation system by further modifying our previous protocol.  The new protocol achieves efficient differentiation of feeder-free hiPSCs to myogenic cells via small-scale culture in six-well microplates to large-scale culture in 384-well microplates for high-throughput applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqREjRCcfo_fbVg90H21EOLACvtfcHk0lhDqICG9IqOtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslyksL7P&md5=e03af6a36fa0d931f92ecf20cde2befb</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.scr.2017.10.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.scr.2017.10.023%26sid%3Dliteratum%253Aachs%26aulast%3DUchimura%26aufirst%3DT.%26aulast%3DOtomo%26aufirst%3DJ.%26aulast%3DSato%26aufirst%3DM.%26aulast%3DSakurai%26aufirst%3DH.%26atitle%3DA%2520human%2520iPS%2520cell%2520myogenic%2520differentiation%2520system%2520permitting%2520high-throughput%2520drug%2520screening%26jtitle%3DStem%2520Cell%2520Res.%26date%3D2017%26volume%3D25%26spage%3D98%26epage%3D106%26doi%3D10.1016%2Fj.scr.2017.10.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5CA1" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5CA1','PDB','5CA1'); return false;">PDB: 5CA1</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i80"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01100">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_07728"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b01100">10.1021/acs.jmedchem.9b01100</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">The structure, EC<sub>150</sub> value, and MEC value of compounds tested in the tubulin depolymerization assay, preparation of compounds S1–S6, and results of TR-FRET based competitive binding assays against 337 kinases (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01100/suppl_file/jm9b01100_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01100/suppl_file/jm9b01100_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01100/suppl_file/jm9b01100_si_001.pdf">jm9b01100_si_001.pdf (747.97 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01100/suppl_file/jm9b01100_si_002.csv">jm9b01100_si_002.csv (1.96 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01100&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01100%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-20%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01100" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799603f398c3d94","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
